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Part I 
 
 
 
Khd1p involved in ASH1 mRNA biology? 
 
 
 1. INTRODUCTION 
A cell is the most basic unit of life. When a cell divides, it gives rise to two exactly like it, or so we 
were told during our basic biological studies. Later, we began to understand that this is not always 
the case, specially during development. A central issue in developmental biology is to explain the 
ability of a mother cell to divide into two daughter cells with different cell fates.  These different 
cell fates are determined by different activated genetic programs. Differences in gene expression 
can be determined by the environment (external stimuli), or even by differential segregation of cell 
fate determinants. mRNA localization and asymmetric cell division are two mechanisms that to 
achieve this goal. Certain cell fate determinants are sorted onto different sister cells (reviewed Du et 
al., 2007). One of the most important events in this process deals with the timing of expression. The 
onset of protein synthesis needs to occur at the right time and this will also mean at the right place. 
Proposedly, intracellular trafficking of a cell fate determinant is coupled to its translation repression 
and upon arrival at the destination, this repression is removed and the cell fate determinant 
expressed, thus creating a cell with a different cell fate (Farina and Singer, 2002; St. Johnston, 
2005). 
The process of mRNA localization plays an instrumental role in development of the fruit-fly, 
Drosophila melanogaster. For example the determination of the embryonic axes occurs by the 
cytoplasmic localization and local translation of specific maternally derived mRNAs within the 
oocyte. Segmentation is also a process that involves mRNA localization and spatially defined 
protein expression (reviewed in Johnstone and Lasko, 2001; Riechmann and Ephrussi, 2001; St 
Johnston, 2005). Although it is a conserved processed throughout evolution per se, the mechanisms 
and the implications of this localization and spatial organization can be quite different. 
mRNA localization is also a very important mechanism in determining cell polarity and polarized 
growth (Farina and Singer, 2002; Farina et al., 2003; Zarnack and Feldbruegge, 2007). 
  
1.1 Mechanisms of mRNA localization 
Intracellular mRNA localization is a widespread mechanism in the eukarya domain (St. Johnston, 
2005). Although the list of known localized messages is ever increasing, the mechanisms are 
somewhat conserved. They range from directional mRNA export from the nucleus, general 
degradation and selective spatial and localized protection, diffusion coupled to specific retention 
and motor-protein driven directed cargo transport along the cytoskeleton. Examples of these 
mechanisms include: i, the localization of the nanos mRNA in Drosophila melanogaster, stabilized 
 by the localized binding of Smaug and destabilized and degraded everywhere else in the embryo (St 
Johnston et al., 1992; Rongo et al., 1995; Jeske et al., 2006) or the localization of prospero and 
numb to the basal pole of the neuroblasts by ubiquitylation and destruction of Miranda (Slack et al., 
2007), ii, targeting of Vg1 mRNA to the vegetal pole of Xenopus laevis oocytes dependent on both 
actin and microtubules (Yisraeli et al., 1990; Alarcon and Elinson, 2001), iii, microtubule 
dependent directed transport of bicoid mRNA (Pokrywka and Stephenson, 1991; Schnoerrer et al., 
2000; reviewed in Saxton, 2001). Recently, bicoid mRNA localization was linked to endosomal and 
vesicle trafficking (Irion and St. Johnston, 2007). The role of the cytoskeleton in mRNA 
localization process is still poorly characterized, but in recent years several well defined examples 
have been studied and it is not unlikely that the cytoskeleton is the driver of the mRNA localization 
process. 
 
1.2 Conceptual Mechanism of cytoplasmic mRNA localization by active transport 
During transcription the nascent transcript is processed to mRNA and packed to an export-
competent ribonucleoprotein complex, an mRNP. This complex, once reaching the cytoplasm is 
recognized by the transport machinery that mediates the delivery to a defined destination. Having 
reached the final cellular address, the mRNA becomes effectively retained and concentrated at this 
location. 
 
1.3 From the birth of a transcript to nuclear export of a mature mRNA 
As the RNA polymerase II transcribes the genes into RNA, several factors, from splicing factors to 
export factors, are loaded onto the RNA making it export competent. For a localized mRNA, one 
supposes that a signal, supposedly a protein, is also loaded onto this mRNP so that it can be 
differentiated from the bulk mRNP particles that are not localized. This sorting is believed to take 
place early in the maturation process. This maturation process is characterized by the sequential 
deposition and removal of several heteregeneous nuclear ribo-nucleoproteins (hnRNP). Some 
hnRNPs are restricted to the nucleus, whereas others escort the RNA during nuclear export and 
remain associated until correctly localized in the cytoplasm (Hoek et al., 1998; reviewed in 
Aguilera et al., 2005; Hieronymus and Silver, 2004). One function for hnRNPs is to provide the 
nascent RNAs a signal for a specific location. It is conceivable that this latter hnRNP is responsible 
for the translation repression of the moving particle, mechanism that ensures the proper localization 
of the protein, only after the mRNA has been localized (Farina and Singer, 2002). For example, 
 hnRNP A2 binds to myelin basic protein (MBP) mRNA. This mRNA localizes to the distal ends of 
dendrites of oligodendrocytes (Hoek et al., 1998). Another example is the Fragile X sindrome, 
caused by loss of function of FMR1, a protein with 2 KH-domains that binds to polyribosomes and 
to a few hundreds mRNAs, thus shaping synaptical activity by on-off translation regulation of 
synaptic localized mRNAs such as MAP1, CaMKII and others (Zalfa et al., 2003; Brown et al., 
2001; Reviewed in Kaytor and Orr, 2001). In addition, dFMR, the Drosophila homolog of FMRP, 
may act as a translational repressor of futsch, the homolog of MAP1B (Zhang et al., 2001).  
Maturation of a nascent transcript into mRNA includes several co-transcriptional processes, such as 
5'-capping, splicing and 3'end processing. The cap-binding complex binds to the 5' monomethylated 
cap structure, the exon junction complex marks the religated splice-sites and poly(A) binding 
protein binds the already processed 3' poly(A) tail. As any properly processed and matured mRNA 
will eventually lead to a protein and will then exert a function, this process of maturation has 
safeguards, to ensure that the mRNA produced is correctly capped, spliced and rejoined, and 
polyadenylated. Transcripts that lack this correct processing are retained at the nuclear periphery 
(Jensen et al., 2003; Galy et al., 2004) and are not exported, becoming then targets for the nuclear 
exosome (Saguez et al., 2005). 
The sequential maturation process indicates that the machinery involved is not only functionally but 
also physically linked. Increasing evidence point to the existence of mRNA factories (Iborra et al., 
1996; Szentirmay and Sawadogo, 2000) or large protein assemblies that are connected by a set of 
adaptor proteins such as Npl3p, Sub2p or Yra1p (Lei et al., 2001; Erkmann and Kutay, 2004; Stutz 
and Izaurralde, 2003; Stewart, 2007) that ensure the swift maturation of mRNAs. 
 
1.4 Reaching the cytoplasm 
The mature mRNA upon reaching the cytoplasm changes its protein inventory, as several factors 
are released and re-enter the nucleus whereas others, cytoplasmic RNA-binding factors and the 
translation machinery, bind to the mature mRNA. This mRNA undergoes the first round of 
translation, circularizes and could then be sorted and loaded onto specialized ribosomes, as has been 
proposed for ASH1 mRNA in budding yeast (Komili et al., 2007). It can be translated immediately 
into protein, be targeted to the proper organelle (Corral-Debrinsky et al., 2000; Marc et al., 2002; 
Margeot et al., 2003) or even be localized via the cytoskeleton to a specific intracellular destination 
and only then become translated, as has been shown for several mRNAs in different organisms, 
being ASH1 mRNA in budding yeast (Paquin et al., 2007; Deng et al., 2008) and nanos mRNA in 
fruitfly (Gavis and Lehmann 1994) just two examples. Another example involves localized 
 destruction of a protein complex and its cargo. One such example is Miranda assymetrical basal 
localization in neuroblast. Miranda is ubiquitylated via its C-terminal domain; removal of this 
domain disrupts Miranda localisation and replacement of this domain with a ubiquitin moiety 
restores normal asymmetric Miranda localisation. These results demonstrate that APC/C activity 
and ubiquitylation of Miranda, in a proteasomal-independent process, are required for the 
asymmetric localisation of Miranda and its cargo proteins to the NB cortex (Slack et al., 2007). 
These movements in the cytoplasm can occur either just by diffusion or by active cytoskeletal-
dependent transport. Whenever the cytoskeleton is involved a reorganization of the microtubules or 
actin cables has to occur and polarization must take place. The existence of mutants that fail to 
polarize or displace cargo and thus fail also to localize mRNAs to their destinations has proven the 
essential nature of the cytoskeleton on mRNA localization. 
 
1.5 mRNPs travelling along the cytoskeleton 
Directed mRNA transport within the cytoplasm is generally mediated through the interaction of 
trans-acting factors, the localization machinery, with some or several localization element(s), or 
“zipcodes” (Kislauskis and Singer, 1992), present within the mRNA sequence (Chartrand et al., 
2002; Jambhekar and DeRisi, 2007). In most cases the localization elements are located within the 
3'-untranslated region, 3'UTR, of the mRNA (for review see Bashirullah et al., 1998; reviewed in 
Jambhekar and DeRisi, 2007). Most zipcodes are characterized by extended secondary structure 
elements like stems, bulges, loops and hairpins (Jambhekar et al., 2005; Olivier et al., 2005). This 
suggests that it is the secondary structure rather than the primary sequence that confers the RNA-
protein specificity. (reviewed in Jambhekar and DeRisi, 2007). 
The minimal localization complex is thought to include the mRNA bound by its zipcode to a RNA 
binding protein, an adaptor and a motor protein. 
In Drosophila it has been hinted that bicoid mRNA is linked to cytoplasmic dynein via the zipcode-
binding protein Swallow, being the adaptor protein the dynein light chain (Schnoerrer et al., 2000; 
Arn et al., 2003). In addition, bicoid mRNA has also been shown to be bound by Staufen, which is 
necessary but not sufficient for proper targetting of bicoid mRNA to the anterior pole of the embryo 
(Ferrandon et al., 1997; Snee et al., 2005). Recently, oskar mRNA/Staufen complexes were shown 
to be linked to bicoid mRNA localization via Miranda protein (Irion et al., 2006). Miranda has been 
shown to bind Staufen in neuroblasts and ganglion mother cells, ensuring assymetrical distribution 
of numb and prospero mRNAs in neuroblast-ganglion mother cells cellular division, thus assisting 
in proper brain development (Schuldt et al., 1998). The observation that Miranda is ubiquitylated 
 (Slack et al., 2007) indicates that coupled to the positive and directed transport a localized 
protection could also contribute to oskar and bicoid Staufen based mRNA localization. 
In Xenopus laevis, a set of mRNAs are localized to the vegetal pole. These include the Vg1, Xvelo 
(Claussen and Pieler, 2004), Xlsirt (Allen et al., 2003), XNIF (Claussen et al., 2004), Xcat2 (Zhou 
and King, 1996) and fatvg (Chan et al., 1999). Targeting of Vg1 mRNA to the vegetal pole of 
Xenopus laevis oocytes is dependent on both actin and microtubules (Yisraeli et al., 1990; Alarcon 
and Elinson, 2001). 
 
1.5.1 Role of the cytoskeleton 
Cytoplasmic mRNA transport has been described in a range of organisms, although the distance of 
transport can vary greatly, from extremely long in oocytes and neurons to relatively short in 
fibroblasts and yeast. Since cytoskeletal requirements can be determined with the help of drugs that 
either specifically depolymerize microfilaments or microtubules, long range transport has been 
associated to microtubules whereas short range transport to actin microfilaments (Nasmyth and 
Jansen, 1997). As an example, the localization of MBP mRNA in oligodendrocytes requires an 
intact microtubule cytoskeleton (Carson et al., 1997), whereas targeting of β-actin mRNA to the 
leading edge in chicken fibroblasts requires microfilaments (Sundell and Singer, 1991). 
Coupled to the selection of the type of cytoskeleton is the selection of the type of motor. In case of 
microtubule directed movement, two types of motors are associated, dynein, for minus-end directed 
movement as in bicoid, gurken and wingless mRNA localization (Januschke et al., 2002b; 
MacDougall et al., 2003; Delnaoue and Davis, 2005; Clark et al., 2007) and kinesin, for plus-end 
directed movement as in oskar mRNA localization (Brendza et al., 2000; Januschke et al., 2002a; 
Arn et al., 2003). In the case of actin filaments, myosin is the associated molecular motor (e.g. 
ASH1 mRNA localization). So, coupled to the sort of cytoskeletal structure involved in mRNP 
transport, a specific type of motor can be found. 
 
1.5.2 Role of the molecular motor binding adaptor proteins in determining cargo 
specificity 
RNA is not the only cargo that is actively transported. It is generally assumed that different loads 
encompass different adaptor proteins, bound to the motor proteins (reviewed by Bretscher, 2003). 
In budding yeast, Myo2p has been implicated in numerous bud directed targetting processes, such 
as organelle inheritance, vesicle transport (Govindan et al., 1995) or even mitotic spindle 
 orientation (Yin et al., 2000). Cargo differentiation is a crucial event to the sorting of the 
localization of the load. The Myo2p motor, for example, has a wide variety of adaptor proteins, one 
for each cargo, which become tethered to separable cargo-binding regions within the Myo2p 
globular tail. Vacuole sorting involves adaptor proteins Vac17p/Vac8p (Catlett et al., 2000; Tang et 
al., 2003; Ishikawa et al., 2003), transport of secretory vesicles involves Sec4p (Pruyne et al., 1998; 
Schott et al., 1999), and segregation of mitochondria requires Ypt11p (Itoh et al., 2002). Sec4p and 
Ypt11p are organelle-binding specific Rab proteins with intrinsec GTPase activity that are located 
on the transported organelle membrane.  
In yeast Sec4p has been shown to be targeted to the incipient bud site and this has been shown to be 
dependent on ER inheritance factors, such as Sec3p (Aronov et al., 2007). Endoplasmic reticulum 
inheritance in yeast has been shown to require She3p and Myo4p (Estrada et al., 2003). Both are 
required for cortical ER retention at the bud and contribute with Sec3 and other proteins to achieve 
proper ER inheritance (Aronov et al., 2007). Interestingly, She3p and Myo4p have also been shown 
to involved in She2p-mRNP cargo transport (Boehl et al., 2000; Schmid et al., 2006), indicating 
that mRNA localization and ER inheritance are intimately linked. Evidence for this linkage is also 
the observation that Xenopus laevis Vg1 mRNA is localized to the vegetal pole by VgRBP/VERA, 
an ER associated protein (Dresher et al., 1997). 
 
1.6 Reaching the destination 
In order to allow the concentration of a specific transcript against the diffusion gradient, it is 
generally assumed that an anchorage mechanism exists at the target site, thus preventing the mRNA 
to diffuse away from the delivery site. The mechanisms underlying  this process are still poorly 
understood. One can imagine that the cargo, upon reaching the destination has to be handed over 
from the transport machinery to the molecular anchor and there be retained. After delivery, 
recycling back to the nuclear envelope of some components must occur whereas other components 
will remain associated to the mRNP. 
At the anchoring site, perhaps with the help of RNA helicases, the mRNA is unraveled into a more 
accessible form that facilitates ribosome recruitment and the onset of protein synthesis. This event 
is normally described as local translation, coupling mRNA localization with protein synthesis. It is 
conceivable that the translation process itself can trigger the anchorage of a localized mRNA. In 
yeast, ASH1 mRNA localization has been shown to require translation (Gonzalez et al., 1999; 
Paquin et al., 2007; Deng et al., 2008). Furthermore, recently it has been reported that the ASH1 
mRNA particle travels with Endoplasmic Reticulum (ER) tubules to the bud tip (Schmid et al., 
 2006). The fact that the ribosomes are intrinsically a part of the localizing mRNP seems to 
strengthen the concept that it is translation itself that triggers the anchorage. The onset of ASH1 
mRNA translation has been proposed to occur upon removal of the translation repressor, Khd1p, 
due to phosphorylation by Yck1p (Paquin et al., 2007). Similarly, another translation repressor, 
Puf6p has also been shown to act on ASH1 mRNA localization and after phosphorylation by Yck2p, 
releasing the translation block (Deng et al., 2008). 
Similarly, in fruit flies oskar mRNA localization depends on local synthesis of Oskar protein 
(Rongo et al,, 1995). 
In addition to polyribosome mediated retention, mRNAs can be anchored by other mRNAs, due to 
complementary base pairing or by other RNA-binding proteins. Such is the case for Xlsirts RNA, a 
short non protein coding RNA from Xenopus laevis oocytes that is required for Vg1 mRNA 
anchorage at the vegetal pole (Kloc and Etkin, 1994). In Drosophila oocytes, the double stranded 
RNA binding protein Staufen anchors both oskar mRNA to the posterior pole (Ephrussi et al., 
1991; Rongo et al., 1995) and bicoid mRNA to the anterior pole (St Johnston et al., 1992; 
Ferrandon et al., 1997; Snee et al., 2005). Anterior Miranda localization requires microtubules, 
rather than actin, and depends on the function of Exuperantia and Swallow, indicating that Miranda 
links Staufen/oskar mRNA complexes to the bicoid mRNA localization pathway (Irion et al., 
2006). 
For some transcripts the cytoskeleton has been proposed to play a role not only in their transport but 
also in their anchorage. The most clear example is the localization of Vg1 mRNA. While the 
cytoplasmic transport process requires microtubules, the cortical anchorage seems to depend on a 
network of actin filaments and cytokeratin (Yisraeli et al., 1990; Alarcon and Elinson, 2001).  This 
mRNA is bound by VgRBP/VERA (Deshler et al., 1997) and this protein has been shown to be 
bound to the ER, indicating that in this organism mRNA transport can be linked to organelle 
trafficking as has been proposed for ASH1 mRNA in budding yeast (Schmid et al., 2006). 
 
1.7 mRNA Localization in S. cerevisiae 
In budding yeast mRNA localization is an important regulatory process aswell. In this organism, a 
set of mRNAs is actively transported into the tip of growing buds, by a set of proteins, the SHE 
machinery (Jansen et al., 1996; Boehl et al., 2000; Long et al., 2000). These SHE-proteins were 
identified in a screen designed to detect mutants that failed to generate asymmetric HO expression, 
an indicator of efficient ASH1 mRNA localization. The set of mRNAs, that are actively transported 
to the bud-tip in a SHE-dependent manner, encode proteins that are restricted to daughter cells (e.g. 
 Ash1p), bud-enriched (e.g. Ist2p) or equally distributed (e.g. Tpo1p) (Shepard et al., 2003). After 
bud localization and once translated, these proteins cannot freely diffuse back between mother and 
daughter cell, equilibrating the protein concentration between the two compartments, since this 
diffusion is prevented by the formation of the septin ring (Kozubowski et al., 2005). The fact that 
only in the case of ASH1 a clear correlation between RNA and protein localization occurs, shows 
that the underlying biological significance of this SHE-dependent localization process is still 
unclear. In addition, it has been suggested that SHE-dependent mRNA localization is not anaphase 
restricted (as in ASH1) and can take place independently of the cell cycle (Long et al., 1997). 
Recently, SHE dependent mRNA localization of polarized growth determinants was uncovered 
(Aronov et al., 2007). SEC4, CDC42 mRNAs that encode membrane associated cell polarization 
factors are localized to the incipient bud site prior to nuclear division in an mRNA transport 
independent manner but SRO7 mRNA, encoding a non-anchored cell polarization factor is targeted 
in an mRNA transport dependent manner to the incipient bud site, prior to nuclear division, leading 
to local protein synthesis and enrichment. This work showed that this process, that relies on 
functional cortical ER inheritance, is Sec3p and She2p dependent, indicating that cortical ER 
inheritance and mRNA localization via She2p are both required for cell polarity establishment. 
mRNA localization in yeast can also be SHE-independent, as observed for the targeting of mRNAs 
encoding a subset of mitochondrial proteins to polysomes located directly at the organelle surface 
(Corral-Debrinsky et al., 2000; Marc et al., 2002; Margeot et al., 2003; Aronov et al., 2007; Saint-
Georges et al., 2008). At this moment it is still unclear if a conserved mitochondria targeting 
sequence exists at the nucleotide level or if on the other hand, a mitochondria peptide signal really 
exists. 
 
1.8 ASH1 mRNA localization 
Budding yeast alternates between a diploid cell division cycle and, under conditions of nutrient 
deprivation, an haploid cell division cycle. The mating of two haploid cells with opposing mating 
type (a and alpha) leads to a diploid cell. Upon budding a mother cell and a daughter cell are 
generated. Mother cells are capable of switching their mating type, while daughter cells are not. 
Mating type switching is regulated by HO endonuclease (Nasmyth et al., 1993), a protein that is 
expressed only in mother cells. HO initiates a genomic rearrangement of the MAT locus, converting 
it from a to alpha or vice versa. In daughter cells the expression of HO is repressed by Ash1p 
(asymmetric synthesis of HO), which is asymmetrically distributed to daughter cell nuclei (Bobola 
et al., 1996; Sil and Herskowitz, 1996; Cosma et al., 1999; Maxon and Herskowitz, 2001). This 
 asymmetric sorting of Ash1p to the daughter cell nuclei correlates with the localization of ASH1 
mRNA to the distal tip of daughter cells during the anaphase stage of cell cycle (Long et al., 1997; 
Takizawa et al., 1997). Ash1p serves a model for studying asymmetric segregation of cell fate 
determinants due to mRNA localization (reviewed in Darzacq et al., 2003). 
ASH1 is only transcribed in anaphase (Bobola et al., 1996; Spellman et al., 1998). Ash1p is not only 
recruited to the HO promoter but also interacts with SGA1 and PCL1 promoters, two loci implicated 
in sporulation and cell cycle control (Lee et al., 2002). Pcl1p is one of the cyclins of the Pho85p 
kinase complex (McBride et al., 2001). Deletion of pho85 leads to a stabilization of Ash1p, so that 
its activity persists in the daughter cell during the cell cycle and thus represses mating type 
switching in the following cell division. 
 
Fig. 1 – Schematic view of ASH1 mRNA, showing the localization elements E1 (598-750), 
E2A(1044-1196), E2B(1175-1447) and E3(1752-1870). 
 
1.9 ASH1 mRNA 
Four zipcode elements (Fig. 1) have been described as essential for transport and for tight 
anchorage at the bud tip cortex, namely E1, E2A, E2B and E3 (Chartrand et al., 1999; Chartrand et 
al., 2002). Of these elements, three are located in the coding region and one, the E3, spans from the 
end of the open reading frame into the 3'UTR. Secondary structure prediction of these elements 
suggest that all ASH1 zipcodes form extensive stem-loops and bulges (Chartrand et al., 1999; 
Gonzalez et al., 1999; Chartrand et al., 2002; Olivier et al., 2005; Jambhekar et al., 2005). The 
disruption of these structures destroys the ability to direct mRNA localization and the ability to be 
bound by She2p (Olivier et al., 2005). In addition, the integrity of the E3 element is essential for the 
binding of She2p (Boehl et al., 2000; Long et al., 2000). Although one element alone was shown to 
be sufficient for localization into the bud (Long et al., 1997; Takizawa et al., 1997; Bertrand et al., 
1998), all four have been proven to be essential for tight anchoring at the bud tip (Chartrand et al., 
2002). These secondary structured localization elements, not only serve as binding sites for trans-
acting localization factors, such as She2p and Khd1p, but also seem to act as molecular obstacles, 
slowing down protein synthesis (Chartrand et al., 2002). It has been suggested that this molecular 
 translation delay contributes to achieve a proper Ash1p asymmetry. Another contributing 
observation to strengthen the idea that translation plays a role in ASH1 mRNA localization, was the 
fact that the presence of premature termination codons (PTC) prior to each of the zipcodes showed 
no decreased mRNA stability although showing a severe impairment in mRNA localization 
(Jaedicke A., PhD Thesis, 2004). 
 
1.10 Translation Regulation 
The local enrichment of an mRNA can lead to a higher concentration of the encoded protein at a 
specific location. Therefore, the cell has to have developped mechanisms by which the localizing 
mRNA is not translated before reaching its final destination. This forces a closer look at how 
translation of a localizing mRNP can be regulated. Not only can translation be regulated at the 
maturation of the ribosome, at the translation initiation step and at ribosomal subunit joining, but 
also, and most likely, translation can also be regulated by the removal of a translation repressor 
from the localizing mRNP. 
The observation that the presence of premature stop codons prior to any of the zipcodes does not 
elicit NMD but severely impairs localization and achoring (Jaedicke, PhD Thesis 2004) seems to 
point to a role for the initial round of translation in the mRNA localization event. Furthermore, 
cycloheximide treatment of yeast cells, that blocks translation elongation leads to a loss of mRNA 
localization (Jaedicke, PhD Thesis 2004) and it has been shown that its own translation is required 
for proper anchoring of the localizing ASH1 mRNA (Gonzalez et al., 1999). 
A recent example suggested that ASH1 mRNA travels to the bud tip in a SHE-machinery dependent 
manner, in an mRNP and that upon reaching its destination Khd1p, a protein that binds the E1 
element of ASH1 mRNA, is phosphorylated by Yck1p, a kinase at the plasma membrane, and 
releases the ASH1 mRNA translation block (Paquin et al., 2007). Furthermore, Puf6p has also been 
shown to be an ASH1 mRNA translational repressor (Gu et al., 2004). Puf6p was shown to bind the 
E3 element of ASH1 mRNA (Gu et al., 2004) and repress its translation by interacting with 
Fun12p/eIF5B (Deng et al., 2008). This interaction was abolished and ASH1 mRNA was translated 
upon Puf6p phosphorylation by Yck2p (Deng et al., 2008). This model of translational repression of 
the localizing mRNA and translation block release upon reaching the final destination is consistent 
with other observations for other mRNPs in higher eukaryotes, as already discussed. 
 
 1.11 The core localization machinery 
The motor protein that mediates the active transport of the SHE mRNP is Myo4p (Jansen et al., 
1996, Muenchow et al., 1999). Myo4p is a non-muscle myosin, that belongs to the class V myosins, 
where the only other member is a protein 57% identical to Myo4p, Myo2p (Haarer et al., 1994). 
Although Myo2p is essential for growth (Johnston et al., 1991), Myo4p is not (Haarer et al., 1994). 
Both myosins localize to the bud tip during bud formation (Lillie and Brown, 1994; Schott et al., 
1999). Although it was previously assumed that Myo2p was only associated with organelle 
inheritance and Myo4p only with mRNA localization, recent publications show that Myo4p is also 
implicated in cortical ER inheritance (Estrada et al., 2003; Schmid et al., 2006). 
 
An interaction partner of Myo4p is She3p, acting as an adaptor protein between the mRNA binding 
protein She2p and the motor (Takizawa and Vale, 2000). More detailed analysis (Boehl et al., 2000; 
Long et al., 2000) have shown that Myo4p interacts with NH2-terminus of She3p. This interaction 
is a direct physical link and is a tight and permanent association (Boehl et al., 2000). 
In addition, gel-shift assays have demonstrated that She2p binding to an ASH1 zipcode element is 
specific and enhanced by She3p (Boehl et al., 2000), providing evidence for a stabilization or even 
a cooperative binding to the mRNA. 
 
She2p acts as a specific mRNA binding protein, that bridges ASH1 mRNA to the She3p carboxy-
terminus (Boehl et al., 2000; Long et al., 2000; Kwon and Schnapp, 2001). Although all four 
localization elements within ASH1 mRNA are contacted and needed for efficient localization and 
transport (Boehl et al., 2000; Chartrand et al., 2002; Olivier et al., 2005; Jambhekar et al., 2005; 
Reviewed in Jambhekar and Derisi, 2007), the affinity of She2p to these elements has been 
proposed to be different (Long et al., 2000; Niessing et al., 2004). Nevertheless, a combination of 
zipcode-swapping and site directed mutagenesis have demonstrated that the zipcodes are redundant 
in function in regard to mRNA localization (Chartrand et al., 2002). 
Despite the fact that the She2p primary sequence does not contain a canonical mRNA binding site, 
information taken from the cristallographic structure of She2p has revealed a region that can be 
responsible for its mRNA binding ability (Niessing et al., 2004). These regions include the COOH-
terminus, the NH2-terminus and a positively-charged surface region, that could bind negatively 
charged nucleic acids (Niessing et al., 2004). Although She2p is distributed uniformly throughout 
the cytoplasm (Jansen et al., 1996), upon ASH1 overexpression, She2p co-localizes together with 
ASH1 mRNA at the tip of growing buds (Boehl et al., 2000). Interestingly, upon mRNA export 
block, using a temperature sensitive MEX67 allele, She2p can be trapped in the nucleus and is 
 excluded from the cytoplasmic fraction (Kruse et al., 2002), indicating that it is a shuttling protein. 
 
Since Myo4p, She3p and She2p all co-localize with trafficking ASH1 mRNA containing particles 
(Takizawa and Vale, 2000; Irie et al., 2002) and co-immunoprecipitate with ASH1 mRNA 
(Muenchow et al., 1999; Takizawa and Vale, 2000), the three proteins are thought to be the core 
locasome, the minimal SHE RNP (Darzacq et al., 2003). Furthermore, She3p and Myo4p have been 
shown to co-localize with ASH1 mRNA in the cytoplasm on string-like filamentous structures 
(Muenchow et al., 1999), resembling transport intermediates. Other factors can be associated with 
this core locasome (reviewed in Paquin and Chartrand, 2007) either transiently, or associated but 
not required for transport. 
 
1.12 Accessory factors 
■LOC1 
The strictly nuclear protein Loc1p was isolated by 3-hybrid screening due to its ability to bind to 
ASH1 3' UTR (Long et al., 2001). In a loc1 disruption, the asymmetric distribution of both ASH1 
mRNA and Ash1p is affected. However, Loc1p has been identified as part of the 66S-pre-rRNA 
complex and been shown to be involved in 25S rRNA processing (Harnpicharnchai et al., 2001). Its 
function in assembly and export of 60S ribosomal subunit has been shown more recently (Urbinati 
et al., 2006),  Loc1p, due to its extremely high isoelectric point, binds unspecifically to double 
stranded RNA (Long et al., 2001). In addition, a loc1 disruption shows a severe slow growth 
phenotype at 30 degrees and an abnormal cell morphology (Long et al., 2001), typical for genes 
involved in ribosome synthesis pathways. Therefore, the connection of Loc1p to mRNA 
localization seems to be rather indirect and a reflex of a defect in ribosome biogenesis and protein 
synthesis. 
Recently however, it has been shown that Loc1p is instrumental in loading the ASH1 mRNA onto to 
a specific non-canonical ribosome that includes a special combination of ribosomal protein 
phenocopies (Komili et al., 2007). These non-canonical ribosomes are then localized to the bud tip, 
in a repressed state, taking with them ASH1 mRNA and are translationally activated once reaching 
the target site. 
 
 ■PUF6 
Another protein that has been shown to bind to the ASH1 3' UTR is Puf6p. This protein is a non 
canonical pumillio-related RNA binding protein and a Δpuf6 has been shown to make ASH1 mRNA 
translation faster and therefore Puf6p was proposed to be a translation repressor (Gu et al., 2004). 
The fact Puf6p could co-purify She2p seems to argue for a transient interaction with at least part of 
the locasome, namely She2p (Gu et al., 2004). The question still remains whether this interaction 
with She2p takes place in the nucleus or whether it takes place in the cytoplasm. 
Interestingly, Puf6p has also been implicated in rRNA processing and ribosome biogenesis (de 
Marchis et al., 2005; Wade et al., 2006; Fromont-Racine et al., 2003) and so the translation 
repressor function could be indirect, due to incorrectly assembled ribosomes. Interestingly, Puf6p 
also co-purifies with pre-60S particles (Nissan et al., 2002). 
Recently, Puf6p was shown to repress ASH1 mRNA translation by interacting with Fun12p/eIF5B. 
This interaction was abolished and ASH1 mRNA was translated upon Puf6p phosphorylation by 
Yck2p (Deng et al., 2008). In addition, Puf6p was also shown to lead to a 50% loss of localization 
to the incipient bud site of mRNAs encoding membrane associated polarization factors CDC42 and 
SEC4, while not affecting localization of SRO7, a non membrane associated polarization factor and 
was proposed to play a role in the localization of mRNAs encoding the membrane-anchored 
 small GTPases (Aronov et al., 2007). 
 
■SCP160 
Another accessory factor proposed to have a role in ASH1 mRNA localization is SCP160 (Irie et 
al., 2002), a member of the vigilin-like protein family (Lang and Fridovich-Keil, 2000; Baum et al., 
2004). This protein contains 14-KH domains, domains that are known to bind double stranded 
nucleic acids (Wintersberger et al., 1995). It has also been shown to interact with membrane-bound 
polysomes (Frey et al., 2001) and to be a component of RNPs (Lang and Fridovich-Keil, 2000). 
Scp160p could play a more general role, as it has been shown to interact with 69 mRNAs with 
diverse functions, among which ASH1 mRNA was not found (Li et al., 2003). A more general role 
for Scp160p functions seems to be supported by the observation that a SCP160 disrupted cell has 
been shown to be sensitive to translation impairing drugs (Baum et al., 2004).  
A distinct function for Scp160p in mRNP formation, stability or maturation has not yet been found 
and has revealed difficult to analyse as a SCP160 disruption leads to chromosomal instability and 
loss of ploidy control (Wintersberger et al., 1995). 
  
■KHD1 
The KH-domain protein 1, Khdp1, has been reported to bind the ASH1 N-element (Irie et al., 2002), 
the region spanning the first 800 nucleotides of the coding sequence. This region, that comprises 
also the E1 element (Chartrand et al., 1999) had been previously shown to be sufficient for 
targeting a reporter RNA to the bud tip (Gonzalez et al., 1999). Interestingly, a deletion of khd1 had 
only little effect on HO expression and no significant change on the frequency in mating type 
switching was observed in khd1 disrupted cells. Although a genetic interaction between MYO4 and 
KHD1 has been shown no physical interaction has been shown.  
It has been shown that a KHD1 overexpression resulted in a decrease of ASH1 mRNA localization 
efficiency and in a reduction of Ash1 protein levels (Irie et al., 2002). It has been proposed that the 
anchorage deficiency observed for khd1 disrupted cells is caused by the inhibition of translation of 
ASH1 mRNA. Translation dependent ASH1 mRNA anchorage to the bud tip has been observed 
earlier (Gonzalez et al., 1999), which would fit nicely to the model proposed (Irie et al., 2002). 
Recently, this model has been confirmed. Not only has it been shown by immunoprecipitation that 
Khd1p binds to a part of eIF4Ep (Paquin et al., 2007) and to eIF4G (Gavin et al., 2006), indicating 
that it might be connected to a eIF4E translation regulation event, but also the loss of Khd1p leads 
to an accumulation of ASH1 mRNA in the heavier polysome fractions, indicating that it is Khd1p 
that somehow prevents the transition from the lighter polysome fractions to the heavier ones, thus 
blocking translation (Paquin et al., 2007). Furthermore, the fact that Khd1p can be phosphorylated 
and thus release ASH1 mRNA to be translated strengthens the translation repressor model (Paquin 
et al., 2007).  
Khd1p, similarly to She2p, is steady state localized in the cytoplasm but is a shuttling protein, and 
can be trapped in the nucleus in an mRNA dependent manner, when using a MEX67 temperature 
sensitive allele (Du et al., 2008). This fact, and localization data for Puf6p and Loc1p, points out 
that some localization factors have a transient nuclear localization, although being involved in a 
cytoplasmic process. 
 
1.13 Aim of this work 
The aim of this work is to elucidate the role of Khd1p in ASH1 mRNP architecture and to elucidate 
its function in the ASH1 mRNA localization process. In order to achieve it, a biochemical approach 
was designed that includes protein purification and interacting partner identification. 
 2. MATERIAL 
 
 
2.1 PLASMIDS LIST: 
 
Number Construct 
 PRS416-XRS2 
1617 PRS416-RAD52 
1620 PRS425-pADH1-YKU70 
1621 PRS423-pADH1-YKU80 
1063 pGAL-ASH1-MS2 on a HIS3 marker 
1213 PFA6a-natNT2 
1214 PYM13 ProtA-TEV-CaBP, kanMX4  
1407 YCplac133-KHD1 
1417 p415-GAL1-ASH1-E1Stop (LEU2) 
1438 PRS424-TLC1 
1461 p413-GAL-HA6-SHE3-Cterm 
1515 pJET-KHD1 
1518 pGAL-KHD1-HA6 
1525 pJET-KHD1-pointmutant1A-I59R 
1526 pJET-KHD1-pointmutant1B-I68R 
1527 pJET-KHD1-pointmutant2B-I183R 
1528 pJET-KHD1-pointmutant3C-L284R 
1529 pRS315-KHD1 
1530 pRS315-KHD1-point mutant1A-I59R 
1531 pRS315-KHD1-point mutant1B-I68R 
1532 pRS315-KHD1-point mutant2B-I183R 
1533 pRS315-KHD1-point mutant3C-L284R 
1570 pJET-SIR2 
1591 pRS424-SIR2 
1599 pRS314-SIR2 
1601 pRS314-KHD1 
1602 pRS314-KHD1-pointmutant3C-L284R 
1615 pRS424-KHD1 
1616 pRS424-KHD1-pointmutant3C-L284R 
 Number Construct 
254 p415-GAL1-ASH1 (LEU2) 
276 pYM2 3xHA, S.p.HIS 
277 pYM3 6xHA, K.l.TRP1 
279 pYM5 3xMYC, S.p. HIS 
280 pYM6 9xMyc, K.l. TRP1 
285 pYM11 TEV-GST-7HIS, kanMX4 
413 pRS315 (LEU2) 
46 YEplac-ASH1-Myc9 
700 pRS424 
701 pRS314 
741  pGPD-NLS-HA-MS2-RFP on a leu2 marker 
88 YEplac-ASH1 
909 SL plasmid-KHD1 
287 YEplac181-ASH1-STOP-E1 
113 p415-pGAL 
135 pFA6-S.p.HIS3MX6 
1618 pRS426-CLB1 
1619 pRS426-CLB6 
 
 
 
 2.2 YEAST STRAINS: 
 
Number Genotype Origin 
JBL 
white... 
 Katja Straesser 
RPY126 
Mat alpha, trp1-1, leu2-3, his3-11, ura3, 
ade2-1, HO-ADE2, HO-CAN1, 
SHE2::URA3  
Jansen et al., 1996  
RPY2000 RPY585 scp160::TRP1 + 254 Jaedicke, PhD Thesis 
RPY2017 RPY2049 puf6::kanMX4 Euroscarf 
RPY2049 BY4741 Mat a, his3 delta 1, leu2 delta 0, 
met15 delta 0, ura3 delta 0 
Euroscarf 
RPY2172 
Mat alpha, trp1-1, leu2-3, his3-11, ura3, 
ade2-1, HO-ADE2, HO-CAN1, SHE2-myc3
Eap1-HA6::K.l. TRP1 (Knop) 
Jaedicke, PhD Thesis 
RPY2209 RPY668 + 254 This study 
RPY2210 RPY668 + 1417 This study 
RPY2211 RPY671 + 254 This study 
RPY2212 RPY671 + 1417 This study 
RPY2213 RPY676 + 254 This study 
RPY2214 RPY676 + 1417 This study 
RPY2215 RPY585 + 1417 This study 
RPY2220 RPY585 + 254 This study 
RPY2368 
MATa, ade2-1, trp1-1, can1-100, leu2-
3,112, his3-11,15, ura3, GAL, psi+ 
KHD1::HIS3MX6 This study 
RPY2448 RPY2017 + 254 This study 
RPY2449 RPY2017+ 1417 This study 
RPY2450 RPY585 UPF1::TRP1 This study 
RPY2451 RPY2450 + 254 This study 
RPY2452 RPY2450 + 1417 This study 
RPY2460 RPY2368 + 254 This study 
RPY2461 RPY2368 + 1417 This study 
RPY2466 RPY676 upf1::TRP1 This study 
RPY2467 RPY2466 + 254 This study 
RPY2468 RPY2466 + 1417 This study 
RPY2471 RPY676 vts1::TRP1 This study 
RPY2482 RPY2471 + 254 This study 
 Number Genotype Origin 
RPY2483 RPY2471 + 1417 This study 
RPY2492 RPY585 vts1::TRP1 This study 
RPY2493 RPY2492 + 254 This study 
RPY2494 RPY2492 + 1417 This study 
RPY2501 RPY676 PUF3::TRP1 This study 
RPY2502 RPY585 PUF3::TRP1 This study 
RPY2503 RPY2502 + 254 This study 
RPY2506 RPY2501 + 254 This study 
RPY2507 RPY2501 + 1417 This study 
RPY2521 RPY585 ccr4::TRP1 This study 
RPY2522 RPY2521 + 254 This study 
RPY2523 RPY2521 + 1417 This study 
RPY2525 RPY676 ccr4::TRP1 This study 
RPY2526 RPY2525+ 254 This study 
RPY2527 RPY2525 + 1417 This study 
RPY2537 
Mat a, his3 delta 1, leu2 delta 0, met15 
delta 0, ura3 delta 0, XRN1::KANMX4 
Roy Parker (euroscarf) 
RPY2538 
Mat a, his3 delta 1, leu2 delta 0, met15 
delta 0, ura3 delta 0, upf3::kanMX4 
Roy Parker (euroscarf) 
RPY2539 
Mat a, his3 delta 1, leu2 delta 0, met15 
delta 0, ura3 delta 0, upf1::kanMX4 
Roy Parker 
RPY2541 Mat a, his3 delta 1, leu2 delta 0, met15 
delta 0, ura3 delta 0, upf2::kanMX4 
Roy Parker (Euroscarf) 
RPY2544 
Mat alpha,, ura3-52, leu2-2 112, trp1-
delta1, cup1::LEU2/PM, dcp1::URA3, lys2 
Roy Parker 
RPY2544 Mat alpha,, ura3-52, leu2-2 112, trp1-
delta1, cup1::LEU2/PM, dcp1::URA3, lys2 
Roy Parker 
RPY2591 RPY2541 ash1::HIS3MX6 This study 
RPY2592 RPY2591 + 254 This study 
RPY2593 RPY2591 + 1417 This study 
RPY2595 RPY2538 ash1::HIS3MX6 This study 
RPY2596 RPY2595 + 254 This study 
RPY2597 RPY2595 + 1417 This study 
RPY2599 RPY2537 ash1::his3MX6 This study 
RPY2600 RPY2599 + 254 This study 
RPY2601 RPY2599 + 1417 This study 
 Number Genotype Origin 
RPY2603 
Mat alpha,, ura3-52, leu2-2 112, trp1-
delta1, cup1::LEU2/PM, dcp1::URA3, lys2 
she2::KANMX6 
This study 
RPY2603 Mat alpha,, ura3-52, leu2-2 112, trp1-
delta1, cup1::LEU2/PM, dcp1::URA3, lys2 
she2::KANMX6 
This study 
RPY2608 
mat a, leu2-3,112, trp1, ura3-52, his4, 
cup1::LEU2/PGK1pG/MFA2pG 
DHH1-GFP-Neo 
she2::URA3 
This study 
RPY2655 
mat a, leu2-3,112, trp1, ura3-52, his4, ade- 
SHE2-URA3 
DCP1-GFP-Neo 
This study 
RPY2665 
MAT??, ade???, trp1-1, can1-100, leu2-
3,112, his3-11,15, ura3, GAL, psi+  
SHE2::URA3 KHD1::HIS3MX6 
This study 
RPY2666 
MAT??, ade???, trp1-1, can1-100, leu2-
3,112, his3-11,15, ura3, GAL, psi+  
ASH1::URA3 KHD1::HIS3MX6 
This study 
RPY2667 RPY2665+ 254 This study 
RPY2668 RPY2665 + 1417 This study 
RPY2670 RPY2666+ 254 This study 
RPY2671 RPY2666 + 1417 This study 
RPY2687 
mat ?, leu2-3,112, trp1, ura3-52, his4, ade+
DHH1-GFP-Neo 
This study 
RPY2688 mat ?, leu2-3,112, trp1, ura3-52, his4, ade+
DCP1-GFP-Neo 
This study 
RPY2689 RPY2688 + 741 This study 
RPY2690 RPY2689 + 1063 This study 
RPY2691 RPY2687 + 741 This study 
RPY2692 RPY2691 + 1063 This study 
RPY2693 RPY2655 + 741 This study 
RPY2694 RPY2693 + 1063 This study 
RPY2695 RPY2608 + 741 This study 
RPY2696 RPY2608 + 741 + 1063  This study 
RPY2698 
Mat a, his3 delta 1, leu2 delta 0, met15 
delta 0, ura3 delta 0 PUF6::KANMX4 
SHE2::URA3 This study 
 Number Genotype Origin 
RPY2911 
MATa, ade2-1, trp1-1, can1-100, leu2-
3,112, his3-11,15, ura3, GAL, psi+ KHD1-
TAP::KANMX6 
This study 
RPY2913 Mat a, his3 delta 1, leu2 delta 0, met15 
delta 0, ura3 delta 0, puf6::kanMX4 
khd1::his3 
This study 
RPY2915 
UCC506 
mat a ade2-101 his3-delta200 leu2-delta1 
lys2-801 trp1-delta1 ura3-52 
URA3::TEL VR 
Xavier Marsellach et al., 
2006 
RPY2915 
UCC506 mat a ade2-101 his3-delta200 
leu2-delta1 lys2-801 trp1-delta1 ura3-52 
URA3::TEL VR 
Gottschling et al., 1990 
RPY2920 RPY2915 khd1::S.p.HIS3 This study 
RPY2922 RPY2915 rpd3::LEU2 Marsellach et al., 2006 
RPY2923 RPY2915 rif1::TRP1 Marsellach et al., 2006 
RPY2924 RPY2915 RIF2::LEU2 Marsellach et al., 2006 
RPY2925 RPY2915 RIF1::TRP1 RIF2::LEU2 Marsellach et al., 2006 
RPY2926 RPY2923 khd1::S.p.HIS3 This study 
RPY2927 RPY2924 KHD1::S.p.HIS3MX6 This study 
RPY2929 
RPY2925 RIF1::TRP1 RIF2::LEU2 
KHD1::HIS3 
This study 
RPY2933 MATa, ade2-1, trp1-1, can1-100, leu2-
3,112, his3-11,15, ura3, GAL, psi+ KHD1-
GST::KANMX6 
This study 
RPY2961 
ucc506 RIF1::TRP1 KHD1::HIS3MX6 
PBP2::ClonNATNT2 
This study 
RPY2962 RPY2927 PBP2::ClonNATNT2 This study 
RPY2963 RPY2923 PBP2::ClonNATNT2 This study 
RPY2972 RPY2920 PBP2::ClonNATNT2 This study 
RPY2988 RPY2923 SIR3::ClonNATNT2 This study 
RPY2989 RPY2926 SIR3::ClonNATNT2 This study 
RPY2990 RPY2927 SIR3::ClonNATNT2 This study 
RPY2991 RPY2920 SIR3::NAT2 This study 
RPY2993 RPY2915 SIR4::S.pombe HIS3 This study 
RPY2994 RPY2923 SIR4::ClonNATNT2 This study 
RPY3033 SIR4::S.pombe HIS3 diploid Heidi Feldmann 
RPY3036 RAD52::KANMX4 Euroscarf 
RPY3037 XRS2::KANMX4 Euroscarf 
 Number Genotype Origin 
RPY3038 RAD52::KANMX4 KHD1::S.pombeHIS3 This study 
RPY3039 XRS2::KANMX4 KHD1::S. pombe HIS3 This study 
RPY3040 
EAP1-HA6::TRP1 SHE2-MYC3 KHD1-
TAP::KANMX6 
This study 
RPY3041 SIR4::S.pombe HIS3 KHD1::ClonNATNT2 This study 
RPY3046 XRS2::KANMX4 KHD1::S.p.HIS3 This study 
RPY3047 rad52::KANMX4 KHD1::S.p.HIS3 This study 
RPY3091 rad52::KANMX4 Euroscarf 
RPY3120 xrs2::KANMX4 Euroscarf 
RPY3135 RPY358 Sir2p-Myc9::K.l.TRP1 This study 
RPY3154 RPY2922 khd1::S.p.HIS3 This study 
RPY3154 RPY2922 khd1::S.p.HIS3 This study 
RPY3155 RPY2922 pbp2::S.p.HIS3 This study 
RPY3159 RPY2915 yku70::S.p.HIS3 This study 
RPY3160 RPY2923 rad27::S.pHIS3 This study 
RPY3167 RPY3160 khd1::ClonNATNT2  This study 
RPY3172 RPY2922 sir2::ClonNATNT2 This study 
RPY3174 RPY2922 rad27::ClonNATNT2 This study 
RPY3176 RPY2915 rad27::S.p.HIS3 This study 
RPY3177 RPY2920 rad27::ClonNATNT2 This study 
RPY3182 RPY2915 sir2::ClonNATNT2 This study 
RPY3186 RPY3135 khd1::S.p.HIS3 This study 
RPY3187 RPY3159 khd1::ClonNATNT2 This study 
RPY3219 RPY2915 pbp2::ClonNATNT2 This study 
RPY3245 RPY3135 pbp2::ClonNATNT2 This study 
RPY3286 RPY3177 + 1529 This study 
RPY3288 RPY2920 + 1529 This study 
RPY3290 RPY3187 + 1529 This study 
RPY3299 RPY3177 + 1532 This study 
RPY3300 RPY3177 + 1533 This study 
RPY3301 RPY3187 + 1532 This study 
RPY3302 RPY3187 +  1533 This study 
RPY3303 RPY2920 + 1532 This study 
RPY3304 RPY2920 + 1533 This study 
RPY3313 RPY3159 + 297 This study 
 Number Genotype Origin 
RPY3314 RPY3187 + 297 This study 
RPY3317 RPY3177 + 413 This study 
RPY3317 RPY2920 + 297 This study 
RPY3318 RPY3176 + 413 This study 
RPY3323 RPY2915 + 1438 This study 
RPY3324 RPY2920 + 1438 This study 
RPY3325 RPY3159 + 1438 This study 
RPY3326 RPY3187 + 1438 This study 
RPY3327 RPY3176 + 1438  This study 
RPY3328 RPY3177 + 1438  This study 
RPY3333 RPY359 SIR3-Myc9::K.l.TRP1 This study 
RPY3341 RPY3159 sir2-myc9::TRP1 This study 
RPY3342 RPY3159 sir3-myc9::TRP1 This study 
RPY3343 RPY2922 + 1438 This study 
RPY3344 RPY3154 + 1438 This study 
RPY3348 RPY2915 sas2::S.p.HIS3 This study 
RPY3353 RPY2915 vts1::ClonNATNT2 This study 
RPY3359 RPY2922 sas2::S.p.HIS3 This study 
RPY3394 RPY612 Vts1-Myc9::K.l.TRP1 This study 
RPY3396 YKU70::URA3 yku70::leu2 Heidi Feldmann 
RPY3404 YKU70::URA3 KHD1::S.p.HIS3 This study 
RPY3407 RPY2922 vts1::ClonNATNT2 This study 
RPY3411 RPY2915 + 1570 This study 
RPY3413 RPY2920 + 1570 This study 
RPY3415 RPY3154 + 1570 This study 
RPY3416 RPY2922 + 1570 This study 
RPY3422 RPY2915 + 700 This study 
RPY3425 RPY2920 + 700 This study 
RPY3428 RPY2922 + 700 This study 
RPY3431 RPY3154 + 700 This study 
RPY3443 RPY3154 + 1599 This study 
RPY3444 RPY2922 + 1599 This study 
RPY3445 RPY2920 + 1599 This study 
RPY3446 RPY2915 + 1599 This study 
RPY3447 RPY3407 + 1438 This study 
 Number Genotype Origin 
RPY3448 RPY3353 + 1438 This study 
RPY358 
MATa, ade2-1, trp1-1, can1-100, leu2-
3,112, his3-11,15, ura3, GAL, psi+  
 
RPY359 
MATalpha, ade2-1, trp1-1, can1-100, leu2-
3,112, his3-11,15, ura3, GAL, psi+  
 
RPY585 
Mat a, trp1-1, leu2-3, his3-11, ura3, 
ade2-1, HO-ADE2, HO-CAN1. 
ASH1::S.pombe HIS3  
Jaedicke, PhD Thesis 
RPY612 
Mat a, ade2, his3, leu2, trp1, ura3, 
mex67:HIS3 (pUN100-LEU2-mex67-5) 
Segref et al., 1999  
RPY668 RPY585 she3::URA3 Jaedicke, PhD Thesis 
RPY671 RPY585 myo4::URA3 Jaedicke, PhD Thesis 
RPY673 RPY585 she4::URA3 Jaedicke, PhD Thesis 
RPY676 RPY585 SHE2::URA3 Jaedicke, PhD Thesis 
 
 
 
2.3 OLIGONUCLEOTIDES LIST 
 
 
Name Oligo Sequence Number 
PUF3_KO_F CGCATTTAAATTTCTTCTGAATAACGCAATATTGC
GGGTATAACTGTGCGGTATTTCACACCG 
2167 
PUF3_KO_R AAATAGTAAAAAGTGAAAGGAGAACGATGATAAC
ACTAAAGATTGTACTGAGAGTGCAC 
2168 
natNT2 fw AATCGGACGACGAATCGGACG 2330 
KHD1kor ATAGTCTCGATGATATTGCTATTG 1884 
VTS1_KO_F GAAAAACTGTTCATATAAAGTAATTGTCAGCAAA
GAAATCCTGTGCGGTATTTCACACCG 
2046 
VTS1_KO_R CTTTATGCAACGTCAAGACAATCAACTTTATTATG
CCAGATAGATTGTACTGAGAGTGCAC 
2047 
Vts1_KOFO
RKnop 
GAAAAACTGTTCATATAAAGTAATTGTCAGCAAA
GAAATCCGTACGCTGCAGGTCGAC 
2700 
VTS1_KORE
VKNOP 
CTTTATGCAACGTCAAGACAATCAACTTTATTATG
CCAGATATCGATGAATTCGAGCTC 
2701 
pbp2-ko-his-
ss 
GCCACATCCACTCTAACAATTTTAATCGTCCAGCG
CGGCAGCTGAAGCTTCGTACGC 
1260 
pbp2-ko-his-
ass 
GAGGGGCGACCTTCTTTTACGTTCAGCATTTGATC
GCATAGGCCACTAGTGGATCTG 
1261 
 Name Oligo Sequence Number 
aKHD1-KO-
HIS 
GTTTTGTCTGTGTGGGACGTGCGCACGCACACGTA
TATAGCATAGGCCACTAGTGGATCTG 
1293 
sKHD1-KO-
HIS 
CGGGTAACTTAGAGACAGCATTAGTATATATACC
AGCCCAGCTGAAGCTTCGTACGC 
1292 
pbp2-ko-
select-ass 
GTCTTCTCTCCGAAGAGCC 1265 
SIR2_KNOP
KOF 
GGGCGTGTATGTCGTTACATCAGATGAACATCCCA
AAACCCTCCGTACGCTGCAGGTCGAC 
2741 
SIR2_KNOP
KOR 
GTAAATTGATATTAATTTGGCACTTTTAAATTATT
AAATTGCCTTCTACAATCGATGAATTCGAGCTC 
2742 
SIR2_cloning
F 
CCGATCGGAAGCTCTAATTTG 3048 
Sir2_cloning
R 
CAACGCTGGACCACGACATG 3059 
KHD1_KNO
P_F 
AAGAAGAACCTCAAGAGAATCATGATAACAAAGA
GGAGCAGTCGCGTACGCTGCAGGTCGAC 
2115 
KHD1_KNO
P_R 
TTTGTTTTGTCTGTGTGGGACGTGCGCACGCACAC
GTATATAATCGATGAATTCGAGCTC 
2116 
She2_seqfor_
P_300 
CTTATAGAATGGTTCTTCGTGCATGCC 1813 
She2_seqrev_
UTR_250 
CGGAGGAGACTACACCCTCCC 1815 
Khd1_for CAGTTTGCCAATATAAGCGC 1751 
Khd1_rev AATCTAGAGGAAACGCCAATAGTCTCGA 1752 
KH1.1F CATTGAAAGAGGCTGCCAAGAGGATTGGCACTAA
GGGCTCCAC 
2803 
KH1.1R GTGGAGCCCTTAGTGCCAATCCTCTTGGCAGCCTC
TTTCAATG 
2804 
KH1.2F GAGCTGCAAACGCCGTCAAGAGAGGTATTTCTGA
AAAGGTGCC 
2805 
KH1.2R GGCACCTTTTCAGAAATACCTCTCTTGACGGCGTT
TGCAGCTC 
2806 
KH2.1F CCAATTCCCATATCTCATCGCGTATCGGGAAAGCA
GGCGCCAC 
2807 
KH2.1R GTGGCGCCTGCTTTCCCGATACGCGATGAGATATG
GGAATTGG 
2808 
KH2.2F CAATAAGCACGGCGTTAAGAGGGTGGCTTCCAAG
GACTTCTTAC 
2809 
KH2.2R GTAAGAAGTCCTTGGAAGCCACCCTCTTAACGCCG
TGCTTATTG 
2810 
 Name Oligo Sequence Number 
KHL-RF GTGGCTTCCAAGGACTTCCGACCTGCTAGCGACGA
GAGAATTATC 
2811 
KHL-RR GATAATTCTCTCGTCGCTAGCAGGTCGGAAGTCCT
TGGAAGCCAC 
2812 
KH3.1F CCAGAACTGTATGTAGGCGCCAGGATTGGCCGTG
GAATGAACAG 
2813 
KH3.1R CTGTTCATTCCACGGCCAATCCTGGCGCCTACATA
CAGTTCTGG 
2814 
KH3.2F GAAAACTTTCACAAAAACCAATAGGGTCGTGGAA
AGGAAGGATGACGATG 
2815 
KH3.2R CATCGTCATCCTTCCTTTCCACGACCCTATTGGTTT
TTGTGAAAGTTTTC 
2816 
VTS1_KNOP
TAGF 
CAAAGAACGTGATTTAATTGATAGATCTGCTACGC
TGCAGGTCGAC 
 
VTS1_KNOP
TAGR 
GCAACGTCAAGACAATCAACTTTATTATCGGAGAT
AATCGATGAATTCGAGCTC 
 
RIF1_KNOP
F 
TATTACTCAAACAGGGATAATGATATGAATTGAC
GTACGCTGCAGGTCGAC 
3052 
RIF1_KNOP
R 
TTTATTGCCATTTTGATCTATTCTACATACTAAATC
GATGAATTCGAGCTCG 
3053 
RIF2_KNOP
F 
CTTCCACTTAAGTTAACTCGAAAAGTACATGATAG
ACGTACGCTGCAGGTCGAC 
3054 
RIF2_KNOP
R 
GTATTGTTCGAACTCTTTCAAAAGACCTTGGTAAT
ATCGATGAATTCGAGCTCG 
3055 
SIR3_KNOP
F 
GAATTCAAAAATATGGACTGCATTCGTACGCTGCA
GGTCGAC 
2934 
SIR3_KNOP
R 
GGAAGTGAAAATGAATGTTGGTGGATCGATGAAT
TCGAGCTCG 
2935 
PDA1_F CTGCCAATGCTTGCTGCTT 321 
PDA1_R TCCCTAGAGGCAAAACCTTG 322 
CCR4_KO_F  AGGGAACTCCGACTGACGTTATCCCTGCAAACTAC
CGCTACTGTGCGGTATTTCACACCG 
2171 
CCR4_KO_F
R 
TACAGAGAGGAGGGAGGGAGTGGGATGAAAGTG
TGCGGTAGATTGTACTGAGAGTGCAC 
2172 
CCR4_KO_
XEKF 
 CGACCCTTCTTTACTAGGC 2173 
CCR4_KO_
XEKR 
 CCGTGCCTGAGGGAGTG 2174 
PUF3_KO_X
EKF 
GAACTCGCATCCATAGTTTC 2169 
 Name Oligo Sequence Number 
PUF3_KO_X
EKR 
CATCTTGTTGGTTAGGAAGC 2170 
vts1rsal1clon AAAAGTCGACCTTGTACCATTCATTGTATAAAC 2121 
UPF1_KO_x
ekf  
TTCCGGTTCTCACACTCC 2050 
UPF1_KO_R  AATATACTTTTTATATTACATCAATCATTGTCATTA
TCAAAGATTGTACTGAGAGTGCAC 
2053 
UPF1_KO_F   GCCAAGTTTAACATTTTATTTTAACAGGGTTCACC
GAACTGTGCGGTATTTCACACCG 
2052 
UPF1_KO_x
ekr 
TTGCCATTGATCAGTATCCC 2051 
ASH1-
Xho(+2300) 
CTACTCGAGTACTAGACATAG 141 
ASH1-BH1(-
1) 
AAGCGGATCCATGTCAAGCTTATAC 142 
SAS2_KOF TATTTTCTAGTTGCTTTTTGTTTTCACTCGCAAAAA
AACGTACGCTGCAGGTCGAC 
2801 
SAS2_KOR GAAATACATATGCCATTAAGTTACATCCTGAATAG
ATTCATCGATGAATTCGAGCTCG 
2802 
rad27_KOF AAAGAAATAGGAAACGGACACCGGAAGAAAAAA
TCGTACGCTGCAGGTCGAC 
2743 
rad27_KOR GGACCAAAAGAAGAAAGTGGAAAAAGAACCCCA
TCGATGAATTCGAGCTCG 
2744 
RAD27_rev  GAGAAACCCACTTTCTTGGAG 3060 
TLC1_probF GATGCTTGTGTGTGCGCAA 2564 
TLC1_probR GTCACCTTAAACAGTGTCAG 2565 
RAP1_probF CACTGGTGCTACTGCTGC 2560 
RAP1_probR CACCGTTTGCTCTAATCAGACGC 2561 
SIR3_probF GATGCATAAGATGGGAGTTGA 2562 
SIR3_probR TCGGCCGTCAACGAGTTC 2563 
SIR2_probF GATGAACCTTCACATAAGAAG 2948 
SIR2_probR ATGGAGGCCTTTCCGACA 2949 
1800_ecoRI CAGCCGAATTCATGTCACAGTTCTTCGAAGC  
 
 
 
 
 2.4 General Laboratory Material 
2.4.1 Laboratory equipment and disposables 
Standard Laboratory equipment and disposables have been used. All solutions have been autoclaved 
or sterilized by filtration. 
 
Standards 
Chemicals       Merck, Fluka, Serva, Sigma, ICN 
Enzymes       NEB, Roche, Biomol, Axon, MBI  
        Fermentas  
Oligos        Thermo Scientific, MWG. 
 
Kits 
Plasmid Miniprep      Metabion, Macherey-Nagel 
Plasmid Midiprep      Qiagen 
Gel Extraction/PCR Purification    Qiagen, Metabion 
Colloidal Blue Stain      Invitrogen 
QuickChange Site Directed Mutagenesis Kit  Stratagene 
Prime-It II Random Primer Labelling   Stratagene 
ECL Detection      Applied Biochem 
RNAse Away       Molecular Bioproducts 
Quick Ligation Kit      NEB 
pJET Cloning Kit      Fermentas 
TOPO-TA Cloning Kit     Stratagene 
 
Special equipment 
1.Hardware 
Criterion eletrophoresis system   Bio-RAD 
Ika vibrax VXR     NeoLab 
Beadmill        
2.Disposables 
glass beads, 0.45-0.5mm    NeoLab 
Positive TM membrane    Qbiogene 
Hybond-P       Pharmacia 
 Hyperfilm ECL     Pharmacia 
NytranN      Schleicher&Schuell 
GB 003/GB 004 Gel-Blotting Paper   Schleicher&Schuell 
Micro Bio-spin 30 Chromatography Columns BIO-RAD 
Mobicol, 35 ⎧m pore filters    MOBITEC 
 
3.Reagents 
Poly-L-Lysine     Sigma 
Triton X-100      Gerbu 
Tween 20      Sigma 
IGEPAL CA-630, equals to NP40   ICN 
Trichloroacetic acid, TCA    Sigma 
Salmon Sperm DNA     Roche 
RQ1 DNAse      Promega 
 Oxalyticase      Enzogenetics 
 IgG Sepharose     Pharmacia 
 Calmodulin Affinity Resin     Stratagene 
 Complete EDTA-Free Protease Inhibitor Cocktail Roche 
 Diethylpyrocarbonate, DEPC   Roth 
 diamidino-2-phenylindol dihydrochloride  Roth 
 zymolase 20T/100T     ICN 
 Cycloheximide     Sigma 
 Paromomycin      Sigma 
 Hygromycin B     Sigma 
 Geneticin      Sigma 
 Hydroxyurea      Applichem 
 MethylMethanoSulphonate    Sigma 
 5' Fluorotic Acid     Apollo Scientific 
 RNAseA      Roche 
 DNAse I      Sigma 
 Taq Polymerase     Axon 
 VENT Polymerase     NEB 
 
      4.  Antibodies 
  Primaries 
 rabbit anti protein A     Sigma 
 Peroxidase anti-peroxidase    Sigma 
 3F10, rat anti HA     Roche 
 9E10, mouse anti Myc    Roche 
 rabbit anti Sec61     M. Seedorf, ZMBH, Heidelberg 
 Mab414, mouse anti actin    Chemicon 
 rabbit anti Histone H4    BioLegend 
 rabbit anti Histone H4 Lys16    Upstate 
 rabbit anti Histone H4 Lys12    Upstate 
 rabbit anti Histone H4 Lys8    Upstate 
 rabbit anti Histone H3    Upstate 
 rabbit anti Histone H3K79Me3   Upstate 
 rabbit anti Histone H3K4Me3   Upstate 
 rabbit anti Histone H3K36Me3   Upstate 
 mouse anti Rpl13     M. Seedorf, ZMBH, Heidelberg 
 mouse anti Rps3     M. Seedorf, ZMBH, Heidelberg 
 
 Secondaries 
 rabbit anti rat, peroxidase conjugated   DIANOVA 
 sheep anti mouse, peroxidase conjugated   DIANOVA 
 donkey anti rabbit, peroxidase conjugated   DIANOVA 
 rabbit anti mouse, Alexa 488    Molecular Probes 
 3. METHODS 
 
 
3.1 Bacteria 
 
3.1.1 Preparation of E. coli competent cells. 
E. coli strain: TOP10 
hint: it is better to scale up the volume to get more aliquots (4fold) 
1. inoculate 3ml LB-media with one colony from a fresh plate, incubate ON at 37°C on a wheel  
2. the next evening take 500µl  of this culture and inoculate 20 ml LB-Media in an Erlenmeyer 
flask, incubate ON at 37°C (shaking) 
3. with this ON-culture inoculate 50 ml LB-Media the next morning with a dilution of 1:100; let 
cells grow at 37°C to an OD 600 0,7-0,8 (shaking)  
4. cool down culture on ice for 15 min, centrifuge for 15 min at 5000 rpm  in a GSA rotor 
5. cool pellet on ice, resuspend with the half of the culture volume with cold 0,1M CaCl2-solution,   
transfer to SS34 tubes 
6. incubate 30min on ice 
7. pellet cells at 5000 rpm for 15 min at 4°C 
8. resuspend the cellpellet with 1/20 volume of your culture volume in 0,1 M CaCl2/10% Glycerol 
solution, make 100µl aliquots  
9.store aliquots at -80°C 
 
3.1.2 E. coli transformation 
quick method (high efficiency 5min transformation of E. coli) 
(Nucleic Acids Research, 1996, Vol.24, No.3) 
 
1. thaw an aliquot of competent cells slowly on ice 
2. 1-10ng of DNA or  5-10µl ligationmix (which have to be transformed) have to be cooled on ice 
in an Eppi 
3. add 50-100µl of the competent cells and incubate at least 5 min on ice 
4. plate on a warm LB-Amp-plate 
 
 
 
3.1.3 Preparation of Electro-Competent cells. 
Preparation of  electrocompetent cells (DH5alpha) 
 
 
1. inoculate1Liter LB-Media with 10 ml of a fresh ON-culture 
2. incubate the culture on a shaker up to a cell density of O.D.600= 0,5-1,0. Measure during   your 
incubation time (takes about 2-3 hours) 
3. if the cells are dense enough, incubate the culture for 15-30 min on ice, then centrifuge at 4°C 
with a COLD rotor for 15 min at 4000 x gmax. 
 4. discard SUP, resuspend pellet with 1l cold water, centrifuge like in step 3 
5. discard SUP, resuspend pellet in 0,5l cold water, centrifuge like in step 3 
6. discard SUP carefully (pellet is not very stable), resuspend pellet in 20 ml cold 10% Glycerol, 
centrifuge like in step 3 
7. discard SUP, resuspend pellet in 10% glycerol up to a final volume of 2-3 ml 
8. make aliquots of 100 µl, store at -80°C, durable for 6 months 
 
 
3.1.4 Transformation of Electro-Competent cells. 
1. prepare the cuvettes( they can be used more than one time, for re-using wash them with    0.1% 
SDS, then with water (3 times), after that with EtOH (2 times), then dry for 20 min, crosslink in the 
UV-Stratalinker  
2. thaw the competent cells slowly at RT (2min), after that put them on ice 
3. pipet 1-2µl ligation mix (or 1ng Plasmid-DNA) in an Eppi-tube and cool on ice, the clean and dry 
cuvettes also cool on ice. Add 50µl competent cells to the DNA, mix and transfer directly into the 
cuvette, the mix should be at the bottom of the cuvette, incubate for 1 min on ice 
4. because you use the BIORAD cuvettes (0,2cm) chose the program EC2 (2,5 kV) , put the cuvette 
in the electroporator and pulse; if this was successful, no noise will be heard 
5. add 1ml warm LB-Media (or SOC medium) to the transformationmix and transfer it with a 
pasteur-pipet into a fresh Eppi. incubate 30-45 min at 37 °C (shaking), plate 100µl and 900 µl on 
LB-Amp-plates 
 
 
SOC-Medium:  
1g Bactotryptone, 0,25g Yeast-extract, 166µl 3M NaCl, 125µl 1M Kcl, 44,21ml H2O, autoclave. 
add: 
500µl 1M MgSO4, 500µl 1M MgCl2, 4,5ml 4% Glucose 
 
 
3.2 Eukarya 
 
3.2.1 Transformation protocols 
 
• High efficiency Yeast transformation 
(adapted from Gietz and Schiestl, 1991) 
 
-inoculate 50 ml YEPD medium with an over night culture so that the start-OD is 0.25 (check) 
-let cells grow for 2 generations, if OD600 is 1 - START 
-harvest the cells in a Falcon tube at 2500 rpm, 5 min 
-discard SUP,resuspend the cells in 25 ml sterile water, centrifuge again 
-discard the water, resuspend the cells in 1 ml 100mM LiAc (freshly diluted from stock) and 
transfer the suspension to an Eppi 
-pellet the cells at top speed for 15 sec and remove the LiAc with a micropipette 
-resuspend the cells to a final volume of 500 µl - about 400 µl of 100 mM LiAc+pellet 
-boil a 1 ml sample of SS-DNA for 5 min, then quickly chill on ice 
-vortex the cell suspension and pipette 50µl samples into labeled Eppis - do not forget one for the 
 negative control! Pellet the cells and remove the LiAc with a micropipette 
-add the transformation mix in the following order: 
-240µl PEG (50%w/v) 
-36 µl  1M LiAc 
-25 µl  SS-DNA (2mg/ml) 
-50 µl  water and plasmid DNA (0,1-10 µg) 
-vortex each tube vigorously until the cell pellet has ben completely mixed. Usually it takes about 1 
min 
-incubate 30 min at 30°C 
-heat shock 20-25 min at 42°C  (NOTE: for tranformation of pseudohyphal strains it is better to 
make just a 20 min heat shock, for TS mutants just a 15 min heat shock) 
-centrifuge at 6000-8000 rpm for 15 sec and remove the transformation mix with a micropipette 
-Pipette 1 ml of water into each tube and resuspend the pellet by pipetting it up and down (gently!!) 
-plate 100 and 300 µl of the transformation mix onto selective plates (2 plates) 
 
 
• Yeast One-Step Transformation 
(modified from Chen et al., Curr Genet 21:83-84, 1992) 
 
1. Cells. 
You should have a culture of at least 10exp8 cells/ ml. You need 1ml per  transformation. They can 
be e. g. stationary phase cells from an YEPD culture (harvested by centrifugation in Eppendorf 
tubes). It works well with cells scraped off a fresh (1-2 days) plate and is reported to work (less 
well) even with cells from an old plate kept at 4 ºC. 
 
2. Procedure. 
a.) Thaw ssDNA ("helper DNA"), heat 5-10' at 95 C, then chill on ice. 
b.) Pellet 1ml of culture by centrifugation in Eppendorf centrifuge, discard supernatant. Resuspend 
cells in 100 µl of ONE-STEP buffer, vortex heavily. 
c.) Add 20µg ssDNA (10 µl of 2mg/ml) + 100ng - 500ng plasmid DNA to be transformed, vortex, 
incubate at 45 ºC for 30 min. 
d.) Add 1 ml YEPD (or YEPGal), mix and spin 10 sec full speed. Discard supernatant. 
e.) Resuspend cell pellet in 1000 µl YEPD (or YEPGal) and plate 100 µl directly on appropriate 
selective plates. Colonies appear after 2 days. 
 
3. ONE-STEP buffer. 
0.2 M LiAc, 40% PEG 3350 (is the same as old PEG 4000), 100 mM DTT. Dissolve LiAc and 
PEG, then add DTT, filter sterilize. Keep in 1 ml aliquots at -20 ºC. 
 
 
 
3.2.2 Determining mRNA half-life: 
 
 Total mRNA extraction 
(modified from Cross and Tinkelenberg, 1991) 
 
 
- Start with cca 15 ml of YEPD cultures O.D. cca 0.7 - 0.8. (they can be obtained by diluting an 
overnight inoculum 0.25 ml into 20 and 4-5 h cultivation - as for spheroplasts). 
 - Spin cells down at 4 degrees 2000 rpm 2 min (Heraeus centrifuge), discard supernatant. 
- Resuspend pellets into cca 1 ml of ice-cold TE, transfer into 2 ml safelock Eppendorf tubes. Spin 
for 10s in the cold and discard supernatant. You can freeze the pellet here (-20 ºC is O.K.). 
 
To the pellet add:  
1. cca 200 µl of glass beads 
2. 400 µl of 50:49:1 mixture of phenol: chloroform: isoamylalcohol, equilibrated with TE 
3. 500 µl of Cross RNA buffer 1 
 
- Close the tubes. Shake vigorously on the Ika-Vibrax-VXR mixer in the coldroom for 10 min. 
- Spin for 5 min in an angle microfuge and transfer the upper phase (carefully, w/o interphase!) into 
1ml of precooled -20 degrees ethanol in 1.5 ml Eppendorf tubes. Mix and leave at -20 for 10 min. 
- Spin in the angle microfuge in the coldroom for 5 min full speed. Dissolve sediment in 30-100µl 
Cross RNA buffer 2,  by 10 min incubation at 65 degrees. Measure RNA concentration. Store in -20 
freezer. 
 
Cross RNA buffer1: 0.3 M NaCl, 10 mM Tris pH 7.5, 1 mM EDTA, 0.2 % SDS 
Sterility and DEPC-treatment NOT essential since this is to be added to phenol. Keep at 4 degrees. 
Shake the buffer well before use and try to get as homogeneous suspension as possible. 
 
Cross RNA buffer 2: 1x TE + 0.2 % SDS 
Sterility ESSENTIAL. DEPC-treated water recommendable. Keep at room temp. 
 
 
 
 
 DOT BLOT 
 
For dot blotting follow the instructions from the manufacturer - “Schleicher and Schuell Blotting 
Manual” 
 
 
Sample preparation 
 
- dissolve reasonable amount of RNA (10µg ) in 10 µl H2O 
- add 7ul 37% formaldehyde 
            20 µl 100% formamide 
           2 µl 20xSSC 
- heat 15 minutes 68°C, cool on ice 
- add 2 volumes (=78µl ) of 20xSSC 
 
 
Membrane preparation 
 
- wet precut S+S Nytran for 10 minutes in H2O, then transfer for 10 minutes to 6xSSC 
 
 
Blot assembly 
 
- clean each component of the blotter that is going to be in direct contact with the sample with 
 ‘RNase away’ 
- make sure that the plastic rings under each well of the top plate fit correctly 
- place 1 sheet of GB003 blotting paper prewet in 6xSSC on filter support plate and roll out possible 
air blobs with a pipet 
- cover with equilibrated membrane, roll out possible air blobs with a pipet and carefully assemble 
the clamps in antiparallel direction 
 
 
Sample application 
 
- connect blotter with water pump and apply vacuum to a flow  rate of approximately 1ml per 
minute per well 
- wash wells 2x500 µl 6xSSC 
- apply sample 
- wash 1x500 µl 6xSSC  
- carefully open clamps in antiparallel direction and remove the membrane 
- crosslink RNA to the membrane using twice the ‘autocrosslink program’ from the 
STRATALINKER. 
- stain blot with methylene blue solution 
 
 
 
Hybridization and washing 
 
HYBRIDISATION 
 
use 8.7ml of hybridization solution per 100cm2 of filter 
 
Prehybridization: 
 
1.4ml H2O (0.46 vols.) 
14µl SpermDNA (10mg/ml) (0.0046vols.) 
heat at 95°C for 7min 
rapidly chill on ice  
add 1.6ml Scp/Sarc/DS Mix (0.54vols.) 
 
add the solution to filter in hybridisation-tube, wet the filter thoroughly by rolling the tube. 
Incubate at 65°C for 1-2h 
 
meanwhile prepare the hybridization-solution: 
1.4ml H2O (0.46 vols.) 
14µl SpermDNA (10mg/ml) (0.0046vols.) 
heat at 95°C for 7min 
rapidly chill on ice  
add 1.6ml Scp/Sarc/DS Mix (0.54vols.) 
 
Before adding your probe to the hybridisation-solution, heat your probe at 95°C for 5min. 
Add the hybridisation-solution to your filter in the tube and incubate it overnight. 
 
 
 WASHING AND AUTORADIOGRAPHY 
 
After removing the probe wash the filter 2x briefly with 2xSSC, 0.1% SDS at RT and then 2x 20 
min in 0.5x SSC, 0.1% SDS at 43 degrees. Rinse in 3mM Tris-HCl pH 8 at RT, place your filter 
between 2 overhead-foils and autoradiograph with intensifying screen  
 
Solutions: 
 
10xMOPS: to 800 ml of DEPC-treated water add 48.1 g MOPS, adjust pH to 7 with NaOH (the 
"pH-strip" accuracy is sufficient) (that is app. 25.005 mL of 5 M stock), add 16.6 ml of DEPC-
treated 3M Na acetate and 20.0 ml of DEPC-treated 0.5 M EDTA pH 8, adjust volume to 1l w. 
DEPC-treated water and filter. Keep at RT in a bottle wrapped in aluminium foil. The solution can 
turn yellow, but it does not matter. 
 
1x MOPS: by dilution of 10x MOPS. 
 
Loading buffer: 1mM EDTA pH8, 0.25% bromophenol blue, 0.25% xylene cyanol, 50%  
glycerol. 
 
20x Scp: 
2M NaCl, 0.6M Na2HPO4, 0.02M EDTA, ph 6.2 (with HCl), autclave 
 
Scp/Sarc/DS: 
Dissolve 20g of Dextran sulfate (500,000) in 60ml of 20x Scp, making up to 101ml with H2O (this 
will need gentle heating and stirring). Then make up to a final vol of 108ml with 7ml of 30% SLS.  
 
 
 
 Probe preparation 
 
ASH1 probe 
Template – plasmid RPP88 
Expected product size - 1Kb 
 
SIR2 probe 
Oligo 1 - 2948 
Oligo 2 - 2949 
Template – Genomic DNA 
Expected product size - 0,8kb 
 
TLC1 probe 
Oligo 1 - 2564 
Oligo 2 - 2565 
Template – Genomic DNA 
Expected product size - 300pb 
 
RAP1 probe 
Oligo 1 - 2560 
Oligo 2 - 2561 
Template – Genomic DNA 
 Expected product size -  500pb 
 
SIR3 probe 
Oligo 1 - 2562 
Oligo 2 - 2563 
Template – Genomic DNA 
Expected product size - 500pb 
 
PDA1 probe 
Oligo 1 - 321 
Oligo 2 - 322 
Template – Genomic DNA 
Expected product size - 1,2kb 
 
 
 Detection 
 
- Scan intensifying screen on Typhoon scanner. 
 
 
3.2.3 Determining protein content 
 
  Very quick western extracts 
 
- have ready 10 OD-units of your culture 
- spin down cells 5 min at 4000 rpm 
- heat 1x SDS-sample buffer at 80°C 
- wash the cell pellet once with 1 ml cold water and transfer to an Eppi (WORK ON ICE!!!) 
- spin down 1min at full speed 
- discard Supernatant, ressuspend pellet in 200 µl 1xSDS sample buffer 
- vortex 30 sec 
- add 100µl glassbeads 
- vibrax 1 min full speed 
- 2 min at 95°C 
- vibrax 1 min full speed 
- 2 min at 95°C 
- spin down 5 min @ full speed 
- take SUP and load 15µl (= 0,75 OD-units) on a SDSgel 
 
 
 Whole cell extracts 
 
- Start with 15-20 OD600 units of exponentially growing cells. 
- Spin down cells (2minutes at 3000rpm in Heraeus). Resuspend cell pellet in 1ml  H20 and transfer 
to Eppendorf tube. Spin down cells 10-15sec at full speed, discard supernatant. You may snap-
freeze the pellet at this point in liquid N2 or on dry  ice  and store at -80 ºC. 
- Work on ice. 
- Resuspend the sediment in 2x its volume (i.e. 300-400 µl for 20 OD units) of the breaking buffer: 
50 mM Tris pH 7.5, 1 mM EDTA, 20 mM DTT, 100X protease inhibitor cocktail (store the buffer 
 without inhibitors in aliquots at -20 ºC). 
- Add a bit less than an equal volume of acid-washed glass beads (there should be some liquid 
above the beads) and mix on the  IKA vibrax at 4 ºC for 2x 3-5 min with a 2 min break on ice. 
- Take 10 µl of the extract for protein determination. Spin this aliquot (5 min max. speed), take 0.2 
µl (i.e. 1 µl of 1:5 dilution) and 1 µl for the BioRad protein assay (protocol 15). 
- Transfer 120µl of cell extract to new tube and add 40µl of 4xSDS loading buffer, boil for 5 min 
(or 95 ºC). 
- Spin down, then take the supernatant. Load 70 µg (minigel) to 150 µg (large pocket gel) /lane. Or  
load 15 or 20µl, respectively, if you have not determined  protein conc. 
- Store the rest at -20 ºC. 
 
 
3.2.4 Tandem Affinity Purification (TAP) 
 
1. Yeast Culture 
- inoculate 3 ml YPD with single clone from plate 
- grow overnight at 30°C (wheel) 
- dilute culture to OD600 = 0.2 
- grow during the day at 30°C 
- inoculate 2 l YPD (in 5 l flask) with 1 ml of culture 
ON @ 30°C, 130 rpm to OD600 = 3.5 – 4.0 
- harvest cells by centrifuging 5 min at 5000 rpm at 4°C 
- resuspend P in 20 ml water, transfer to 50 ml Falcon  
- spin 5 min at 4000 rpm at 4°C  
 
2. Cell Lysis 
- add to harvested cell pellet (about 20 ml) 
- add 20 ml Lysis Buffer (LB) (prepare 500 ml) 
  50 mM Tris Hcl pH7.5 
  100 mM NaCl 
  1.5 mM MgCl2 
  0.15% NP-40 
- add 40 ml acid-washed glass beads 
- bead mill (default program, approx. 15 min) 
- remove glass beads by filtering (50 ml syringe) 
- spin 1 h at 20,000 g (13000 RPM, SS-34) at 4°C;  
- remove fatty top layer with waterpump (important! fat clumps IgG beads) 
- transfer lysate to 15 ml Falcon tube 
+ glycerol (cf = 5%) 
freeze lysate in liquid N2, store at -80°C  
 
3. Purification 
3.1.IgG beads 
- wash 0.2 ml packed IgG beads (0.4 ml 50% slurry) with cold LB 
- thaw cell lysate at 37°C (waterbath) 
- put on ice 
- remove aliquot T(otal) 
- add beads to lysate 
- incubate 1 h at 4°C (wheel) 
 - spin 3 min at 1800 rpm, at 4°C 
- remove aliquot “FT” 
- remove supernatant to Vf = 0.8 ml (waterpump) 
- transfer beads to Mobicol with luerlock cap (closed at bottom) 
- fix 20 ml syringe to Mobicol 
- wash Mobicol with 10 ml LB + 0.5 mM DTT (gravity flow) 
- close Mobicol 
 
3.2.TEV cleavage 
- add 150 µl LB + 0.5 mM DTT 
- add 4 ul TEV (1 mg/ml) 
- mix by inverting 
- incubate 1 h at 16°C (wheel) 
 
3.3.Calmodulin (CaM) beads 
buffer preparation: 
• 1 ml LB + 4 mM CaCl2 + 1 mM DTT 
• 25 ml LB + 2 mM CaCl2 + 1 mM DTT 
bead preparation: wash 250 µl packed beads 3 × with LB + 2 mM CaCl2 + 1 mM DTT 
(centrifuge always 2 min at 1800 rpm) 
transfer beads to new Mobicol 
- let excess buffer drop out 
- close new mobicol 
- prepare 150µl LB + 4 mM CaCl2 + 1 mM DTT 
 
 
TEV Elution:  
- Spin Mobicol 1 min at 2000 rpm, at 4°C (in 1,5 ml tube) 
- add 150 µl of TEV eluate to second Mobicol, keep rest of TEV eluate at -20°C 
- mix by inverting 
- incubate for 1 h at 4°C (wheel) 
- connect Mobicol to 10 ml syringe 
- wash with 5 ml LB + 2 mM CaCl2 
 
 
4. Elution 
- close Mobicol 
- add 600 µl Elution Buffer 
 10 mM Tris/HCl pH 8.0 
 5 mM EGTA 
 (adjust pH to 8.0 !)  
 and mix by inverting 
- shake for 10 min at 37°C (600 rpm Eppendorf Thermomixer) 
- To elute, spin 1 min at 2000 rpm in 1.5 ml tube 
- add cold TCA (cf=10%) 
- leave 15 min on ice 
- spin 15 min at 13000 rpm, at 4°C 
- remove Supernatant 
- ressuspend pellet in 25-50 µl 1× SDS-LD 
- neutralize with 1 M Tris Base 
  
 
3.2.5 Determining Telomeric Silencing 
 
- 10-fold serial dilutions from an overnight culture were plated out on YEPD plates, 5'FOA 
containing plates and SDC-URA and incubated at 30 and 37 degrees for 2-5 days. 
 
λTelomeric Length analysis:  
 
 Genomic Extraction 
 
−Harvest 10ml of an overnight culture. 
−Centrifuge for 5 minutes, 4000 RPM, at room temperature. 
−Ressuspend pellet in 0,5ml H2O. 
−Centrifuge at maximum speed for 5 seconds and remove supernatant. 
−Vortex pellet. 
−To the pellet add 200 µl Breaking Buffer, 200 µl Glass Beads, 200 µl Phenol-Chloroform-
Isoamylic acid. 
−Vortex hard for 3-4minutes. 
−Add 400⎧l TE, vortex carefully. 
−Remove aqueous phase into a new tube. 
−Add 1ml 96% Ethanol. 
−Centrifuge maximal speed for 3 minutes, at room temperature. 
−Remove supernatant and dry pellet. 
−Ressuspend in 50 µl H2O. 
 
 
 
 Restriction Digestion of the genomic DNA 
 
- Digest extracted DNA overnight with Xho I and add RNAseA (µg/µl). 
 
 
 
 Southern Blot 
 
- Load digested samples onto 0.8% agarose gel containing EtBr in the gel and in the running buffer 
(1XTAE). Run at no more than 100V.  Takes between 2 and 5h. It is best to have 32P-endlabelled 
Lambda markers.  If your DNA is a bit dilute, then you might consider digesting 10 µl. Take a 
picture of the gel. 
 
BLOTTING: 
 
- De-purinate by shaking in 0.5 liter 0.25 M HCl (1 to 50 dilution of conc HCl) for 20 min. The 
bromophenolblue dye should turn yellow. 
- Rinse in H2O. 
- Denature by shaking  the gel(for 2 X 20 min) in 0.5 liter denaturing solution: 0.5M NaOH 1.5 M 
NaCl (20g NaOH and 87g of NaCl in 1 litre). 
- Set up blotting with 5 sheets of Whatman 3MM folded around a glass plate sitting in a shallow 
 plastic container with a  shallow reservoir of denaturing solution in the bottom. 
- Place the gel upside down on the filter paper (avoiding air bubbles), surround the gel with 
parafilm so that there are no short circuits. Put a pre-wetted Hybond N+ filter on the gel (pre-wet in 
H2O followed by soaking in denaturant and blot excess liquid off) and then put a couple of sheets 
of semi-dry/prewetted and blotted dry whatman 3MM paper on the membrane filter. Remove all air 
bubbles by rolling a 25ml pipet over the sheets. Then put several stacks of hand towels on top and 
leave to blot for 2-3 hours. When unmounting the blot, note that the membrane should be marked 
with a pencil so that you know which side the DNA is on. 
- Rinse the membrane in 2x SSC for 1 min, blot dry on filter paper (3MM). Cross link immediately 
after drying by exposing the DNA side of the filter in a Stratalinker (AUTO program).    
 
 
 Preparation of Probe 
 
−Telomeric DNA probe 
Amplified by PCR. 
Template – TG-repeat-containing plasmid (Heidi Feldmann) 
 
 
 Hybridization and washing 
 
- See Northern Blot.  
 
 Detection 
 
- See Northern Blot. 
 
 
3.2.6 FACS 
 
−Harvest 2 OD600 units of logarithmically growing cells. 
−Wash twice with 50mM Tris-HCl pH8.0 
−Resuspend in 1ml 50mM Tris-HCl pH8.0, 70% EtOH. 
−Incubate for at least 1 hour at room temperature or for up to several days at 4degrees. 
−Spin down 100 µl of the suspension in a safelock tube, wash twice with 1ml 50mM Tris-HCl 
pH8.0 (spin at least 1 minute). 
−Resuspend in 0,5ml 50mM Tris-HCl pH8.0 containing 2mg/ml RNAse A (pre activated for 
15minutes at 100 degrees). 
−Incubate at 50degrees for 2 hours in roll oven. 
−Add 20 µl of 20 mg/ml Proteinase K stock solution (in H20) and incubate for 1 hour at 50 degrees. 
−Spin down, wash with 1ml FACS buffer. Samples can be stored ON at 4degrees at this time. 
−Resuspend cells in 500 µl FACS-PI and incubate for 1-2 hours in the dark at room temperature on 
a wheel. 
−Prior to analysis, incubate for 10seconds in an ultrasonic bath. 
−Prepare 1:4 dilution in 50mM Tris-HCl pH8.0 buffer. 
 
 
FACS Buffer (100mL) 
200mM TrisHCl pH7.5, 211mM NaCl, 78mM MgCl2 
  
FACS-PI 
180mM Tris-HCl pH7.5, 190mM NaCl, 70mM MgCl2, 50 µg/ml propidium iodide. 
 
 
3.2.7 Immunofluorescence 
 
Cell preparation 
−Grow overnight culture. 
−Dilute to OD600=0.3 and let grow until OD600=1 
−Split culture into two.  
−To one culture add 10% final volume of Formaldehyde and incubate 1h at 30 degrees. 
Thereafter on ice.  
−The other culture place to 37 degrees for 2hours, in a shaking waterbath. 
 
−After the 2 hours at 37 degrees, add 10% final volume of formaldehyde. Keep for 15 minutes more 
at 37 degrees and change to 30 degrees for 45 minutes. 
−Spin both cultures for 3minutes at 3000RPM. 
−Remove supernatant and ressupend pellet in spheroblasting buffer. 
−Wash 3 times. 
−Add spheroblasting buffer + beta-mercaptoetanol + zymolase 100T and incubate for 45 minutes at 
30 degrees. 
−Wash once with spheroblasting buffer 
−Ressuspend in 250 µl, aliquot and freeze. 
 
Slide preparation and protocol 
−coat slide wells with 10ul Poly-L-Lysine (1:5) during 5 minutes, soak off. 
−Add 10 µl H2O for 5 minutes and let dry. 
−Wash wells with PBS+0,1% BSA for 5 minutes. 
−Add 10 µl first antibody containing solution, anti-myc 9E10, 1:300 diluted in PBS+0,1% BSA. 
Incubate for two hours in a wet chamber. 
−Wash three times with PBS/BSA/TritonX 0,1%, each 1 minute. 
−Add 10ul of secondary antibody solution, Alexa488-coupled goat anti-mouse, for 1 hour in a wet 
chamber and kept in the dark. 
−Wash three times with PBS/BSA/TritonX 0,1%, each 1 minute. 
−Add 10 µl Hoechst for 15minutes and suck off. 
−Wash once with 1xPBS. 
−Mount with 80% Glycerol in DEPC. 
 
 
 
3.2.8 UltraViolet CrossLinked Immuno-Precipitation (CLIP) 
 
 
Day 0 
- grow overnight the cultures 
Day 1 
- harvest, crosslink, lyse, IP, label, SDS-PAGE 
 - blot overnight 
Day 2 
- expose 
 
Controls and the expected result when compared to protein of interest: 
 
- no tagged protein: no labelling 
- tagged protein + no crosslinking: absence or reduce labelling  
- treatment with different RNase concentrations: change in the mobility of the RNA-protein 
complex expected, shifted up when lower amount or no RNase is used 
- the band obtained by autoradiography should NOT fit EXACTLY with the band seen in Western 
Blot from the very same membrane. The reason is that not all protein gets crosslinked and only the 
crosslinked ones would give a shift. This shifted band would not be visible in Western blot. 
 
Protocol: 
 
Sample preparation (volumes for 200 ml culture) 
 
- grow o/n. Dilute to OD 600/ml = 0.15 with fresh media. Grow until OD 600/ml = 0.5. Use 200 ml 
culture/testing condition. 
- Pellet cells at 4°C and wash once with cold 1x PBS 
- Resuspend in 10 ml (final volume) of cold 1x PBS and plate them into a precooled 10 cm Petri 
dish. place the Petri dish in an ice-water bath 
- Crosslink in UV-crosslinker (Spectrolinker XL-1500 from Spectronics Corporation) 2x at 
4500x100 microJ per square cm at 15 cm distance from the lamps on an ice-water bath. Shake 
vigorously the petri dish between crosslinking cycles. 
- Recover all cells from the Petri dish with the help of cold 1x PBS. Pellet the cells at 4°C. 
- Resuspend the cells in 400 microliter of 1x PXL buffer  (cells can be stored at -80°C at this point) 
- Add protease inhibitors while thawing the extract 
- Add 250 microliter glass-beads. Lyse cells in vibrax for 3 cycles of 3 min on and 3 min off at 4°C. 
- Spin cells at 3600 rpm in microfuge (1200 xg aprox.) for 3 min at 4°C. Take sup. 
- Optional: Add 400 microliter of 1xPXL buffer + Protease inhibitors. Vibrax 1 x 3 min on. Spin in 
microfuge as before. Pool both sups. 
- Add 8 microliter RNasIn (Promega) and 8 microliter RQ1 DNase (Promega). Incubate at 37°C for 
15 min in a Thermomixer at 1000 rpm 
- Dilute T1 RNase (Roche, 100 U per microliter) 1:40 in 1x PXL buffer. Add 12 microliter and 
incubate at 37°C for 10 min in a Thermomixer at 1000 rpm. 
- Spin at 90000 rpm (360000xg aprox.) for 25 min and 4°C in RP120AT rotor in Polycarbonate 
tubes. Take sup (see note 6) 
- Perform IP 
 
 
IP (for Khd1-TAP) 
 
- Add 30 microliter of equilibrated IgG-Sepharose and resuspend to 1:1 in 1x PXL buffer. Incubate 
for another 1 h at 4°C in a rotating wheel. 
- Wash 2x with 1x PXL buffer and 3x with 1x PNK+ buffer 
- Label RNA fragments 
 
 
 Labelling 
 
- Resuspend beads in 100 microliter of 1x PNK+ buffer (remove 10 microliter for checking IP) and 
add 5 microliter of gamma-32P-ATP (Amersham) and 5 microliter of PNK enzyme RNase free. 
- Incubate in Thermomixer at 37°C and 1000 rpm for 20 min 
- Finish reaction by adding 10 microliter of 1 mM ATP. Let the reaction go another 5 min. Take 2 
microlier and count them with Cherenkov program in scintillation counter (TOTAL) 
- Wash 4x with 1xPNK+ buffer 
- Prepare for SDS-PAGE 
 
 
SDS-PAGE (Bis/Tris gel) 
 
- Resuspend beads in 30 microliter of 1x PNK+ buffer and 30 microliter of Novex loading buffer. 
- Incubate at 70°C fro 10 min at 1000 rpm. Take 2 microliter and count them in scintillation counter 
with cherenkov program (IP) 
- Isolate beads and take sup for loading. count beads in scintillation counter with cherenkov 
program (Beads) 
- load 2 wells per tube 
- run gel following manufacturer conditions in 1xMOPS/SDS buffer (200V for about 1h) 
 
 
 
Gel transfer 
 
- Transfer to S&S BA-85 nitrocellulose using a wet transfer apparatus following manufacturer 
instructions in 1x Novex transfer buffer + 20% methanol (p.a.) 
- Blot overnight at 30V and 90 mA in a Bio-Rad Mini Trans-Blot wet transfer unit without cooling 
unit and stirring the buffer 
- After transfer, rinse the membrane in 1x PBS, and gently blot on Kimwipes. Wrap membrane in 
plastic wrap 
- Expose to film with 2 intensifying screens at -80°C. Signal varies from experiment to experiment. 
I use to expose 3 films simultaneously and develop them at different exposition times 
 
 
 
Buffer composition for the CLIP assay 
 
20x PBS (treat with DEPC) 
+ 2.74 M NaCl, (160 g/l) 
+ 53.6 mM KCl, (4 g/l) 
+ 202.9 mM Na2HPO4, (36 g of Na2HPO4xH2O per liter) 
+ 29.4 mM KH2PO4 (4.8 g/l) 
 
1x PXL (prepare with DEPC treated water), for 50 ml 
+ 1x PBS (without Mg++ or Ca++) , 2.5 ml 20xPBS 
+ 0.1% SDS, 250 microliter 20%SDS 
+ 0.5% deoxycholate, 2.5 ml 10%DOC 
+ 0.5% NP-40 2.5 ml 10%NP40 
+ DEPC water, 42.25 ml 
  
1x PNK+ or PNK (prepare with DEPC treated water), for 50 ml 
+ 50 mM Tris-HCl pH 7.4, 2.5 ml 1M Tris 
+ 10 mM MgCl2, 500 microliter 1M MgCl2 
+ 0.5% NP-40, 2.5 ml 10% NP40 
+ DEPC water, 44.5 ml 
 
1x PNK + EGTA (prepare with DEPC treated water) 
+ 50 mM Tris-HCl pH 7.4 
+ 20 mM EGTA 
+ 0.5% NP-40 
 
20x MOPS/SDS running buffer (from Hahn's lab methods http://fhcrc.org/science/labs/hahn/) 
+ 1 M MOPS (195.2 g/l) 
+ 1 M Tris base (121.1 g/l) 
+ 69.3 mM SDS (20 g/l) 
+ 20.5 mM EDTA free acid (6 g/l) 
make it with ultrapure water. 1x buffer should be pH 7.7 (do not adjust with acid or base) 
 
20x NuPAGE transfer buffer (from Hahn's lab methods http://fhcrc.org/science/labs/hahn/), for 250 
ml 
+ 500 mM Bicine (81.6 g/l), 20.4 g 
+ 500 mM Bis-Tris (104.64 g/l), 26.2 g 
+ 20.5 mM EDTA free acid (6 g/l), 1.5 g 
make it with ultrapure water. 1x buffer should be pH 7.2 (do not adjust with acid or base) 
 
1x PK buffer (prepare with DEPC treated water) 
+ 100 mM Tris-HCl pH 7.5 
+ 50 mM NaCl 
+ 10 mM EDTA 
 
1x PK/7M urea buffer (this buffer must be fresh), for 10 ml 
+ 100 mM Tris-HCl pH 7.5, 1 ml of 1 M 
+ 50 mM NaCl, 250 microliter of 2 M 
+ 10 mM EDTA, 200 microliter of 0.5 M 
+ 7 M Urea, 4.2 g 
+ DEPC-water up to 10 ml 
 
10XTBE 
+ 890 mM Tris,  (108 g/l) 
+ Boric acid, (54.1 g/l) 
+ 20 mM EDTA, 40 ml 0.5 M 
 
20% PAGE/UREA (it has to pre-run for at least 15 min) 
+ 12.6 g urea 
+15 ml acrylamide (40%, 19:1) 
+3 ml 10XTBE 
+2.5 ml DEPC-water 
+300 microliter 10% APS (in DEPC-water) 
+11 microliter TEMED 
  
10% PAGE/UREA (it has to pre-run for at least 15 min) 
+ 12.6 g urea 
+ 7.5 ml acrylamide (40%, 19:1) 
+ 3ml 10xTBE 
+ 10 ml DEPC-water 
+ 300 microliter 10% APS in DEPC-water  
+ 11 microliter TEMED 
 
Nucleic acid elution buffer, for 9 ml 
+ 1 M NaOAc pH 5.2, 3 ml 3 M 
+ 1 mM EDTA, 18 microliter 0.5 M 
+ DEPC-water, 6 ml 
 
 
3.2.9 Flotation Assay 
 
Spheroblast preparation 
−Chill cultures on ice 
−Harvest 400 OD units of an early logarithmic culture (0,5-1,0), spin 10minutes at 6000xG 
−Wash cells once, spin 5 minutes at 2000xG 
−Resuspend cells in 5ml SB-buffer under gentle shaking 
−Spheroblast cells for 1h at 37 degrees in SB-buffer under gentle shaking 
−Pellet Spheroblasts trhough a 8ml sorbitol cushion at 600g for 12 minutes 
 
 
SB buffer 
1,4M sorbitol, 50mM KP pH7,5 
add freshly before use: 
10mM NaN3, 0,4% beta-MeEtOH, 2mg/ml Zymolyase 20T 
 
Sorbitol cushion 
1,7M Sorbitol, 50mM KP pH7,5 
 
−lyse spheroblasts im 4ml Lysis buffer 
20mM Hepes 
140mM KAc 
1mM MgAc 
1mM EDTA 
+Protease inhibitors 
 
−stroke 22 times, up and down, in a douncer. 
−Spin 5x at 450xG to remove cell debris. 
−Layer Sucrose gradient: 4 layers, 3ml each. 
Upper layer - 0% 
second layer - 40% 
sample loading layer - 50% 
lowest - 70% 
 
 −Spin 8,75 hours in a SW40 rotor, at 4degrees 
−Take aliquots from each layer, interfaces and resuspended pellet 
−precipitate with 15% TCA. 
 
 
3.2.10 Yeast Colony PCR 
 
−suspend small amount of cells in 100 µl 0,02M NaOH. 
−Add glass beads 
−5minutes at 100 degrees, 1400RPM 
−spin at full speed, 15 seconds 
−use 5 µl as template for PCR 
 
 
3.2.11 Immunoprecipitation 
 
Day1 
−Innoculate yeast strains and grow them overnight. 
−Block coupled beads: 
25 µl beads per 15OD culture. 
Wash 3 x 10minutes with RNA buffer. 
 
Day2 
−dilute culture to 100 ml OD600=0,3, grow at 30 degrees to OD600=0,8-1,0. 
−Harvest 15 OD600: 3 minutes at 3600RPM at 4 degrees and discard supernatant. 
−Resuspend pellet in 1 ml cold H2O, transfer to 1,5ml tube. 
−Spin at maximum speed for 15 seconds and discard supernatant. 
−Add to pellet 200 µl breaking buffer and ressuspend. 
−Add 200 µl glass beads 
−break cells 4x 3 minutes with vibrax with a 1 minute break in between. 
−Add 100 µl breaking buffer. 
−Centrifuge 2 minutes at 3000RPM at 4 degrees. 
−Transfer 250 µl into a new tube, keep a 30 µl aliquot (Total). 
 
−Remove blocking solution from blocked beads (MPC) 
−resuspend beads in 500 µl breaking buffer. 
−Transfer aliquots in needed number of tubes. 
−Add cell extract 
−incubate 2hours at 4degrees (wheel) 
−place tubes into MPC 
−discard supernatant, but take an aliquot for western blot 
−wash twice with 1ml wash buffer 
−suspend in 350 µl wash buffer 
−place tubes in MPC, discard supernatant 
−resuspend pellet in 30 µl 1xSDS-loading buffer 
−place 5minutes at 95 degrees 
−place in MPC and transfer sup into a new tube. 
 
 Covalent Coupling of mouse anti-myc 9E11 to Dynabeads Protein G 
 
−use 1ml antibody per 100 µl packed beads 
−wash 500 µl beads twice with 1ml 0,1 M sodium phosphate pH7.0, use MPC for washing 
−thaw 15ml aliquot bybridoma supernatant anti-myc 9E11 
−add 12 µl 1M Tris-HCl pH7.5 
−distribute beads to 4 1,5ml tubes (125 µl each). 
−Add 1,25 ml hybridoma supernatant 
−40 minutesat room temperature with gentle rotation (wheel) 
−wash twice in 1ml 0,1 M Na-Phosphate buffer pH7.0 
−wash twice in 1ml 0,2 M Triethanolamine pH7,2 
−pipet all beads into one 2ml tube 
−add 1ml 20mM DMP in 0,2 M triethanolamin (5,4mg in 1ml, prepare freshly). 
−Incubate for 30minutes at room temperature with gentle rotation. 
−Add 1ml 50mM Tris-HCl pH7,5 
−incubate 15 minutes at room temperature with gentle rotation. 
−Wash 3 times in 1ml 1xPBS/0,1% Tween 
−wash beads in MPC, twice with 1ml 1xTBS 
−wash beads once with 1ml 0,1M glycine/HCl pH2,5 
−wash beads once with 1ml 0,1 M Tris/HCl pH8,8 
−wash twice with 1ml 1xTBS 
−take up beads in 1xTBS pH7,4 (50% slurry, 500 µl) 
−store beads at 4 degrees. 
  
 
Breaking buffer 
50mM Hepes/KOH pH7,3, 20mM KOAc, 2mM EDTA pH8,0, 0,1% (w/V) Triton X-100, 5% 
(w/V) Glycerol +1x Protease inhibitor Mix 
 
wash buffer 
50mM Hepes/KOH pH7,3, 50mM KOAc, 2mM Mg(OAc)2, 0,1% (w/V) Triton X-100, 5% (w/V) 
Glycerol 
 
RNA buffer 
50mM Hepes/KOH pH7,3, 20mM KOAc, 0,1% (w/V) Triton X-100, 5% (w/V) Glycerol, 0,1mg/ml 
tRNA 
 
 
 
3.2.12 Point mutant generation 
 
Site directed mutagenesis kit 
2 µl plasmid DNA (1:10) 
0,625 µl Oligo 1 (10pmol) 
0,625 µl Oligo 2 (10pmol) 
2,5 µl buffer 
0,5 µl Super Taq 
18,125 µl H2O 
 
 - Add 1 µl DpnI and digest for 1hour at 37 degrees. 
−Add Top10 cells, heat shock at 42 degrees, for 30 seconds and incubate in preheated LB for 1hour 
shaking at 37 degrees. 
 
 
 
3.2.13 Polysome profiling analysis 
 
Prepare buffers: 
- 10xPolysome Buffer 
 200mM Hepes/KOH pH7.5 
 750mM KCl 
 25 mM MgCl2 
 10 mM EGTA 
−60% Sucrose in DEPC (pH7,5) filtrated 
−10mg/ml Cycloheximide in water (freshly prepared) 
 
 
- Grow overnight culture. 
−Dilute to OD600=0,1 and let grow until OD600=0,5 
−Add 0,1mg/ml cycloheximide to 50ml of cells (500 μl of 10mg/ml stock) 
−Incubate 10 min at 30 degrees 
−Harvest cells by centrifugation: 3minutes, 3000RPM at 4 degrees 
−Prepare 1 eppendorf tube per strain with 50% glass beads 
−Remove all traces of supernatant 
−Add 20 μl 1xPolysome buffer (plus 0,1mg/ml Cycloheximide, plus 1mM DTT) per OD 600 cells 
(500μl for OD0,5) 
−Lyse cells by vortexing in the cold room (250⎧l beads, 500 μl 1x Polysome buffer) for 5minutes. 
−Spin 5minutes 13000RPM at 4 degrees. 
−Take 10 μl of supernatant, dilute in 990 μl H2O and measure A260. 
−Load 250 μg RNA onto the gradient (1 OD 260=40μg/ml RNA) 
−Spin 2 hours, 38000 RPM, SW40 rotor. 
−Collect 500μl fractions. 
 
TCA precipitation 
−Provide 1 ml TCA premix (10-15% TCA: 37,5ml H2O + 10 ml TCA) in tube on ice. 
−Vortex sample. 
−Take out 250 μl (enough for 2 blots) and add to TCA premix 
−Vortex 
−Incubate ON on ice in the cold room 
−Spin 30 minutes maximum speed, at 4 degrees. 
−Take off supernatant 
−Add 500 μl ice cold aceton 
−Spin 10 minutes, maximum speed at 4 degrees (small white pellet) 
−Take off supernatant 
−take off remaining supernatant with yellow tip. 
−Add 20 μl 1x sample buffer Premix (1 ml 1 x Sample Buffer + 50 μl Tris base) 
−Vortex 
 −Let stand for 1 hour 
−Vortex sample 
−Boil for 1 minute 
−Vortex sample 
−Boil for 1 minute 
−centrifuge 1 minute, 13000RPM 
−Load gel. 
 
Preparation of gels: 
−prepare 12 ml (enough for 2 gradients) a 10% and a 50% sucrose solution both with 1mM DTT 
and cycloheximide 0,1mg/ml. 
−prepare 12 ml (enough for two gradients) a 10% and a 50% sucrose solution both with 1mM DTT 
and cycloheximide 0,1mg/ml and 0,01M EDTA. 
−Pour 6ml of the 50% solution and then 6ml of the 10% solution, onto the same SW40 rotor tube. 
Cover with parafilm and lay gently down, allowing the fractions to mix. Let lie for 2hours. After 
that put them upright in the coldroom for 2 hours or until the cells are ready. 
 4. RESULTS 
 
4.1 Relationship of ASH1 mRNA localization and nonsense mediated decay (NMD)? 
As the ASH1 mRNA localization process is a temporally well defined event and it has been shown 
that a premature stop codon (PTC) causes a loss of anchoring at the bud tip, while still bud localized 
(Jaedicke, PhD Thesis) we wanted to investigate whether there was a link between NMD and 
mRNA localization factors (RLFs). 
 
To first address this issue we decided to use a galactose driven ASH1 system (Fig. 2) to measure the 
half-life of this mRNA. 
 
Fig. 2 - Schematic view of the ASH1 construct used to determine ASH1 mRNA half-life.  
Another construct containing a PTC before the E1 element was also used in the same setup. The 
GAL promoter was induced and ASH1 mRNA was transcribed from both constructs, the wildtype 
containing one and the PTC containing one. Half-life was determined by analysing the rate of decay 
after promoter repression. 
 
 WT (n=3) E1-Stop (n=3) 
wt 9,9 8,66 
∆ccr4 7,8 10,47 
∆ccr4 ∆she2 7,6 7,62 
∆dcp1 10,1 11,55 
∆upf1 7,69 9,43 
∆upf1 ∆she2 7,96 10,12 
∆vts1 9,57 9,72 
 ∆she2 ∆vts1 7,7 12,1 
∆she2 8,66 9,32 
∆khd1 9,9 10,7 
∆khd1 ∆she2 11,55 17,33 
∆puf6 11,55 11,55 
∆puf6 ∆she2 16,08 14,84 
∆scp160 20,10 20,04 
Table 1 – Comparison of influences of different mutants on the half-life of ASH1 mRNA, both 
wildtype and ASH1-Stop-E1. 
 
These results, presented in Table 1, led us to the surprising finding that the disruption of the major 
ASH1 mRNA binding protein, SHE2, has no influence on its own in ASH1 mRNA half-life. 
Furthermore, factors involved in the NMD pathway, such as CCR4, UPF1 and DCP1, also do not 
show any change in ASH1 mRNA half-life, not even in combination with ∆she2. Interestingly, no 
measurable effect was observed for mRNA nonsense mediated decay mutants, indicating that there 
is no nonsense mediated decay for ASH1 mRNA. VTS1, the yeast Smaug homolog and a partner to 
CCR4-NOT complex, when in combination with a ∆she2 showed a 30% increase in ASH1-E1-Stop 
mRNA as compared to the wildtype, or even to ∆she2. 
On the other hand, two other ASH1 mRNA binding proteins, shown to be translation repressors, 
encoded by PUF6 and KHD1 do cause a change in ASH1 mRNA half-life when in combination 
with ∆SHE2. ∆puf6 ∆she2 shows a 40% half-life increase for the wildtype and 30% increase for 
ASH1-Stop-E1 when compared to ∆puf6 alone and ∆khd1 ∆she2 shows a 15% half-life increase for 
the wildtype ASH1 and 60% increase for ASH1-Stop-E1 when compared to ∆khd1. In addition, 
another gene involved in translation regulation, SCP160, showed a 2x fold increase in ASH1 mRNA 
half-life, for both constructs tested. 
We found that Δshe2 Δkhd1 and Δshe2 Δpuf6 did show a cumulative effect on ASH1 mRNA half-
life. These findings were not so surprising, since these proteins are mRNA binding proteins and are 
active in localization of ASH1 mRNA to the daughter cell. Although mRNA localization per se is 
not an essential process we wanted to test for cell viability and temperature sensitivity, in order to 
try to identify other processes that might be impaired. 
 
 
 
 
 
 4.2 Relationship between RNA localization factors and cell viability? 
Fig. 3 - Temperature sensitivity of mRNA localization factors. 10-fold serial dilutions from an 
overnight culture were plated in YEPD media and then incubated at 30 and at 37 degrees. 
 
The results (Fig. 3) show that there is a temperature sensitive growth defect for Δloc1 Δshe2, that 
does not grow at 37ºC. Surprisingly, this double disruption grows better at 30ºC than a Δloc1 She2-
myc3. In addition, a Δshe2 Δkhd1 shows a synthetic growth defect at 37ºC. 
 
 
4.3 What is Khd1p connection to ASH1 mRNA localization process? 
Khd1p, has been shown to be localized with the ASH1 mRNA to the bud tip (Irie et al. 2002). These 
results made us interested in addressing the questions: i) is Khd1p a part of the locasome? ii) Does 
it travel with the ASH1 mRNP together? Is Khd1p involved in ASH1 mRNP formation? 
In order to achieve this, we set out to identify interacting protein partners of Khd1p and therefore a 
Khd1p-Tandem Affinity purification was established. 
 
 It has been observed, in our lab and others, that the addition of an epitope to the COOH-end of a 
determined gene can lead to a non functional or growth defect/growth impaired phenotype. To 
answer this question, drop tests were performed (Fig. 4A). No detrimental effect was found for a 
Khd1p-TAP tag. 
Fig. 4 – Can Khd1p be purified with a tandem affinity purification approach? 
A – Drop test for growth viability of a Khd1-TAP. 
B – Coomassie stained gel of TEV cleaved eluates. 
C – Silver stained gel of Calmodulin binding eluates. 
 
4.4 Which co-purifying proteins can be found with this approach? 
When the Khd1p purification was performed using a 100.000G 1hour centrifugation step only the 
bait was found on a coomassie stained gel, after the calmodulin binding step (data not shown). As 
Khd1p may play a role in the nucleus (Denisenko et al., 2002; Du et al., 2008), the centrifugation 
speed was reduced to 10.000g. Again, this approach did not yield after the calmodulin binding step, 
apart from the bait, coomassie detectable bands that were different from a mock purification. On the 
other hand, when a silver staining was performed a few co-purifying bands could be found on the 
 same calmodulin eluates (Fig, 4C). Furthermore, the TEV cleaved eluates after this slower 
centrifugation step showed additional coomassie co-purifiers, as expected. (Fig. 4B)  
4.5 Is Khd1p a part of a RNA dependent protein complex? 
How could Gavin and co-workers (Gavin et al., 2002; Gavin et al., 2006) find so many other co-
purifying proteins? Could we be facing mRNA mediated interactions? Is She2p tethering any 
Khd1p binding partners? 
 
Fig. 5 - Khd1p tandem affinity purification. 
A – Coomassie Stained Khd1p-Tandem affinity purification. 
B – Coomassie Stained TEV cleaved eluates after RNAse treatment. 
C – Silver Stained TEV cleaved eluates, with and without RNAse treatment. 
 We observed that the RNAse treatment showed no change on the coomassie stained protein pattern 
(Fig. 5B). The RNAse treatment led to changes in the co-purifying protein pattern in the silver 
stained TEV-cleaved eluates (Fig. 5C). 
 
4.6 Is Khd1p a part of the locasome? Can it co-purify other members of the ASH1 
mRNP? 
As can be seen above, a Khd1p tandem affinity purification did not yield coomassie stainable co-
purifying bands and did not allow us to conclude whether Khd1p was a part of the locasome. We 
decided to tackle this question directly, by looking for the other members of the locasome in the 
eluates and trying to see whether some of the proteins that were missing in the silver stain after 
RNAse treatment corresponded to any of the locasome members. 
 
Fig. 6 - Can Khd1p co-purify She2p? 
Western blot analysis of TEV cleaved eluates, probed with a Anti-She2p antibody. 
Lane 1 – Khd1p-TAP TEV cleaved eluate; Lane 2 – Untagged strain TEV cleaved eluate; Lane 3 – 
Khd1p-TAP TEV Cleaved Eluate, after 20minutes RNAseA, at 16°C; Lane 4 - Khd1p-TAP TEV 
Cleaved Eluate, after 20minutes at 16°C. Lane 5 – Khd1p-TAP ∆she3 TEV cleaved eluate. 
 
She2p can be co-purified when using Khd1p as bait (Fig. 6). Surprisingly, this purification is 
independent of RNA, as a 20min 1mg/ml RNAse A treatment does not abolish this co-purification. 
 
4.6.1 Does it also co-purify other members of the locasome? 
She3p is the adaptor protein between She2p and Myo4p, the motor that transports the cargo. So we 
wanted to know whether She3p and Khd1p can also be co-purified. 
She3p-myc6 can also be co-purified with Khd1p (Fig. 7). Interestingly this purification is also 
independent of She2p and of RNA. These findings indicate a direct interaction of Khd1p with 
She3p, thus suggesting that Khd1p is itself, and not only She2p, a cargo of the SHE machinery. 
  
Fig. 7 - Khd1p co-purifies She3p-Myc6? 
A - Western blot against She3p-Myc6. Lane 1 – Khd1p-TAP She3-Myc6 TEV cleaved eluate; Lane 
2 – Khd1p-TAP She3-Myc6 TEV cleaved eluate, after 20minutes RNAse A treatment at 16°C; 
Lane 3 – untagged Khd1p She3p-Myc6 TEV cleaved eluate; Lane 4 – untagged Khd1p She3p-
Myc6 TEV cleaved eluate, after 20 minutes RNAse A treatment at 16°C; Lane 5 – Khd1p-TAP 
She3-Myc6 TEV cleaved eluate after 20minutes at 16°C. 
B -  Western blot against She3p-Myc6. Lane 1 – Khd1p-TAP ∆she2 She3-Myc6 TEV cleaved 
eluate; Lane 2 – Khd1p-TAP ∆she2 She3-Myc6 TEV cleaved eluate, after 20minutes RNAse A 
treatment at 16°C; Lane 3 – Khd1p-TAP ∆she2 She3p-Myc6 TEV cleaved eluate, after 20minutes 
at 16°C. 
 
4.6.2 Is there a direct interaction between She3p and Khd1p? 
The next question was to map the interaction between Khd1p and She3p. For this we performed a 
Khd1p tandem affinity purification again, but this time looking for co-purified HA-tagged She3-
COOH. 
 
Fig. 8 - Can Khd1p bind to the C-terminal end of She3p? Does it bind to the N-terminal end 
of She3p? Western Blot against HA-tagged She3p-COOH. 
Lane 1 – Total, Khd1p-TAP induced pGAL-HA3-She3-COOH. 
Lane 2 – TEV cleaved eluate, Khd1p-TAP induced pGAL-HA3-She3-COOH. 
  
HA-She3p-COOH was not co-purified with Khd1p in this approach (Fig. 8). Does it not bind to the 
COOH-end of She3p? Is this end not stable enough? 
 
What about the NH2-end of She3p? 
A Khd1p tandem affinity purification with a genomically Myc-tagged-She3p-NH2end was 
performed and analysed by western blot for Myc signal. A myc signal was observed even on the 
Khd1p-untagged strain, making this approach inconclusive (data not shown). 
 
 
 
 4.7 Khd1p, another mRNA binding protein associated to the Endoplasmic Reticulum 
(ER)? 
Schmid and coworkers (2006) have shown that She2p binds to the ER and that it floats on a sucrose 
sedimentation gradient. As Khd1p can co-purify She2p the question arose whether Khd1p could 
also interact with the ER-associated pool of She2p. ER flotation assays were performed (Fig. 9A) 
and analysed for flotation of Khd1p.   
 
Fig. 9 - Khd1p association to ER? 
A – 4-step gradient sedimentation profiling. Lane 1 - 0%, Lane 3 - 40%, Lane 5 - 50% and Lane 7 - 
70% sucrose layers. 
B – Western Blot against Sec61p, on Khd1p-TAP Total and TEV cleaved eluate. 
 
Khd1p partly mimicks the distribution observed for She3p-Myc6 in the lower fractions 40% to 
Pellet fractions. On the other hand, Khd1p floats to the top of a 4-step gradient profile as described 
 for She2p (Schmid et al., 2006) and surprisingly this happens also in the absence of She2p – 
fraction 0-40% (Fig. 9A), indicating that She2p is not required for Khd1p-ER association. 
4.7.1 Does Khd1p-affinity purification also yield ER-bound proteins? 
After having shown that Khd1p floats with the ER membranes, the question arose whether Khd1p 
binds directly to the ER and whether Khd1p could co-purify ER proteins, such as Sec61p. After a 
Khd1p tandem affinity purification we observed that it is not the case (Fig. 9B). 
 
4.8 Khd1p proposed to be a translation repressor. Does it show translation inhibitor 
sensitivity? 
Khd1p has been putatively identified as a translation repressor and shown to be accumulating with a 
U1A-mRNP at the budtip. (Irie et al., 2002). Recently it has been shown that indeed it has a 
translation repressor function (Paquin et al., 2007). 
 
Khd1p contains 3-KH domains. Scp160p is also a 14-KH domain containing protein and Δscp160 
has been shown to be sensitive to translation inhibitors (Baum et al., 2004). To map any other 
possible roles for Khd1p in translation regulation, Δkhd1 cells were tested with different translation 
inhibitor drugs for differential sensitivity. 
 
Paramomycin is a drug that inhibits protein synthesis by binding to 16S ribosomal RNA (Vicens 
and Westhof, 2001). 
Cycloheximide is an inhibitor of protein biosynthesis in eukaryotic organisms, produced by the 
bacterium Streptomyces griseus. Cycloheximide exerts its effect by interfering with the 
translocation step in protein synthesis (movement of two tRNA molecules and mRNA in relation to 
the ribosome) thus blocking translational elongation. 
Geneticin (G418) is an aminoglycoside antibiotic similar in structure to gentamicin B1. It is 
produced by Micromonospora rhodorangea. G418 blocks polypeptide synthesis by inhibiting the 
elongation step in both prokaryotic and eukaryotic cells. 
Hygromycin B is an aminocyclitol antibiotic with broad spectrum activity against prokaryotes and 
eukaryotes. Hygromycin B strongly inhibits protein synthesis through a dual effect on mRNA 
translation (Cabanas et al., 1978; Lacal and Carrasco, 1983). Like other aminoglycoside antibiotics, 
hygromycin B induces misreading of aminoacyl-tRNA by distorting the ribosomal A site (decoding 
center) (Cabanas et al., 1978; Davies and Davis, 1968; Moazed and Noller, 1987; Spahn and 
Prescott, 1986). Hygromycin B also affects the ribosomal translocation process (Cabanas et al., 
 1978; Gonzalez et al., 1978; Hausner et al., 1988). In the presence of the antibiotic, mRNA is often 
mistranslocated, being moved more or less than the three necessary bases. 
Anisomycin is an antibiotic produced by Streptomyces griseolus which inhibits protein synthesis. 
Partial inhibition of DNA synthesis occurs at anisomycin concentrations that effect 95% inhibition 
of protein synthesis (Grollman, 1967). Anisomycin interferes with protein and DNA synthesis by 
inhibiting peptidyl transferase or the 80S ribosome system. 
 
 
Fig. 10 – Drug sensitivity assay.  
An exponentially growing culture was plated on to YEPD plates, were filters containing 
anysomycin, paromomycin, hygromycin B, cycloheximide, geneticin and 100% ethanol were 
placed. Plates were incubated for 18 hours and the halos of inhibition were measured. 
 
We observed that ∆khd1 does not show any difference in regard to translation inhibitor sensitivity, 
indicating that it is not directly involved in translation regulation. 
 
 
4.9 Is Khd1p associated with polysomes? 
Polysomes, or multiple ribosomes, form around actively translated mRNAs. In order to confirm the 
hypothesis that Khd1p is a translation repressor, one should be able to see that Khd1p affects 
ribosome loading onto an mRNA and one should not find Khd1p associated to heavy polysomes as 
they should dislodge the repressor from an actively translated mRNA. 
Therefore, in a polysome profile one should encounter ASH1 mRNA in the heavy polysome 
fractions but no Khd1p. 
To test this idea polysome profiles were analysed. 
  
Fig. 11 – Is Khd1p associated to polysomes? 
Polysome profile showing Khd1p-ProA, She3p-myc9, Rpl13p fractionation along the gradient. 
 
 
 
 Fig. 12 – Does Khd1p co-migrate with the ribosomes upon EDTA treatment? 
Khd1-ProA She3p-myc9 after EDTA treatment. 
 
As can be seen above (Figure 11) Khd1p-myc9 associates with the polysomes, with 80S ribosomes 
and with 40S ribosomes. Upon EDTA treatment (Figure 12), that disrupts ribosome subunit 
association, Khd1p-ProA partially mimicks the distribution of the ribosomal protein Rpl3p. She3p-
Myc9 mimicks Rpl3p distribution perfectly.   
 
 
 
 
 4.10 Khd1p, an mRNA binding protein? 
 
Can we validate the purification from the TAP procedure for a stable mRNA-protein association? 
If so, to which other mRNAs, apart from E1-ASH1 mRNA element, does Khd1p bind? Could it be 
that messages that encode for the telomeric remodelling complex are bound by Khd1p and therefore 
show this striking effect on telomeric length? 
 
An approach to determine if any of the mRNAs involved in this process is also bound by Khd1p 
was followed. 
 
Fig. 13 -  RNA binding? 
A – Northern Dot blot. 
B – CLIP assay. Khd1p-CaBP-TEV-ProA 
Top – Autoradiograph; Lane 1 – Total, Lane 2 – Total, Lane 3 – Non crosslinked, Lane 4 – High 
RNase, Lane 5 – Low RNase. Bottom – Western blot, anti-CaBP. 
 
  
We observed that after a 10.000G centrifugation step 3x more ASH1 E1-element mRNA could be 
detected than after a 100.000G centrifugation step (Fig. 13A). ASH1 mRNA can be effectively 
purified bound to Khd1p, using the standard TAP protocol. However, other mRNAs were not 
enriched when analysed using this approach. We observed that RAP1, SIR2, SIR3 and TLC1 were 
not enriched, indicating that either these mRNAs are not bound by Khd1-CaBP-TEV-ProA (Fig. 
13A) or the regions that the probes were directed against are not bound by this protein. 
 
4.11 Ultraviolet CrossLinked ImmunoPrecipitation (CLIP) 
Still, the question remained. To which other mRNAs does Khd1p bind to? 
In order to follow this idea, a CLIP (Ule et al., 2003; 2005) assay, based on the tandem affinity 
purification approach, was used. 
We observed that even after RNAse treatment radioactively labeled protein still remained, 
indicating that Khd1p binds to DNA. In addition, upon treatment with less amounts of RNAse, the 
radioactively labeled protein is more intense and also larger in size, indicating that indeed the 
labeled material is in part RNA (Fig. 13B). 
 
 
 
 
 
 5. DISCUSSION  
 
5.1 Is there a relationship between ASH1 mRNA localization and nonsense mediated 
decay (NMD)? 
The ASH1 mRNA localization process happens quite fast in the cell, since ASH1 mRNA is 
transcribed in early anaphase and localized in late anaphase, thus making a very short time window 
for the localization event to take place. 
The previous observation that a premature stop codon introduced before any of the zipcode 
elements of ASH1 mRNA did not elicit nonsense mediated decay but led to a severe localization 
defect (5% tightly anchored, 95% mislocalized for ASH1-E1-Stop compared to 85% tightly 
anchored to 15% mislocalized for the wildtype ASH1 – Jaedicke A., PhD Thesis, 2004), originated 
two hypothesis (Jaedicke A., PhD Thesis, 2004). i, The premature stop codons were not available to 
the surveillance machinery due to the mRNP architecture, where She2p, which binds to these 
localization elements, could mask these stop codons; ii, the premature stop containing transcripts, 
i.e. shorter transcripts, did not associate with sufficient ribosomes to be effectively anchored. The 
ribosome involvement in anchoring hypothesis is supported by the fact that cycloheximide 
treatment, that blocks ribosomal elongation, decreases ASH1 mRNA tight anchoring (Jaedicke A., 
PhD Thesis, 2004) and also by the observation that Ash1p-COOH is required for active ASH1 
mRNA retention at the bud tip (Gonzalez et al., 1999). Further experiments from A. Jaedicke on 
this issue, showed that disruption of SHE2 did not change ASH1 mRNA stability, indicating that it 
is not the footprint of She2p that prevents premature stop recognition. 
In order to establish whether nonsense mediated decay really occurs for these PTC containing ASH1 
transcripts the half-lives of two different transcripts were analysed (Fig. 2). The results presented in 
Table 1 show that there is no difference between the two transcripts analysed in most of the mutants 
tested. Surprisingly, mutations in genes involved in NMD such as UPF1, DCP1, CCR4 (reviewed 
in Collier and Parker, 2004 and in Macquat, 2004) showed no effect on the half-lives measured for 
the two mRNA constructs, indicating that, indeed, classical NMD pathways do not affect ASH1 
mRNA stability. As most mRNAs in yeast, ASH1 is intronless. In humans it has been described that 
intronless mRNAs do not undergo NMD (Brocke et al., 2002). This observation is not likely to 
apply to yeast, since most of the mRNAs in this organism are intronless and a PTC containing 
mRNA could prove severely detrimental for the organisms viability. Furthermore, if this would be 
true, one would not expect any differences in the measured half-lives. The only observed 
differences were for mutations on SCP160, PUF6 and KHD1 (PUF6 and KHD1 in combination 
 with ∆she2). ∆SCP160 causes a 100% increase in mRNA half-life as compared to wildtype but no 
difference between PTC-containing ASH1 and wildtype ASH1 was observed, indicating that it is a 
more general mRNA decay defect. The fact that SCP160 has been implicated in ribosomal 
architecture in combination with Asc1p (Baum et al., 2004) and bound to the polysomes in an 
mRNA dependent manner (Frey et al., 2001) seems to point to a general defect instead of a ASH1 
specific defect. LOC1, another protein involved in RNA biogenesis and mRNA localization (Long 
et al., 2001; Horsey et al., 2004; Komili et al., 2007) was not tested, although in light of the 
presented results it should be looked into.  
SHE2 plays apparently no role alone. However, when in combination with PUF6 and with KHD1 
contributes to a significant increase in ASH1 mRNA half-life. In combination with ∆PUF6, ∆SHE2 
increases the half-life of both transcripts analysed, 40% and 30%, an indication that this double 
mutant combination still allows PTC-containing-ASH1 mRNA to evade NMD or that the rate by 
which the PTC-containing-ASH1 mRNA is destroyed is undistinguishable from the rate with which 
the wildtype is translated into protein. As ∆SHE2 causes a loss of ASH1 mRNA localization and 
∆PUF6 contributes to the same process (Gu et al., 2004; Deng et al., 2008) it is possible that this 
loss of efficient mRNA localization leads to an increase of mRNA half-life simply by the loss of 
spatial regulation or due to the misincorporation of these mRNAs into the mRNP or loss of another 
unknown factor targeted to the mRNP by Puf6p. In addition, the same could be true for ∆KHD1 
∆SHE2. The half-life increase for PTC-containing ASH1 mRNA observed for this double mutant 
was 60%, whereas for the wildtype ASH1 almost no change was observed. This observation seems 
to point towards a role for KHD1 in the recognition of this PTC-containing ASH1 mRNA, although 
this seems unlikely as no connection between KHD1 and NMD pathways has been until now 
elucidated. 
These results support the hypothesis that the loss of anchoring at the bud tip and the unchanged  
ASH1 mRNA stability between PTC containing transcripts and wildtype transcripts, observed by A. 
Jaedicke is directly linked to ribosomal function and that ribosomes are an important part of the 
localizing mRNP. They do not, however, allow us to conclude if it is a matter of transcript 
ribosomal loading. It is conceivable that a slower progressing ribosome, either due to a ribosome 
biogenesis problem (PUF6 (Fromont-Racine et al., 2003)) or due to the loss of regulation exerted 
by a translation repressor [PUF6 (Gu et al., 2004; Deng et al., 2008), KHD1 (Irie et al., 2002; 
Paquin et al., 2007)] can cause an extended mRNA half-life for the ribosome-bound transcripts. 
Loss of a translation repressor should speed up translation and thus making the mRNA half-life 
shorter, which is not the case (Table 1). It is conceivable that these translation repressors are also 
involved in the targeting of other factors such as RNA helicases to the mRNP. When the translation 
 repressors are absent the localizing mRNA might require more time to unwind and be translated, 
masking the effect caused by the loss of a translation repressor. 
Although a shorter transcript should be translated faster than a full length one, this was not the case, 
even for the wildtype cells analysed (Table 1), indicating that there is a missing link in the 
regulation of these mRNAs. Another possibility is that the processes involved, localizing mRNA, 
translation and NMD are temporally coupled and their independent analysis therefore very difficult. 
Although being a very atractive hypothesis, the data presented do not allow a conclusion to whether 
this nonNMD effect is a localized mRNA specific effect or not, as no other PTC containing 
transcripts were analysed. 
Another aspect that cannot be ruled out is the possibility that PUF6, KHD1 and SCP160 contribute 
to the processivity and efficiency of the normal NMD process and so therefore the effect observed 
would be a reflex of this loss of processivity of the NMD machinery. 
Recently, an NMD-related pathway was uncovered, the No-Go pathway (Doma et al., 2007). This 
pathway is based on the ribosome being a central part and a key player to the onset of NMD. It 
includes two proteins, Dom34p and Hbs1p, similar to release factors eRF1 and eRF3. Dom34p and 
Hbs1p recognize a stalled ribosome due to a PTC and perform an endonucleolytic cleavage, thus 
eliminating the defective mRNA. This process can have a slower dynamics than the translation 
events and so lead to a higher half-life of a PTC-containing mRNA. It would be interesting to see if 
the disruption of PUF6, KHD1, SCP160 or even LOC1 affect this No-Go pathway. Furthermore, a 
study of epistasis between members of this No-Go pathway and ASH1 mRNA localization factors 
could lead to a better understanding of the missing effects on PTC-containing ASH1 mRNA. If this 
is the case, the fact that a localized mRNA does not suffer classical NMD can have biological 
implications and a more general model can be devised, one that includes the ribosome and the 
stalled-ribosome recognizing proteins, Dom34p and Hbs1p.  
 
5.2 Relationship between RNA localization factors and cell viability? 
As ASH1 mRNA localization is not an essential process per se in yeast, mRNA localization factors 
disruption are unlikely to be lethal. However, the mRNA localization process is not for ASH1 
mRNA alone as other mRNAs are localized with the help of the same machinery (Shepard et al., 
2003; Irie, personnal communication). The fact that some RLFs overlap in their binding abilities 
(e.g. She2p, Khd1p and Puf6p) could prevent the detection of a lethal phenotype, related to the 
mRNA localization process. Although it is true that both ∆she3 and ∆myo4 are not lethal, alone or 
even together, it is possible that the mRNA localization events can still take place, although at a 
 later stage, based on microtubule-directed movements or even on ER inheritance mechanisms 
(Schmid et al., 2006). 
The analysis of several RLF disruptions (Fig. 3) showed that ∆loc1 ∆she2 is extremely temperature 
sensitive, since it does not survive to 37°C growth conditions, increasing even the phenotype 
observed for ∆loc1 she2-myc3. An additional ∆khd1 produced no change in the behaviour of the 
∆loc1 ∆she2 double mutant. On the other hand, a ∆khd1 ∆she2 showed a temperature sensitive 
phenotype, as it grows slower at 37°C than the single deletions. It would be interesting to see what 
effect an additional ∆puf6 would cause to this double mutant in a W303 background. It would 
provide a better understanding as to whether this temperature sensitivity is background specific, 
since a ∆khd1 ∆she2 ∆puf6 (BY background) is not temperature sensitive. In addition it would give 
insights as to whether a ∆puf6 reverts or even increases the temperature sensitivity of ∆khd1 ∆she2, 
arguing for an effect over an essential process, affected by these mRNA localization factors. 
 
5.3 What is Khd1p connection to ASH1 mRNA localization process? 
Khd1p binds to and co-localizes with ASH1 mRNA at the bud tip (Irie et al., 2002). Khd1p has been 
proposed to be a translation repressor (Irie et al., 2002; Paquin et al., 2007) and these observations 
arose our interest in trying to determine whether Khd1p travels together with the mRNP and trying 
to fit Khd1p into the mRNP architecture. 
As the results from a Khd1p-tandem affinity purification yielded no coomassie stainable bands (Fig. 
4-5), other than Khd1p itself, an alternative approach to detect specific mRNP components was 
taken. This approach led to the confirmation that Khd1p can co-purify She2p (Fig. 6), indicating 
that at some point in time and space they are in the same ASH1 mRNP particle. The fact that this 
interaction is RNA independent points to either a direct binding or binding via a common partner. 
The most likely partner would be She3p. Khd1p can also co-purify She3p (Fig. 7). This interaction 
also occurs in the absence of mRNA. In addition, the fact that Khd1p can co-purify She3p without 
She2p (Fig. 7), hints to a direct binding of Khd1p to She3p. These results suggest that Khd1p is a 
novel cargo of She3p. 
Although Khd1p can pull down She3p from yeast lysates, the opposite could not be verified (Fig. 
8), as Khd1p binds to every kind of protein immobilization matrix used. Further in-vitro 
experiments are required to prove that Khd1p and She3p interact directly. Unfortunately, the fact 
that a full length-She3p or a COOH-terminal-She3p cannot be stably expressed in E. coli causes a 
technical setback to the development of this strategy. Nevertheless, the results presented in figures 
6-7 show that there are Khd1p-She2-She3p protein complexes and that also Khd1p-She3p protein 
 complexes exist. The localization destination of these complexes is an interesting question. The 
Khd1p-She2p-She3p complex should be localized to the bud tip (Irie et al., 2002). The fact that 
Khd1p has been proposed to bind over 300 mRNAs (K. Irie, personal communication), can 
potentially increase the number of localized mRNAs to the bud tip. It is not yet clear how many of 
these mRNAs are localized to the bud tip, or even whether they are targeted there by Khd1p. It is 
also unclear whether these over 300 bound mRNAs are just bound by Khd1p as part of its 
translation repressor function and would therefore have no spatial correlation or even be localized in 
a SHE-dependent manner. 
The localization of the Khd1p-She3p complex is however a very interesting question that needs to 
be addressed. It can be hypothesized that the Khd1p-She3p mRNPs are a part of an entirely 
autonomous system from She2p-She3p-Khd1p mRNPs and do not localize especifically to the bud 
tip, but to other parts of the cell, acting in a totally different process, e.g. ER inheritance, delivering 
membrane proteins encoding mRNAs to the daughter cell. To test this hypothesis, She3p and 
Khd1p double live imaging, in a she2 disrupted strain, could provide insights as to whether these 
two partners are in the same particle, whether they still localize to the bud tip and could provide 
insights about its function according to its localization. 
The fact that Khd1p is a conserved protein, homologous to hnRNP K, both in sequence and in 
function (Denisenko et al., 2002), could improve our understanding how hnRNP K works and 
validate yeast as a model organism for studies on this protein. 
It would be interesting to see whether Puf6p, that has the same translation repressor assigned 
function as Khd1p, is also associated to other components of the locasome, like She3p, and not only 
to She2p (Gu et al., 2004). Furthermore, recently it has been shown that Puf6p is also a shuttling 
protein (Gu et al., 2004; Du et al., 2008) and that it is also phosphorylated by Yck2p at the bud tip, 
thus releasing ASH1 mRNA and eliciting ASH1 mRNA translation (Deng et al., 2008). It would be 
extremely interesting to see if both translation repressors are present at the same time, in the same 
mRNP particles, associated to ASH1 mRNA, thus exerting a double translational control. In 
addition, the possibility that Puf6p can bind other mRNAs other than ASH1 mRNA should be 
addressed and detect if Puf6p binds to the same set of mRNAs as She2p or even Khd1p. 
Furthermore, the possible non overlap of binding targets between these three proteins could indeed 
bring mRNA localization in yeast a step forward, by increasing the known number of mRNAs that 
are bound and localized in yeast to closer to the recently published data on Drosophila (Lecuyer et 
al., 2007). 
In addition, a cryptic Scp160p binding site in ASH1 mRNA 3'UTR (APyrUGA tandem repeat in 
position 80 after the stop codon), determined by homology from the binding affinity of Vigilin from 
 X. laevis (Cuningham et al., 2000) should be confirmed. It could help explain the data obtained for 
ASH1 mRNA half-life in SCP160 disrupted cells. 
 
5.4 Khd1p, another mRNA binding protein associated to the Endoplasmic Reticulum 
(ER)? 
It has been found that locasome components She3p and Myo4p are required for proper ER 
inheritance to the daughter cell (Estrada et al., 2003). Furthermore, Jaedicke and Schmid have 
shown that She2p, the major RNA binding protein, also associates with ER (Schmid et al., 2006). In 
fact, they also elegantly showed that the ASH1 mRNP was located at the tip of an ER tubule and 
were also able to confirm biochemically the interaction between the locasome and the ER, most 
strikingly the association between She2p and ER. In the absence of she2, ER is still inherited as 
expected, but the ASH1 mRNP is no longer located at the tip of the migrating ER tubule, but at the 
nuclear periphery. 
Therefore, the question arose whether Khd1p, as a potential member of the locasome, is also 
associated to the ER. 
Results presented in section 4.5 have shown that Khd1p is a binding partner for She3p, 
independently of She2p. In addition, Khd1p has been shown also to float with ER membranes (Fig. 
9A), even in the absence of She2p. Therefore, one can also imagine that at the tip of the migrating 
ER tubule She3p-Khd1p protein complexes can exist, since the association between She3p and 
Khd1p does not require She2p. This hypothesis is strengthened by the fact that one can float Khd1p 
with ER membranes in the absence of She2p. This observation points to either a direct binding of 
Khd1p to ER or to an ER associated factor, such as She3p, as shown in figures 6 and 7, since She3p 
has been shown to be involved in ER inheritance (Estrada et al., 2003). The fact that Khd1p 
distribution partially mimicks She3p distribution in this 4 step gradient (Fig. 9A), strengthens this 
hypothesis. It is conceivable that the ASH1 mRNP detected by Jaedicke and Schmid, associated to 
the tip of the migrating ER tubule, also contains Khd1p, since She2p-She3p-Khd1p-Myo4p should 
be a part of this ASH1 mRNP. As Khd1p binds over 300 mRNAs (Irie K, personnal 
communication) it is possible that part of these mRNAs are localized. In this case, a fraction of 
these could be localized along with the ASH1 mRNP and others could be localized using the ER 
inheritance machinery. 
The finding that She3p-Khd1p interaction is independent of She2p is quite striking and can have 
implications in mRNA localization models. It would be extremely interesting to see whether She3p 
is indeed at the tip of the migrating ER tubule and whether one can also find Khd1p there. This 
 would indicate that Khd1p is indeed a She3p cargo and thus mimicking She2p, although binding a 
different set of mRNAs, but also with some common ones (e.g. ASH1). The possibility that Khd1p 
might not be at the tip of a migrating tubule would indicate that these Khd1p containing particles 
would be the She3p-Khd1p particles refered previously, observation that would also confirm Khd1p 
association to the ER. 
Although Khd1p does not co-purify Sec61p, a bona-fide ER marker (Fig. 9B), one cannot rule out 
that Khd1p binds directly to the ER. In addition, the translation repressor function of Khd1p could 
also be aiding in this ER floatation assay, ribosomes bound to both ER and translationally repressed 
mRNA would float. Additional experiments addressing the issue of direct binding of Khd1p to the 
ER, independently of ribosomes would help in answering these questions and in determining 
whether She3p is the sole bridge between Khd1p and the ER. Instrumental in answering this 
question should be the Khd1-L284R-point mutant that corresponds to Ile304Asn from FMR-1 
(Siomi et al., 1994). This Ile304Asn mutant, a point mutant in a KH domain in FMR-1, leads to loss 
of FMR-1 polysome association (Laggerbauer et al., 2001). 
5.5 A new model for ASH1 mRNP architecture 
 Fig. 14 - Putative Models for Khd1p function in mRNA localization. 
 
Results presented in sections 4.6-4.9 indicate that a revision of the ASH1 mRNP architecture model 
is needed. The results presented also indicate the existence of She3p-Khd1p protein complexes, 
where no She2p exists and that might also be localized in a She-dependent manner. This could 
increase the number of bud tip localizing mRNAs significantly. A new model that includes Khd1p 
directly bound to She3p and to the mRNA is proposed in Figure 14. It also includes a derivation of 
the Schmid et al., (2006) model to include Khd1p associated to ER and associated to She3p, 
independently of She2p. 
 5.6 Khd1p has been proposed to be a translation repressor.  
5.6.1 Does it show translation inhibitor sensitivity? 
Previous contributions on Khd1p function had assigned a translation repressor function to Khd1p 
(Irie et al., 2002; Paquin et al., 2007). The fact that this function was assigned only in regard to an 
effect on a single transcript left space to try and generalize the translation repressor function. Genes 
that tamper with ribosome biogenesis can also be falsely interpreted as translational repressors, due 
to changes in processivity, as discussed above. 
Drugs that can hamper the translation process per se are conventionally used to address roles of 
genes that are thought to be related to the ribosome biogenesis and ribosomal function (e.g. SCP160 
in Baum et al., 2004; CTK1 in Roether et al., 2007). In this way, when a general translation defect 
exists then one can easily observe at which stage this defect takes place, whether it is at rRNA 
processing or other ribosome maturation steps, whether it is at subunit joining or at elongation. For 
Khd1p, no inhibitor of translation gave significantly different results from those observed for 
wildtype (Fig. 10). This would mean that Khd1p has no effect on the ribosome per se, does not 
affect rRNA processing or any other ribosome maturation process, but can be a translation repressor 
as proposed. 
 
5.6.2 Is Khd1p associated with polysomes? 
As a translation repressor generally prevents the translation of an mRNA, it also prevents the 
assembly or the advance of the ribosome. In fact, when a ribosome cannot advance, no more 
ribosomes can be loaded, due to the stalling of this large multiprotein complex and so in order to 
measure the effectiveness of a translation repressor one looks at the presence of the translation 
repressed mRNA at the polysomes. Polysomes are chains of actively translating ribosomes. During 
the course of this work it was shown that in the presence of Khd1p, ASH1 mRNA is not co-
fractionating with heavy and thus highly active polysomes (Paquin et al., 2007). Results presented 
in figures 11 and 12, show that Khd1p is present in the light polysomes and is absent from the 
heavier polysomes, supporting the proposed translation repressor model. Upon disruption of the 
ribosomes, Khd1p migrates to the even lighter fractions, although one should expect more Khd1p 
associated to the 40S subunit if it is indeed an mRNA translation repressor effect. On the other 
hand, if it is a eIF4E-eIF4G related event, so a cap-binding complex event, such as in the case of 
Cup in Drosophila (Wilhelm et al., 2000; Wilhelm et al., 2003), or Maskin (Cao and Richter, 
2002), one should expect that Khd1p only binds to one of them, either to eIF4E (specially to eIF4E) 
or to eIF4G and not to both. In this respect, Gavin and Paquin are in contradiction, since Gavin 
 (Gavin et al., 2002; Gavin et al., 2006) finds Khd1p with both and Paquin (Paquin et al., 2007) only 
with eIF4E. 
Although no experiments were performed in regard to eIF4Ep and eIF4Gp association to Khd1p, 
the observation that Khd1p is not mostly associated to the 40S subunit after EDTA treatment, but is 
still present in the heavier fractions, creates a difficult problem to solve. 
The observation that Khd1p is only present in the lighter polysomes might be an indication that 
these are membrane-bound polysomes and therefore, would point to an ER structure organization, 
specially if one considers that membrane bound polysomes cannot conceptually be loaded 
indefinitely onto an mRNA. Although it might be true that Khd1p is a translation repressor, there is 
still much confusion in regard to the mechanism by which it really functions, since the proposed 
mechanism involving eIF4Ep and Yck1p cannot entirely be fitted on to the data. 
 
5.7 Khd1p, an mRNA binding protein? 
Khd1p has been shown to bind ASH1 E1 element (Irie et al., 2002) and to localize at the bud tip. 
The fact that this was the only available target for Khd1p led us to try to investigate whether other 
mRNAs are also targeted. We were specially interested in analysing whether Khd1p would bind to 
mRNAs that encode for proteins members of the telomere maintenance pathway, since this finding 
could connect the Denisenko and Bomstzky (2002) findings and Khd1p translation repressor 
function (Irie et al., 2002; Paquin et al., 2007). After validation of the experimental approach (Fig. 
13A), involving RNA purification and northern analysis we observed that the SIR2, SIR3, RAP1, 
TLC1 probes used yielded no significant enriched signal, as compared to a mock purification, 
indicating that either they are not bound by Khd1p-CaBP-TEV-ProA or that the probes designed do 
not span over the bound region. The use of other probes could provide additional information that 
could allow us to find out if indeed Khd1p binds any of these messages. 
 
5.8 Ultraviolet CrossLinked ImmunoPrecipitation (CLIP) 
Although the direct and defined binding approach did not yield any relevant results, we still wanted 
to know which other mRNAs, other than ASH1, are bound by Khd1p. For that purpose we used the 
CLIP assay. This assay, developed by the Darnell laboratory, to study protein-RNA interactions is a 
powerful tool to analyse bulk RNA binding to a purified protein complex. In fact, this approach has 
been used successfully to elucidate mRNA binding partners for Nova-1 (Ule et al., 2003; Ule et al., 
2005). With Khd1p, we were able to show that indeed it binds RNA (Fig. 13B), in the sense that 
when a low amount of RNAse was used to treat the purified complex, the gel retardation assay 
 showed a band shift, indicating a heavier complex and that when more RNAse was used this band 
shift was reduced. 
In addition, the results observed for the non-crosslinked lane where there is also a faint signal would 
argue that this signal is due to bound DNA, as it is more stable than RNA. In fact, the observation 
that Khd1p binds to the subtelomeric DNA region (Denisenko et al., 2002) is a strong point in 
favour of this hypothesis. Even so, we still faced two problems: i) the fact that the purified protein 
is not so abundant, as seen by the coomassie gel in Figures 4 and 5, ii) the fact that Khd1p contains 
3-KH domains that can also bind DNA (Denisenko et al., 2002) as DNA contamination of the 
sample can be a problem for the subsequent steps of identifying the mRNA targets bound by 
Khd1p. 
 
In conclusion,  
•  Khd1p seems to be a novel cargo for She3p.  
•  Khd1p floats with ER membranes and does so independently of She2p. 
•  KHD1 disruption is insensitive to translation impairing drugs. 
•  Khd1p is associated with lighter polysomes. 
•  Khd1p can bind both DNA and RNA, although until now no other mRNA other that ASH1 
has been validated as a binding target. 
  
 
 
 
 
 
PART II 
 
 
Role of KHD1 in telomeric gene transcriptional silencing 
and DNA repair 
 6. INTRODUCTION 
 
6.1 Organization of genetic information - Chromosomes 
The nuclear genome of eukaryotic organisms consists of linear chromosomes. These chromosomes, 
unlike the circular ones of most prokaryotic organisms, face a problem during replication. As 
conventional polymerases need RNA primers placed 5' of the DNA sequence to be replicated, the 
chromosome ends might not be fully replicated or are shortened at the end of each round of 
replication (Watson, 1972). Over the years, studies in a wide range of organisms have shown 
different approaches from cells to circumvent this problem. These mechanisms involve inverted-
terminal repeats and a covalently bound protein, a cap, at the 5' end as seen for adenoviral 
replication (Challberg et al.,1980; Lichy et al., 1981) and for Streptomyces (Bao and Cohen, 2001), 
hairpin structure at the chromosomal end, as observed for Vaccinia virus replication and for 
Borrelia burgdorferi (Baroudy et al., 1983; Winters et al., 1985). 
 
Therefore, higher eukaryotes have to deal with a variety of problems that come with the linear 
nature of their genome. Namely, 1, how to replicate ends of linear DNA molecules without loss of 
genetic information and 2, how to prevent chromosome ends to be recognized as DNA double 
strand breaks that have to be repaired.  A special enzyme has evolved and been kept throughout 
evolution to ensure proper replication of chromosome ends and a large protein network is required 
to protect the chromosomal ends from degradation and from being mistaken as DNA damage. 
 
6.2 Replication of DNA ends 
During DNA replication the two DNA strands of a chromosome are separated and serve as single 
stranded templates for newly synthesized DNA. A large protein complex, containing a DNA 
polymerase assembles at the replication fork and polymerizes complementary nucleotides in an 
unidirectional 5'-3' manner to synthesize the new DNA strands. 
While one daughter strand, the leading strand, is continuously generated as the replication fork 
proceeds, the lagging strand is made discontinuously as short DNA fragments, the Okazaki 
fragments. This process requires RNA primers to initiate the DNA synthesis. These primers are 
later removed and the gaps filled in and the fragments are then joined by a DNA ligase. However, at 
the very 5' end of the newly synthesized DNA strand a gap remains caused by the removal of the 
original RNA primer. This shorter DNA strand would then be used as a template in the following 
 rounds of replication leading to an increasing shortening of the chromosomal end with every 
replication cycle. In most eukaryotes a telomere specific reverse transcriptase, telomerase, has been 
identified that maintains chromosome ends in a constant length range. 
Telomerase recognizes the G-rich parental strand via its RNA subunit. Telomerase RNA forms base 
pairs with the G-rich single stranded overhang and a translocation step allows several rounds of 
extension of the single stranded DNA. Replication of the chromosome is then completed by DNA 
polymerase using the extended strand as template for lagging strand elongation. This replication 
mechanism leads to a simple, repetitive DNA sequence at the ends of eukaryotic linear 
chromosomes. The sequence and the length of these repeats varies greatly between different 
organisms, indicating that the telomeric RNA template is not identical among species and that 
different repeat lengths might be required to ensure end protection. A 3' single stranded overhang 
comprised of a few to several repeats of the telomerase synthesized strand has been shown to be 
present at telomeric DNA in ciliates, yeast and humans (Hemann and Greider, 1999). 
 
 
Fig. 15 – End Replication Problem (Source: Telomeres, CSHL 2005) 
 
 6.3 Telomeres, Senescence, aging and cancer 
Early experiments have revealed that normal human fibroblasts show a limited dividing capacity 
and enter a non-dividing state after a defined number of passages (Hayflick and Moorehead, 1961). 
Only a very small portion of cells can escape this cell cycle arrest, termed c risis and become 
immortal, dividing indefinitely. This effect was restricted to somatic cells, whereas germline and 
tumor cells are immortal. Telomerase is active in germline cells and in 90% of all tumors. In 
contrast, most human somatic cells lack significant telomerase activity (Broccoli et al., 1995; 
Counter et al., 1994; Kim et al., 1995; Shay et al., 1993; Vaziri et al., 1993) and telomeres shorten 
with every round of DNA replication (Allsopp et al., 1992). Somatic cells that escape crisis 
stabilize telomere length and activate telomerase (Counter et al., 1994), similar to germline cells. 
Therefore, telomerase is required for indefinite growth of immortal cells in culture. Ectopic 
expression of hTERT in human fibroblasts restores telomerase activity, stablilizes telomere length 
and induces indefinite growth (Bodnar et al., 1998; Vaziri and Benchimol, 1998), providing strong 
evidence that the activation of telomerase is sufficient to induce immortalization. 
In addition to the limited dividing potential of somatic cells, Hayflick perceived that fibroblast 
cultures derived from embryos divided more often than those derived from adults (Hayflick, 1965). 
The observation that the replicative capacity of a cell correlated with donor age, led to the proposal 
that the cellular dividing capacity correlates with the aging process. Hayflick's predictions have not 
been able to be thouroughly confirmed experimentally. First, in vivo a variety of somatic cells are 
quiescent and proliferate seldom if at all. Second, human fibroblasts taken from elderly individuals 
undergo an additional 20-50 doublings in culture (Dice et al., 1993), representing 40-70% of their 
dividing capacity as defined by Hayflick. One possible explanation for this contradicting 
observation would be that most telomere-negative cells may never reach their Hayflick limit in vivo. 
Third, a mouse strain deleted for the RNA component of the telomerase showed no phenotype 
during the first 2-6 generations and age associated phenotypes, such as graying hair or hair loss and 
wrinkled skin did not occur earlier than in the control mice (Lee et al., 1998). Only in later 
generations did the loss of telomerase lead to early-onset of gray hair and hair loss (Rudolph et al., 
1999) and germline mortality, thereby inducing sterility (Lee et al., 1998). These observations argue 
against a model where organismal life span is a function of telomerase activity.  
The possibility that enhanced telomere shortening might play a role in human ageing is supported 
by the analysis of telomeres from patients with premature ageing syndromes. Telomere length of 
fibroblasts taken from patients with Hutchinson-Gilford progeria, a premature ageing syndrome, 
was reduced as compared to age-matched control cells (Allsopp et al., 1992). Werner's and ataxia 
telangiectasia patients, who experience premature ageing exhibit accelerated telomere shortening 
 (Kruk et al., 1995; Smilenov et al., 1997). In addition, the overexpression of telomerase could 
restore wildtype telomere length in Werner's syndrome cells and compensated for the early onset of 
replicative senescence (Wyllie et al., 2000). 
Tumors are highly proliferative cells that have escaped growth control or death control and keep 
dividing indefinitely. Maintaining telomere stability is required for long term proliferation of 
tumors (Shay and Wright, 1996; Wright and Shay, 2001) and telomerase activity has been detected 
in approximately 90% of all tumors. However, another mechanism to stabilize telomere length, 
alternative lengthening of telomeres (ALT), initially described in telomerase negative cells, has also 
been detected in tumor cells. ALT is independent of telomerase and relies on homologous 
recombination (Bryan et al., 1995; Dunham et al., 2000). Seemingly, cancer cells have 
circumvented the progressive telomere loss, present in normal somatic tissues, that is the limiting 
factor for the cellular replicative potential. Although reconstitution of telomerase has been shown to 
antagonize cellular senescence, it is not sufficient to induce tumor formation (Hooijberg et al., 
2000). 
Tumor formation has been shown to be a multistep process in which telomere integrity plays an 
important role. Since telomerase is required for proliferation of most tumors, it is an attractive target 
for anti-cancer drug therapy. Interestingly, the inhibition of telomerase in tumor cancer cell lines by 
a hammerhead ribozyme can induce an immediate apoptotic signal without prior telomere 
shortening (Ludwig et al., 2001), suggesting that telomerase is not only required for telomere length 
regulation but is also involved in the capping of telomeres (Blackburn, 2000). 
 
6.4 Telomere structure and telomere associated proteins 
Telomeres, the ends of linear chromosomes are physically indistinguishable from DNA double 
strand breaks. The genetic information of the budding yeast is packaged into 16 chromosomes 
bearing 32 telomeres in the haploid cell. Simple physical ends of DNA, such as those generated by 
DNA double stranded breaks (DSBs) or naked telomeres, are genetically unstable, mutagenic and 
sometimes oncogenic (de Lange, 2005). A single DSB leads to death in cells incapable of repairing 
these breaks (Resnick and Martin, 1976). Thus, sensing the natural end as a break would be 
deleterious for the cell and therefore telomeres must have properties that distinguish them from 
DSBs.  
In mammalian cells, double stranded telomeric DNA is bound by two proteins, TRF1 and TRF2 
(Chong et al., 1995; Broccoli et al., 1997). Overexpression of TRF1 or TRF2 has been shown to 
trigger telomeric shortening (Smogorzweska et al., 2000; van Steensel and de Lange, 1997) 
 indicating that these proteins negatively regulate telomere length and might inhibit telomerase 
function when bound to telomeres. In mammals, a 75-300 nucleotide long single stranded (ss) 
overhang exists (Makarov et al., 1997; Wright et al., 1999). Upon overexpression of TRF2 lacking 
a basic domain this ss overhang at the telomere is lost (van Steensel et al., 1998) and results in 
chromosome fusions and cell cycle arrest or apoptosis (van Steensel et al., 1998; Karlseder et al., 
1999) without a detectable reduction of the telomere length (van Steensel et al., 1998). These 
results indicate that TRF2 is not only involved in negative telomere length regulation but is also 
essential in telomeric capping.  
Electron microscopy of  telomeric DNA purified from human and mouse cells led to the discovery 
of large loops at chromosome ends in vivo, the t-loops. TRF2 is capable of promoting and 
stabilizing the formation of a t-loop structure, where the single stranded G-rich extension is buried 
into more proximal double stranded regions (Griffith et al., 1999; Stansel et al., 2001). Mutations, 
like the TRF2 basic domain truncation, that might prevent the stable formation of the t-loop could 
facilitate the opening up of the chromosome ends and also fusion events. 
In S. cerevisiae, that has a very short telomere repeat tract, the presence of this t-loop seems to be 
unlikely. However, a number of observations suggest that this back-folding indeed occurs (Fig. 15). 
Budding yeast telomeres repress transcription of adjacent genes, a phenomenon called telomeric 
positioning effect (TPE) (Gottschling et al., 1990). The placement of an enhancer 1-2Kb away from 
the gene at the telomere can be activated (de Bruin et al., 2001). This result strongly supports the 
notion that the S. cerevisiae telomere folds back on itself into subtelomeric regions. The fact that 
Rap1p, repressor/activator protein-1, a protein that binds sequence-specific to telomeres, can co-
immunoprecipitated with sub-telomeric chromation regions (Strahl-Bolsinger et al., 1990) allows 
the prediction of a 3kb telomeric end in budding yeast. 
 
6.5 Telomerase – completing the end 
The telomerase specific DNA polymerase, telomerase, was identified in Tetrahymena using 
biochemical assays designed to test for an activity that incorporates radioactively labeled dGTP in 
chromosomal ends (Greider and Blackburn, 1985). This incorporation could be abolished by 
treatment of Tetrahymena extracts with RNAse, suggesting that the enzymatic activity was 
dependent on an RNA subunit as proposed for reverse transcriptases (Greider and Blackburn, 
1987). The enzymatic activity was purified, yielding also a 160bp RNA fragment (Greider and 
Blackburn, 1989). The purified 160bp RNA fragment, the telomerase RNA, has diverged 
significantly through evolution. It varies from 159 nucleotides in Tetrahymena, to 450 nucleotides 
 in mammals (Blasco et al., 1995; Feng et al., 1995) to up to 1,3kb in Saccharomyces cereviseae 
(Singer and Gottschling, 1994). Strikingly, the secondary structure of this RNA seems to have been 
conserved through evolution (Chen et al., 2000; Lingner et al., 1994; Romero and Blackburn, 
1991). A pseudoknot structure has been proposed for ciliate and vertebrate telomerase RNA 
containing a single stranded template region (Chen et al., 2000). Several other conserved domains, 
helices and stem loops, are present that might play in function or stability of the telomerase RNA or 
might be required for the interaction with the protein subunit of the telomerase (Sperger and Cech, 
2001). 
The catalytic protein component, telomerase reverse transcriptase (TERT) was first identified in 
Euplotes aediculatus (Lingner et al., 1997b). The protein that was purified with telomerase activity 
contains a signature motif for reverse transcriptases. This protein showed homology to yeast protein 
Est2p. Mutations in EST2 had been previously identified as leading to replicative senescence 
(Lingner et al., 1997a) and homology searches have shown that this enzyme is phylogenetically 
conserved. 
In budding yeast, the TLC1 gene, encoding the telomerase RNA, was initially identified in a screen 
for genes that, when expressed in high amounts, would suppress telomeric silencing (Singer and 
Gottschling, 1994). A genetic screen designed to identify mutations that lead to a defect in 
telomerase activity, rendered five genes, as well as TLC1 (Lendvay et al., 1996). These mutations, 
EST1-4 lead to ever shorter telomeres until senescence (Lendvay et al., 1996). Although Est1p, 
Est3p and Est4p are required for in vivo telomerase activity, in vitro, as in higher eukaryotes, it can 
be limited to Est2p and TLC1 (Lingner et al., 1997). Est1p and Est4p have the properties of single 
strand telomere binding proteins (Virta-Pearlman et al., 1996; Wang et al., 2000), but genetic data 
argues for different roles for these two proteins in vivo. Est1p has been proposed to function in 
directing telomerase to the chromosomal terminus (Zhou et al., 2000). In contrast, Est4p has been 
proposed to play a dual role while bound to the telomere: it protects the end of the chromosome 
(Garvik et al., 1995), and regulates telomerase by mediating access  of this enzyme to the terminus 
(Evans and Lundblad, 1999; Grandin et al., 2000). EST3 encodes a novel 20-kDa protein that has 
been shown to dimerize, bind RNA and DNA and contribute to the unwinding of the RNA-DNA 
heteroduplexes (Yang et al., 2006; Sharanov et al., 2006). 
The purification of the telomerase reverse transcriptase from Euplotes aediculatus yielded also an 
uncharacterized protein (Lingner and Cech, 1996), indicating that additional proteins might 
contribute to telomerase function.  
Little is known about the regulation of telomerase activity, especially how chromosome replication 
and telomere elongation are coupled. Recent studies from yeast and humans suggest that telomerase 
 does not act as a monomer but is present as a multimer in vivo (Prescott and Blackburn, 1997; Wenz 
et al., 2001; Beattie et al., 2001). It is feasible that telomerase is a holoenzyme and a number of 
other factors mediate its regulation and temporal cell cycle activity. Recently, and in accordance 
with this prediction, a study has shown that telomerase cell cycle regulation is dependent on Ku 
heterodimer (Fisher et al., 2004). 
 
6.6 Telomere Length regulation 
Within a cell population, telomere length is maintained within a narrow size due to a balance 
between elongation and shortening, preserving telomere structure. In mammals, additional factors 
as tankyrase (Smith et al., 1998), Ku (Hsu et al., 1999), the Mre11-Rad50-Nbs1 complex (Zhu et 
al., 2000), Tin2 (Kim et al., 1999) and hRap1p (Li et al., 2000) associate indirectly with telomeric 
DNA via TRF1 and TRF2. One single stranded binding protein, Pot1p, has been shown to bind to 
the terminal telomeric end (Baumann and Cech, 2001). 
 
 
 
 
 
 
 
 
 
 
Fig. 16 - Schematic view on Telomere structure, showing the main proteins involved in 
telomere regulation. 
 
An extremely complex and increasingly longer list of genes that influence telomere length 
regulation as been drawn from budding yeast (Fig. 16). Several proteins have been shown to be 
responsible for the regulation of telomerase function at yeast telomeres. A conditional loss of 
function mutation in Cdc13p/Est4p, a protein that binds ss telomeric DNA (Lin and Zakian, 1996) 
and is essencial for in vivo telomerase activity (Lendvay et al., 1996), causes an increase in 
telomere length (Grandin et al., 1997). 
When shifted to restrictive temperature, this Cdc13-1p mutant accumulates unusually long 
telomeric single-stranded extensions of the 3' G-rich strand (Garvik et al., 1995; Polotnianka et al., 
Marita Cohn (Lund University)
 1998). A suppresor of this single-stranded phenotype, Stn1p, interacts with Cdc13p by two hybrid 
criteria (Grandin et al., 1997). A third protein, Ten1p, has been shown to be a part of this complex 
(Grandin et al., 2001). Conditional loss of function mutants in Stn1p or Ten1p lead to telomere 
elongation and the accumulation of ss telomeric DNA (Grandin et al., 1997; Grandin et al., 2001) 
as described for the cdc13-1 mutation. Mutations in the catalytic subunit of polymerase 〈, POL1, 
that disrupt its interaction with Cdc13p, cause elongation of the telomere (Qi and Zakian, 2000). 
Interestingly, mutations in Cdc13p have been described that lead to telomere elongation and others 
that lead to telomere shortening (Grandin et al., 2000; Meier et al., 2001). These observations 
provide strong evidence that the telomere regulation cannot be pinpointed to a single factor but has 
to be looked with all its interacting partners. 
Yeast telomeric DNA is assembled into a nonnucleosomal chromatin structure, the telosome 
(Wright et al., 1992). The major protein at the telomere, Rap1p, binds sequence-specifically to 
telomere repeats (Berman et al., 1986; Conrad et al., 1990; Wright et al., 1992). Rap1p was 
originally identified as a transcriptional regulator that can play a role in either repression or 
activation (Kurtz and Shore, 1991; Shore and Nasmyth, 1987). The consensus sequence for Rap1p 
binding (Buchman et al., 1988) is found approximately at every 35 bp in telomeric DNA (Wang 
and Zakian, 1990) and therefore multiple Rap1p proteins bind at telomeres (Gilson et al., 1993). 
Yeast strains carrying a C-terminally truncated Rap1p have elongated telomere repeat tracts (Hardy 
et al., 1992). This C-terminal mutation has been described to prevent the interaction between Rap1p 
and one of the four Silent Information Regulation (SIR) proteins, Sir3p (Roy and Runge, 1999). 
SIR proteins interact with Rap1p at different sites in the genome such as the mating type loci, 
rDNA loci and at the telomeres (Gotta et al., 1996). The SIR complex is essential for silencing in 
yeast and sir2, sir3 or sir4 mutants are no longer able to repress mating type loci HML and HMR 
(Ivy et al., 1986) or telomere adjacent genes (Aparicio et al., 1991). In addition, sir4 mutants have a 
slight but stable  reduction in telomere length (Palladino et al., 1999). 
Interestingly, certain components of the DNA damage response pathways, originally identified by 
their involvement in the repair of DNA double strand breaks (DSBs) are found at telomeres and are 
required for wildtype telomere length and function. The Ku heterodimer, essential for the repair of 
DNA damage by non-homologous end joining, localizes to telomeres in budding yeast (Martin et 
al., 1999). Yeast Ku is required for the normal localization of telomeres at the nuclear periphery and 
has been shown to interact with proteins of the nuclear matrix (Galy et al., 2000). A disruption on 
either YKU70 or YKU80 gene leads to a growth defect at elevated temperatures (Feldmann et al., 
1996; Feldmann and Winnacker, 1993) and to enhanced sensitivity to the DNA damaging agents 
bleomycin and methyl methanosulfonate (MMS) (Feldmann et al., 1996; Mages et al., 1996). Ku is 
 in addition required for the maintenance of wildtype telomere structure and length. Yeast strains 
deficient for YKU exhibit stable but shortened telomeres (Boulton and Jackson, 1998; Porter et al., 
1996), loss of subtelomeric silencing (Galy et al., 2000; Gravel et al., 1998; Mishra and Shore, 
1999; Nugent et al., 1998; Pryde and Louis, 1999) and a G-rich single stranded overhang is 
detectable in yku mutants over the entire cell cycle, not only just during S-phase. In S. pombe and 
mammals, loss of Ku results in telomere-telomere fusions (Baumann and Cech, 2000; Hsu et al., 
2000; Samper et al., 2000). 
Another complex that is required for the repair of DNA damage and also is needed for telomeric 
length regulation in yeast is Mre11p/Rad50p/Xrs2p (Nbs1p in mammals) complex (MRX complex). 
The localization of this complex to telomeres has been investigated in mammalian cells (Lombard 
and Guarente, 2000; Zhu et al., 2000) and a deletion of the corresponding yeast genes leads to 
telomere shortening (Boulton and Jackson, 1998; Nugent et al., 1998). Mutations on TEL1 and 
TEL2, the first genes described that had a role in telomeric length regulation, lead to temperature-
sensitivity and to short telomeres (Lustig and Petes, 1986). This progressive shortening event occurs 
with every generation until reaching a stable level, after approximately 150 generations. Double 
mutations with any component of the MRX complex and a tel1 mutation causes no additional 
change in telomere shortening, suggesting that tel1 and the MRX complex both act in the same 
pathway to regulate telomere length (Ritchie and Petes, 2000). 
 
Rap1p is a key player at the telomere in that it binds the double stranded telomeric repeats and helps 
to recruit additional proteins. Rif1p and Rif2p, Rap1p interacting factor 1 and 2, are recruited to the 
telomeres by their interaction with Rap1p C-terminus. Once at the chromosomal ends, they 
negatively regulate telomere length (Wotton and Shore, 1997). Telomere length homoeostasis is 
thought to be achieved by a negative feedback circuit: the activity of the telomerase on a specific 
telmere creates more binding sites for Rap1p. This would lead to more Rap1p bound to the 
telomere, recruiting more Rif1p/Rif2p in the process. This accumulation of proteins would prevent 
this telomere from further being used as a substrate for telomerase (Smogorzewska and de Lange, 
2004), achieving then a stable steady state. 
 
Genes, other than those already mentioned, have also been shown to play some role in telomeric 
length regulation.  
RAD27 encodes a multi-functional nuclease involved in processing Okazaki fragments during DNA 
replication, base excision repair (BER), and maintaining genome stability (Liu et al., 2004). Its 5'-
flap endonuclease activity is required to cleave the 5' flap from Okazaki fragments that is generated 
 during lagging strand synthesis and to remove the 5'-deoxyribosephosphate end that is formed at 
apurinic/apyrimidinic sites during BER (Kao Hi et al., 2002; Rossi et al., 2006; Wu et al., 1999).  
RAD27 has also been implicated in double-strand break repair via non-homologous end-joining. 
Rad27p is highly conserved in bacteria, other fungi, and mammals (Carr et al., 1993; Reagan et al., 
1995; Bibikova et al., 1998; Hansen et al., 2000). It contains three highly conserved domains, two 
of which are conserved in prokaryotes (Lieber et al., 1997). Because deletion of RAD27 in S. 
cerevisiae leads to expansion of repetitive DNA and trinucleotide repeat instability, RAD27 (known 
as FEN1 in mammals and humans) has been implicated in the triplet repeat expansions that lead to 
Huntington disease and fragile X (Jonhson et al., 1995; White et al., 1999; Otto et al., 2001). 
 
A mutation in both KHD1 and PBP2, genes that encode proteins with 3-KH (hnRNP K homology) 
domains, lead to an elongated telomere (Denisenko et al., 2002). Although this elongated telomere 
has been proposed to be due to the loss of the Telomeric Rapid Deletion pathway function, 
dependent on the MRX complex, it still remains to be proven (Denisenko et al., 2002). In addition, 
KHD1 has been shown to cause a slower growth phenotype in conjuntion with a RAD27 disruption 
(Pan et al., 2006), evidencing a putative link between KHD1 and RAD27. 
 
Telomere length regulation has been a proficuous field in findings. Recently, a checkpoint network 
of genes has been uncovered. Mutations in DDC1 and RAD53 of budding yeast (Longhese et al., 
2000), rad1 and rad3 of S. pombe (Dahlen et al., 1998) as well as mutations in human ATM (Vaziri 
et al,, 1999) have been shown to induce telomere shortening and instability. The observation that a 
tel1 mec1 double mutant, the budding yeast ATM homologs, shows replicative senescence (Ritchie 
et al., 1999) supports these findings. A model for how a checkpoint gene might regulate telomere 
length was provided by the finding that the telomere shortening observed for rad53 mutants could 
be restored by increased dNTP pools, indicating that limiting dNTPs may cause a defect in DNA 
replication at the telomere (Longhese et al., 2000). On the other hand, ddc1 mutants exhibit short 
telomeres independent from the intracellular dNTP level, suggesting that the DDC1 checkpoint 
affects telomere ends by a different mechanism (Longhese et al., 2000). The regulation of 
checkpoint genes and their cell-cycle coordination, are therefore, very important mechanisms in 
maintaining telomere length. 
 
6.7 Telomere disfunction and the DNA damage checkpoint 
The RAD9 checkpoint in S. cerevisiae (Fig. 17) serves to arrest the cell cycle in G2 phase when a 
 DNA damage is present or when DNA replication is incomplete (Weinert and Hartwell, 1988; 
Weinert and Hartwell, 1993). The ends of linear chromosomes are capped and folded into a special 
structure and a large network of proteins is required to maintain telomere integrity. Analysis of the 
cdc13-1 mutation, that affects telomere capping, provided evidence that a defect at telomeres can 
trigger a RAD9 dependent cell cycle arrest. When cdc13-1 cells were grown at a semipermissive 
temperature an increase in recombination events could be detected at telomeric regions but not at 
the centromere (Garvik et al., 1995). In addition, an accumulation of ss DNA was detectable at 
elevated temperatures at the telomeres in cdc13-1 mutant cells (Garvik et al., 1995), suggesting that 
the viable phenotype observed might be due to a loss of essential genetic information. The loss of 
Stn1p, an interactor of Cdc13p, also induces ss DNA formation at the telomeres and mutants show 
an activated RAD9 checkpoint (Grandin et al., 1997). 
 
Fig. 17 - RAD9 checkpoint (Adapted from Mitchelson and Weinert, 1999). 
 
Fig. 18 - Recognition of the ssDNA stretch. 
 
 Single stranded DNA (Fig. 18) might be one lesion that activates the DNA damage checkpoint 
(Garvik et al., 1995; Lydall and Weinert, 1995). This control mechanism also becomes active in yku 
mutants when they are shifted to elevated temperatures (Teo and Jackson, 2001). Overexpression of 
telomerase has been shown to suppress the temperature sensitivity (Nugent et al., 1998). Although 
it can suppress the checkpoint activation, ssDNA is still present at the telomeres (Teo and Jackson, 
2001). This suggests that the telomerase might cap the telomere in yku mutants and thus prevent it 
from being recognized as a DNA break. 
In mammalian cells there is evidence that one critically short telomere is may be recognized as a 
DNA damage and as a consequence induce p53 cell cycle arrest to cause senescence (Burkhart et 
al., 1999; Chin et al., 1999). In addition, mutations on TRF2 cause the degradation of the ss DNA 
overhang and lead to the formation of dicentric chromosomes and eventually to senescence (van 
Steensel et al., 1998) or to p53-mediated apoptosis (Karlseder et al., 1999). Increasing evidence 
arises that telomere regulation machinery overlaps with the cellular DNA repair machinery and with 
the apoptotic pathway and that this interconnection is an essential process for proper cellular 
function. 
As a safeguard against the ocurrence of DNA damage 
prokaryotic and eukaryotic cells have developed at least three 
different DNA repair mechanisms. In S. cerevisiae DNA 
double strand breaks are repaired by the activities of the 
RAD52 epistasis group (Friedberg et al., 1995) (Fig. 19) and 
this pathway seems to be evolutionarily conserved (Bezzubova 
et al., 1993). Another mechanism of DNA DSB repair and 
recombinational events was uncovered (Gottlieb and Jackson 
et al., 1993; Harley et al., 1995) that involves a DNA-activated 
protein kinase and its regulatory subunit, the Ku heterodimer 
(Fig. 19), also known as non-homologous end joining (NHEJ). 
It has been shown that the Ku heterodimer can be coeluted 
with Rpb1p and Rad51p (Maldanado et al., 1995) and that it 
also interacts with DNA polymerase ∑, a specific polymerase 
involved in DNA repair synthesis (Hwang et al., 1995; 
Aboussekhra et al., 1995). 
Fig. 19 - DNA Double Strand Break Repair Pathways 
(adapted from R&D Systems DNA Damage Response 
Minireview, catalog 2003) 
 6.8 Telomeres and Nonsense mediated decay 
TLC1, the RNA subunit of the telomerase had until recently two possible models for its biogenesis. 
(Ferrezuelo et al., 2002). i) the shuttling model, that the maturation of TLC1 occurs in the 
cytoplasm and is imported back into the nucleus, in a Mtr10p dependent manner and ii) the 
processing enzime model, where the enzyme responsible for the maturation of the TLC1 RNA 
would be imported in an Mtr10p dependent manner. Recently, it has been shown that TLC1 shuttles 
into the cytoplasm (Gallardo et al., 2008) and that this shuttling, dependent on Mtr10p, is essential 
for biogenesis and for telomerase function (Ferrezuelo et al., 2002; Teixeira et al., 2002) . The fact 
that telomerase includes an RNA intuitively hints that RNA turnover and surveillance mechanisms 
would be somehow related to telomerase function and maturation. The observation that TLC1 is a 
polyadenylated RNA (Lowell and Pillus, 1998) supports the idea that it would follow a regular 
mRNA processing pathway. It was only very recently that a link between the surveillance NMD 
mechanism, namely UPF1, and TLC1 and telomerase function was shown (Azzalin et al., 2006; 
Azzalin et al., 2007). UPF1 seems to be essential for the cell to cope with basal transcription events 
that occur at the telomere. This basal transcription produces telomeric transcripts, partially 
complementary to TLC1. These incomplete transcripts, that could compete with TLC1 for Est1-4p 
binding, would not elicit a functional telomerase after maturation and the cellular surveillance 
mechanism targets them for destruction at the nuclear exosome. 
 
 
6.9 Aim of this work 
The aim of this work is to elucidate the role of KHD1 in telomeric gene transcriptional silencing 
and the mechanisms underlying its function. For this, a strategy designed to address the role of 
KHD1 in this process and in connected processes such as DNA repair, was implemented. 
 7. RESULTS 
 
 
Khd1p, also known as Hek2p, has already been shown to have a dual role in the cellular context. 
Firstly, Irie and coworkers showed that Khd1p accumulates at the bud tip, by using a reporter assay 
called the green mRNA technology. This assay is based on a fusion of a GFP to a U1A binding 
protein, that recognizes and attaches to specific U1 RNA loops fused to your mRNA of choice. 
They also showed that Khd1p binds the E1-element of ASH1 mRNA and they propose a translation 
repressor activity for this protein (Irie et al., 2002). Recently this translation repressor activity has 
been proven (Paquin et al., 2007). Secondly, Khd1p has already been shown to bind to subtelomeric 
DNA and to play a role in telomeric positioning effect (Denisenko et al., 2002). The work of this 
group also showed that a HEK2 deletion leads to a longer telomere (in combination with a PBP2 
deletion, a gene similar to KHD1 in the sense that it also encodes a 3 KH domain-protein) and 
probably due to a defect in the telomeric rapid deletion pathway. 
 
7.1 Is KHD1 involved in Telomeric silencing? 
How could Khd1p be involved in such different cellular processes? Telomeric positioning and 
length control occur in the nucleus and mRNA localization and translation regulation occurs in the 
cytoplasm. Can Khd1p shuttle between cellular compartments? 
In the course of this work, Du and coworkers showed that indeed Khd1p shuttles between 
cytoplasm and nucleus (Du et al., 2008) 
With these results in mind we set out to determine if KHD1 had indeed a role in telomeric silencing 
and telomeric length control. By using the telomeric silencing system (Fig. 20) developed in the 
Zakian laboratory (Gottschling et al., 1990), the role of Khd1p was analysed in this pathway. 
 
Fig. 20 - Schematic view of the gene transcriptional silencing assay 
  
Fig. 21 - KHD1 in telomeric silencing? 
A -  Serial dilutions growth tests in different media 
B – Serial dilutions growth tests in different media and at different temperature 
 
 
KHD1 has no significant effect on its own on telomeric silencing. In fact, the surprising result is 
observed in a combination with Δrpd3. RPD3, a deacetylase (Rundlett et al., 1996), shows a 
silenced phenotype, as expected and when KHD1 is disrupted it leads to a desilencing effect (Fig. 
21A). 
 PBP2 is very similar to KHD1, it also has 3 KH domains and it has been shown also to contribute to 
telomeric silencing and to control telomeric length (Denisenko et al., 2002). Again, in our 
observations Δpbp2 had no significant effect on silencing by itself. Interestingly it also reverted the 
silencing phenotype of Δrpd3, although to a lesser extent. To rule out a translation related effect, 
another translation repressor was analysed, VTS1, and we observed that it does not cause 
desilencing  with Δrpd3 (Fig. 21B). On the other hand, Δrpd3 is slightly temperature sensitive and 
an additional Δkhd1 rescues this phenotype, whereas an additional  Δvts1 increases this temperature 
sensitivity. 
 
 
Fig. 22 - Influence of other chromatin remodellers in telomeric silencing? 
 
In addition, we observed that other chromatin remodellers, as SIR2, a deacetylase (Aparicio et al., 
1991) or SAS2 (Osada et al., 2001), an acetyl-transferase, lead to a similar phenotype as a Δrpd3 
Δkhd1. A Δsir2 Δrpd3 and Δsas2 Δrpd3 also show desilencing (Fig. 22), as observed for Δkhd1 
Δrpd3. 
 
 
 
 
7.2 KHD1 and other mutant combinations 
We also analysed the effects khd1 disruption has in combination with other mutants that have been 
shown to be involved in telomere gene transcriptional silencing. 
 Fig. 23 - KHD1 and other genes involved in telomeric silencing. 
 
We observed (Fig. 23) that a Δpbp2 Δrif1 combination leads to a loss of silencing, whereas the 
single rif1 disruption is clearly silenced. Furthermore, we observed that a ∆rif2 ∆khd1 ∆pbp2 is 
surprisingly desilenced as compared to a rif2 disruption or even to ∆rif2 ∆khd1, that is slightly 
better silenced than a rif2 disruption.  
We also observed that an additional khd1 disruption to both rif1 or rif2 disruptions leads to better 
silencing. 
 As expected cells that do not possess an active SIR complex (meaning ∆sir2, ∆sir3 or ∆sir4) are 
desilenced and do not grow. 
 
7.3 Does Δkhd1 influence telomeric length? Does Δpbp2 act the same way? 
 
Fig. 24 - Telomeric length – Southern Blot probed with TG1-3 repeat probe. 
 
KHD1 disruption does not change the length of the telomeric region on its own (Fig. 24). Not 
surprisingly it does not change telomeric length on Δrpd3 (Fig. 24), suggesting that the observed 
loss of silencing is not related to a change in telomeric length. 
 
 
 
 
 7.4 Can the other phenotypes observed be explained by changes in telomeric 
length? 
 
Fig. 25 - Telomeric Silencing – Southern Blot, probed with TG1-3 repeat probe. 
 
We observed that an additional Δkhd1 increases the telomeric length of a Δrif1 (Lanes 13 and 21 – 
Fig. 25) fitting with a minor increase in the gene transcriptional silencing of Δrif1. Furthermore, we 
observed that an Δkhd1 ∆rif2 (Lanes 10 and 16) shows no change in telomeric length, although this 
cannot explain the change in telomeric gene transcriptional silencing observed (seen in Fig. 25). In 
addition, Δpbp2 ∆rif1 and ∆rif1 (Lanes 17 and 21) show differences in telomeric length, but this 
cannot also explain the variation on gene transcriptional silencing observed (Fig. 25). 
Δpbp2 Δrpd3 and Δrpd3 (Lanes 9 and 12) show no telomeric difference indicating the changes 
observed for gene transcriptional silencing cannot be due to a change in telomeric length. 
Although both ∆khd1 and ∆pbp2 contribute to Δrif1 telomeric elongation, that is not the case for 
∆rif2 (Lanes 10, 14, 16). 
Another surprising finding is that an aditional khd1 disruption to a Δrif1 Δrad27 leads to an even 
 more elongated telomere (Lanes 2 and 15 – Fig. 25). 
7.5 Loss of Silencing due to loss of SIR complex? 
As shown on figure 22, mutations that affect Sir2p localization (e.g. SAS2) or even a complete 
disruption mimick the observed phenotype for Δrpd3 Δkhd1. 
Could the desilencing effect observed for Δrpd3 Δkhd1 be related to a loss of Sir2p or to its 
mislocalization?   
 
Fig. 26 - Sir2p-Myc9 levels downregulated due to Δkhd1? 
Myc9 signal quantification (n=5) by Western Blot, using ImageQuant 5.0. 
A disruption of khd1 leads to a severe downregulation of Sir2p-Myc9, by approximately 3/4, 
whereas this is not observed when PBP2 is disrupted (Fig. 26), thus indicating that this is a specific 
effect of KHD1. This downregulation of Sir2p is at the post-transcriptional level, since mRNA 
levels did not differ (Fig. 27). 
 
Fig. 27 - SIR2 mRNA levels, measured by Northern Blot (n=2) 
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 7.6 Does this decrease of Sir2p amount also lead to a displacement of Sir2p from 
subtelomeric regions, thus further explaining why a desilencing is observed? 
 
Fig. 28 - Indirect Immunofluorescence. 
Imaging of Sir2-myc9 on wt, Δkhd1 and Δpbp2. Primary – 9E10, anti myc 1:200, Secondary - 
rabbit anti mouse Alexa 488. 
 
As can be seen in figure 28, almost no signal was observed for Sir2p-myc in a Δkhd1. This result, 
consistent with the very low abundance on the western blot level (Fig. 26), does not allow any 
conclusion on the localization of Sir2p in a Δkhd1. 
 
 
 
 
 7.7 Can the desilencing effect observed for Δrpd3 Δkhd1 be rescued by providing an 
excess of SIR2? 
It has been shown that overexpression of SIR2 leads to cell death (Holmes et al., 1997) and that this 
effect can be rescued by an upregulation of Histone H4 (Matecic et al., 2002). 
 
 
 
 
 
 
 
Fig. 29 - Serial dilutions and growth analysis. 
 
We observed that SIR2 driven from a multicopy plasmid causes indeed death on FOA for the 
wildtype but does not do so for Δkhd1. This result indicates that our Sir2p downregulation model 
for Δkhd1 is true (Fig. 29). 
 
7.8 Can a Δrpd3 Δkhd1 desilencing effect be rescued with a lower copy number 
SIR2? 
As can be seen in figure 30, a CEN-plasmid bourne-SIR2 increases cell viability of Δrpd3 Δkhd1 on 
5'FOA containing media, but does not restore complete silencing, indicating that in this double 
mutant combination, other factors are also affected, apart from Sir2p. 
 
 
 
 
 
 
 
 
 
Fig. 30 - Serial dilutions of CEN-plasmid bourne copies of sir2 (or empty) containing cells. 
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 7.9 Does a Sir2p downregulation, a deacetylase lead to a change in acetylation 
levels of Histone H4K16? 
Sir2p has been shown to actively deacetylate Histone H4K16, and determine the establishment of 
the euchromatin/heterochromatin boundary (Suka et al., 2002). Could ΔKHD1 influence changes in 
heterochromatin/euchromatin formation, namely an increase in Histone H4K16, consistent with the 
downregulation of Sir2p? 
 
Fig. 31 - Changes in histone modifications? 
Western blot of whole cell extracts. Quantification performed using Imagequant 5.0 (N=3). 
 
 
Table 2 - Histone H4 acetylation levels. 
 HH4K8/H4 HH4K12/H4 HH4k16/H4 
Wt 0,24 0,75 2,205 
Δkhd1 0,215 0,55 2,41 
Δrpd3 0,395 1,30 1,65 
Δkhd1 Δrpd3 0,09 0,93 3,4 
Δsir2 0,28 1,49 2,085 
Δyku70 0,14 0,265 2,515 
Δyku70 Δkhd1 0,13 0,3 1,015 
Δrad27 1,415 2,27 3,08 
Δrad27 Δkhd1  0,36 1,27 1,97 
  
Table 3 - Histone H4 acetylation levels 
 HH4k8/Actin HH4k12/Actin HH4k16/Actin 
Wt 1,02 1 1,72 
Δkhd1 1,03 1 0,64 
Δrpd3 1,03 0,97 0,06 
Δkhd1 Δrpd3 1,18 0,92 3,97 
Δrif1 22,89 1,04 4,1 
Δrif1 Δkhd1 2,18 0,96 1,03 
Δpbp2 1,02 1 0,97 
Δpbp2 Δrpd3  0,73 0,9 0,26 
Δsir2 1,02 0,99 2,8 
Δrad27 1,05 0,96 1 
Δrif2 9,67 0,44 0,93 
Δrif2 Δkhd1 37,78 0,93 1,11 
Δrif1 Δpbp2 1,04 0,98 1,12 
Δrif1 Δpbp2 Δkhd1 0,97 0,99 0,43 
 
 
RPD3 disruption shows consistently less Histone H4 and the disruption of KHD1 reverts this effect. 
The acetylation levels of Histone H4 on Lys 8 and 12 are not significantly different as to explain the 
changes observed in silencing, when actin is used as a loading control. We looked at the acetylation 
levels on Lys16, as it is known to be the boundary of telomeric heterochromatin (Suka et al., 2002). 
This residue shows a significant increase of acetylation in Δrpd3 Δkhd1 as compared to Δrpd3, or 
even to Δkhd1 indicating that transcription is therefore more active in this region. 
When Histone H4 total levels are taken as a loading control the picture looks somewhat different. 
Still, there is 2-fold increase for HH4K16Ac between Δrpd3 Δkhd1 and Δrpd3. In addition, the 
levels of Histone H4 K8Ac are also decreased in Δrpd3 Δkhd1.  
We observed that Δsir2 shows almost no changes in HistoneH4 acetylation when HistoneH4 is 
taken as a loading control, but on the other hand when actin is taken as a reference one can see a 
1,7x increase on HH4K16Ac. When Δkhd1 is analysed in combination with other mutants we 
observed that it changes the acetylation levels of HH4K8 and of HH4K16, when in combination 
with Δrif1 and of  HH4K8 when in combination with Δrif2. 
  
 
Table 4 - Histone H3 Trimethylation levels. 
 H3K4Me3/H3 H3K36Me3/H3 H3K79Me3/H3 
Wt 0,93 1,2 1,63 
Δkhd1 0,97 1,38 1,78 
Δrpd3 1,01 1,5 5,51 
Δkhd1 Δrpd3 1,67 1,59 2,5 
Δsir2 0,91 0,78 1,5 
Δyku70 1,56 0,85 2,41 
Δyku70 Δkhd1 11,95 12,62 15,24 
Δrad27 1,05 1,12 1,47 
Δrad27 Δkhd1  0,92 1,7 3,21 
 
Another histone modification that regulates transcription is Histone H3 trimethylation (Schneider et 
al., 2004). We observed that an additional Δkhd1 to Δrpd3 leads to an increase of H3K4Me3 and a 
decrease in H3K79Me3 as compared to Δrpd3. In addition, we observed that Δkhd1 Δyku70 leads to 
dramatic increases in the trimethylation levels for all three lysines analysed, when compared to the 
wildtype or even the single mutants. Furthermore, the Δrad27 Δkhd1 also shows an increased 
H3K79Me3 level as compared to both single mutations. 
 
 
 
 
 
 
 7.10 Is there a relationship to the telomerase RNA subunit? 
As KHD1 encodes an mRNA binding protein with a translation repressor function, and the 
telomerase is an enzyme with an RNA subunit, we wanted to see if there was any connection 
between the two. For this we analysed gene transcriptional silencing when additional copies of the 
telomerase RNA subunit, TLC1, were supplied. 
 
Fig. 32 - Telomerase RNA subunit affects telomere gene transcriptional silencing of mRNA 
binding proteins mutants?  
Serial dilutions and growth for 72hours at 30 degrees. 
 
We observed that an overexpression of TLC1 leads to death of Δkhd1 in 5'FOA containing media. 
We were also able to determine that this effect is not a general translation repressor or even a 
general mRNA binding protein defect, since Δvts1 fails to show a similar phenotype, although 
exhibiting less fitness. 
 
 
 
 7.11 Is Khd1p a part of a heterochromatin remodelling complex? 
As we have shown that Δkhd1 causes a loss of telomeric silencing, downregulates Sir2p and plays a 
role in stabilizing the telomere when an excess of TLC1 is provided, we were wondering if Khd1p 
is a part of any telomeric protein complex. To address this question, a tandem affinity purification 
was performed and the co-purification of specific proteins, Sir2p and Rif2p, was investigated. Both 
can indeed be purified when using Khd1p as bait, but this interaction seems to be DNA dependent 
(Fig. 33). 
 
Fig. 33 – Is Khd1p a part od a chromatin remodelling complex?  
Khd1-TAP TEV-cleaved eluates were probed on western blot for Rif2-myc9p and for Sir2-myc9p. 
The same experiment was performed after a 20minutes DNAse I treatment. 
 7.12 Is KHD1 involved in DNA repair? 
Denisenko and co-workers proposed that Khd1p is involved in the Telomeric Rapid Deletion 
Pathway (Denisenko et al., 2002). A major complex involved in this process is the 
Mre11p/Rad50p/Xrs2p complex. This complex is responsible for homologous recombination events 
in the telomeric regions leading to Telomeric Rapid Deletion events, i.e. telomere length reduction 
and is also responsible for non-homologous End-joining and DNA recombinational repair.  
We decided to analyse the relationship between this complex and Khd1p and to see if KHD1 played 
also a role in DNA repair. 
 
 
Fig. 34 - Temperature sensitivity of ∆khd1 ∆rad52. 
10-fold serial dilutions of overnight cultures were plated onto YEPD plates and incubated at 
different temperatures. 
 
As shown previously khd1 plays a role in telomere maintenance. Telomere maintenance and DSB 
repair are intimately linked. Telomeres are double stranded breaks (DSB's) per se, that surprisingly 
escape the recognition mechanism. Recognition of the double stranded break is mediated by 
RAD52, that distinguishes between DSB's and telomeres (Fig. 19). Another gene that is involved in 
both telomere maintenance and DSB repair is YKU70. This gene binds the telomerase RNA and 
acts in double stranded break repair by non-homologous end joining. We tested KHD1 for synthetic 
lethality with RAD52 and YKU70 and both turned out to be negative. We were able to determine 
that ∆rad52 ∆khd1 cells are Synthethic Growth defective at 37ºC while at 30ºC no impaired growth 
was observed. Furthermore, this observed growth defect was specific for ∆rad52 ∆khd1 as ∆xrs2 
∆khd1 cells do not exhibit it. This result indicates that KHD1 can contribute to a pathway parallel to 
RAD52. 
 
 
 7.13 Involved in which pathway of DNA repair? 
Proteins involved in telomeric silencing are also related to DNA damage and repair pathways. 
Defects in DNA repair pathways are usually detected with the help of DNA damaging agents such 
as MethylMethanoSulphate (MMS), Hydroyurea, ionizing radiation, UV radiation and others. 
MethylMethanoSulphonate, although initially thought to cause alkylation of the DNA and thus 
induce DSBs, causes stalling of the replication fork and mutants in the homologous recombination 
pathway cannot overcome this fork stalling and thus exhibit extreme sensitivity to this agent 
(Lundin et al., 2005). 
Ultraviolet radiation causes thimidine-dimer formation, that cannot pair with the opposing strand, 
thus leading to a bulge of the DNA molecules. As the DNA replication machinery progresses it can 
cause stalling, mispairing and mutations (Matsumura and Ananthaswamy, 2004; Davies et al., 
2002; Schreier et al., 2007). 
Hydroxyurea is a DNA replication inhibitor that causes ribonucleotide depletion by inhibiting the 
ribonucleotide reductase and can ultimately result in DNA double strand breaks due to the extended 
replication forks (Platt et al., 2008). 
Cells were subjected to increasing amounts of UV radiation exposure and their viability was 
measured. khd1 disrupted cells showed no increased sensitivity to UV radiation as compared to the 
wildtype, in normal growth conditions (Fig. 35). However a Δrad52 Δkhd1 survived poorly when 
subjected to elevated temperature and to UV radiation (Fig. 35), indicating an intolerance to this 
combination of effects, not observable in the single mutants. This intolerance is however not 
significantly higher than the growth defect observed for growth at 37 degrees. 
In addition, a Δkhd1 Δxrs2 showed an increased sensitivity to 50μJ and to 100μJ as compared to the 
single mutants, indicating that indeed khd1 plays a role in UV damage induced repair. 
 
Fig. 35 - UV radiation sensitivity essay. 
 10-fold serial dilutions of an overnight culture were plated on YEPD and then subjected to 
increasing doses of UV radiation. Plates were then incubated at 30 and at 37 degrees. 
 
 
In order to test if ΔKHD1 is also sensitive to damage-inducing chemical agents, cells were 
subjected to increasing concentrations of hydroxyurea. We observed that ∆khd1 caused no change 
in sensitivity to hydroxyurea (Fig. 36), indicating that ∆khd1 does not play a role in replication.  
 
Fig. 36 - Hydroxyurea sensitivity essay. 
10-fold serial dilutions of an overnight culture were plated on media containing increasing 
concentration of Hydroxyurea. 
 
The same experiments were performed with increasing concentrations of MMS. As ∆khd1 showed 
an increased sensitivity phenotype to 0,05% MMS than wildtype cells (data not shown), we decided 
to repeat the same experiments with different combinations of mutants from the contributing double 
strand break repair pathways, to try to elucidate with which Khd1p, could be involved. 
Fig. 37 - MethylMethanoSulphonate sensitivity essay. 
10-fold serial dilutions of an overnight culture were plated on media containing increasing 
concentration of Hydroxyurea. 
 
We observed that a ∆rad52 ∆khd1 shows an increased sensitivity to MMS than the single ∆rad52 
 mutant, for all MMS concentrations tested (Fig. 37). In addition, the same is true for ∆xrs2 ∆khd1. 
 
7.14 Involved in Non Homologous End Joining? 
Non homologous end joining is a process where loose ends of DNA are ligated to other DNA ends, 
and therefore, repaired. This process normally does not require sequence homology between 
fragments to take place. We decided to investigate if KHD1 played a role in this process.  
 
 
Fig. 38 - Non Homologous End Joining Efficiency. 
An overnight culture was diluted to 0.2 and let grow exponentially. When OD600=1 was reached 
cells were transformed with 0,5μg DNA of a linear plasmid and of a circular plasmid in parallel and 
plated out in selective media. Plates were incubated 3 days and cfus were counted. Bars represent 
the ratio between number of cfus with linear plasmid/ number of cfus with circular plasmid. 
 
We observed that KHD1 alone leads to a dramatic decrease in NHEJ, which can be rescued when 
supplying an additional KHD1 copy on a plasmid. As khd1 has been shown to be involved in 
telomeric maintenance we also wanted to see if it was a general telomeric maintenance defect. 
Therefore we analysed Δrpd3 and Δrif1 deletions, both alone and in combination with Δkhd1. We 
observed that these genes when disrupted alone do not affect NHEJ but when in combination with a 
KHD1 disruption, a NHEJ defect is also observed (Fig. 38). This finding was extremely surprising, 
as Khd1p has been proposed to be a translation repressor and an mRNA-binding protein (Irie et al., 
2002; Paquin et al., 2007). In addition, and even more surprising, was the observation that KHD1 is 
epistatic to YKU70 (Fig. 38). This finding would point to a direct role of Khd1p on NHEJ or a 
 regulation of a factor that is essential for NHEJ. 
 
7.15 NHEJ coupled to a specific KH-domain? 
Khd1p contains 3-KH domains, that are known to bind nucleic acids. We wanted to investigate if 
we could couple this NHEJ defect to any of the KH domains. We observed that a point mutant in 
KHdomain3-L284R, still rescues the NHEJ defect but a point mutant in KHdomain2-I183R no 
longer does so (Fig. 39). 
 
Fig. 39 -  Non-Homologous End Joining rescue with plasmid bourne-KHD1 and KHD1-point 
mutants. 
 
 
 
 
 
 
 
 
 
 7.16 VTS1, another translation repressor involved in Telomeric Silencing? 
VTS1 is a gene that has been shown to be functional homologue to Drosophila Smaug protein 
(SMG1) (Aviv et al., 2003; Aviv et al., 2006). Smaug binds poly-C regions and acts as a translation 
repressor of oskar mRNA, during development of the Drosophila embryo (Dahanukar et al., 1999; 
Zaessinger et al., 2006). Smaug has been proposed also to be involved in mRNA deadenylation via 
the CCR4/NOT complex and thus control stability of the target mRNA (Zaessinger et al., 2006). 
 
7.17 Could another protein that has been shown to be involved in mRNA localization 
and translation repression be also involved in telomeric silencing and stability? Is it 
a process specific to Khd1p? 
As can be seen in figure 40 Δvts1 alone shows no effect on telomeric silencing, the same as 
observed for Δkhd1 alone. But in combination with other mutants, Δvts1 behaves differently than 
Δkhd1 (Figs. 21, 23 and 40). Whereas khd1 disruption showed a severe silencing deffect in addition 
to a Δrpd3, a Δrpd3 Δvts1 shows no effect (Fig. 21), indicating that it is not translation per se that is 
affecting the genomic stability but rather a khd1 specific effect. On the other hand, Δkhd1 Δrif1 
showed a slighter increased silencing  effect whereas Δvts1 Δrif1 shows a dramatic loss of telomeric 
silencing (Figs. 23 and 40). In addition, this Δvts1 Δrif1 double mutant is temperature sensitive 
whereas the single mutants are not (Fig. 40). 
 
 
 
 
 
 
 
7.18 Are these effects specific to Δrif1 alone or are they also true for Δrif2? 
Rif2p is a protein partner of Rif1p, and they both act in binding to Rap1p at the telomere and 
regulate telomere length together (Wotton and Shore, 1997). 
 Fig. 40 - Role for VTS1 in telomeric silencing? 
A – Serial dilutions and growth in differential conditions, to address silencing. 
B – Serial dilutions and temperature sensitivity determination. 
 
 
We have observed that Δrif2 Δvts1 does not behave as Δrif1 Δvts1 (Fig. 40), as it is not dead on 
5'FOA and also not sensitive to 37ºC, suggesting that the effects observed are specific to Δrif1 
Δvts1, being the first described events where Rif1p and Rif2p act independently.  
 
7.19 Does  Δvts1 Δrif1 show a replication defect? 
A temperature sensitivity phenotype in combination to rif1 disruption can be found associated to 
loss of silencing, to loss of telomere capping and to very short telomeres (e.g. Yku70) and we 
analysed whether this was also the case for ∆rif1 ∆vts1.  
 
 To address this question we analysed these mutants in media containing incrasing concentrations of 
hydroxyurea. 
Fig. 41 - DNA replication defect? 
A – Hydroxyurea sensitivity assay. 
B – Temperature sensitivity rescue with high-copy cyclins. 
 
 
We observed that Δvts1 Δrif1 is extremely sensitive to hydroxyurea (Fig. 41A), a drug that inhibits 
DNA replication and S-phase progression, indicating a DNA replication problem. This hydroxyurea 
sensitivity was not overcome with a high-copy plasmid contaning CLB1 or CLB6 (Fig. 41B). As 
CLB1 is a G2-M cyclin (Surana et al., 1991) and CLB6 is a DNA-synthesis activator cyclin 
(Schwob and Nasmyth, 1993; both reviewed in Lew et al., 1997), we ruled out that the arrest would 
be at these two stages. These results led us to try to map the point of the replication problem. We 
wanted to check if the cells were arrested at G1-S or at G2-M or not at all, by using FACS analysis.  
  
Fig. 42 - Cell Cycle Arrest? 
FACS analysis. 
 The FACS analysis revealed that the Δvts1 Δrif1 mutant (Fig. 42), already at 30ºC shows a severe 
difference to the wildtype or even to the single mutants. We observed (Fig. 42) that this mutant 
increases DNA content, indicating that DNA replication occurs but that citokinesis does not occur 
properly, as has been observed for Guanydine depleted cells (Sagot et al., 2005). In order to 
confirm these results we have also looked at the cells in the microscope. (Fig. 43). In fact, Δrif1 
Δvts1 cells accumulate chains of multiple buds, showing indeed a defect in cytokinesis. In addition 
these mutants also show a number of tripartide spindles (Fig. 43), lagging and bridging 
chromosomes (Fig. 43), indicating a defect in chromosome segregation aswell, most likely linked to 
anaphase checkpoint recognition defect. 
 
 
 Fig. 43 - Defects in cell division? 
DAPI staining of ∆rif1 ∆vts1 cells. 
 
 
How can a cytoplasmic protein that is involved in translation regulation be involved in telomeric 
silencing and cause such dramatic effects in combination with Δrif1? Is there a direct nuclear 
function associated to VTS1?  
 
 7.20 Is Vts1p  a shuttling protein? 
 
 
Fig. 44 - Vts1p in nucleus? 
A – Immunofluorescence using a mex67 temperature sensitive allele, that blocks nuclear mRNA 
export. 
 
As can be seen in the figure 44, Vts1-myc9 is steady state cytoplasmic and cannot be trapped in the 
nucleus in an mRNA dependent manner. Khd1-myc9 and She2p, two mRNA binding proteins have 
been shown to accumulate in the nucleus, using the same assay (Du et al., 2008; Kruse et al., 2002). 
 
7.21 Could it be due to telomeric length regulation control? Could Δvts1 reduce so 
dramatically the telomere that renders the cell uncapable of dividing? 
Could Vts1p be a part of the Rap1-Rif1/2 counting model? 
 
 
We observed that vts1 disruption does not by itself give a shorter telomere than wildtype. The 
combination of Δrif1 with Δvts1 gives an extremely surprising result as the whole subtelomeric 
region is lost in these mutants, as seen in figure 45. 
  
Fig. 45 - Telomeric Length analysis 
Southern Blot probed with TG1-3 repeat probe. 
 
 
We also analysed telomeric length in the Δrif2 Δvts1 mutants to see if they also showed a total loss 
of the subtelomeric region. We observed that indeed these mutant cells do not, showing that this 
phenotype is specific for Δvts1 Δrif1 (Fig. 45). 
 8. DISCUSSION 
 
Telomeres are the ends of chromosomes. These DNA regions are places of intense chromatin 
remodelling and one of the three loci, together with the mating type and rDNA loci, where gene 
transcriptional silencing occurs. 
KHD1 has already been shown to play a role in telomere positioning effect (TPE) and to bind to 
subtelomeric DNA (Denisenko et al., 2002). PBP2, or polyA-binding protein-2, encodes for another 
3-KH domain containing protein, with a 30% similarity to KHD1, has been shown to also play a 
role in telomeric gene transcriptional silencing and in combination with Δkhd1 contribute to an 
elongated telomeric region (Denisenko et al., 2002). This elongation was suggested to be related to 
a defect in the telomeric rapid deletion pathway (Denisenko et al., 2002).  
In order to study TPE a plate based assay, that measures activation of a normally silenced URA3 
marker positioned at the telomere, was used (Fig. 19). 
 
8.1 KHD1 involved in telomeric silencing? 
Results presented in this work show that khd1 disrupted cells have no drammatic phenotype in 
telomeric gene transcriptional silencing, when compared to the wildtype (Fig. 20). Surprisingly, a 
double rpd3 khd1 deletion loses telomeric gene transcriptional silencing characteristic to Δrpd3. 
RPD3 encodes for a Histone H3 deacetylase and influences general acetylation levels and at the 
telomeric region induces gene transcriptional silencing (Rundlett et al., 1996; Sun and Hampsey, 
1999). The fact this additional khd1 disruption causes such a drammatic loss of silencing shows that 
khd1 really plays a role in the telomeric gene transcriptional silencing process. In order to prove that 
this ∆rpd3 ∆khd1 loss of silencing phenotype is a khd1 specific event we also chose to test whether 
pbp2 also caused the same phenotype. Δpbp2 Δrpd3 mutant cells do not behave significantly 
different from Δpbp2 mutant cells, although showing a partially weaker silencing than rpd3 
disrupted cells. This could mean that pbp2 is epistatic to rpd3. The fact that Δpbp2 Δrpd3 show a 
less pronounced desilencing phenotype than Δkhd1 Δrpd3 argues for a khd1 specific effect. As 
changes in strength of telomeric positioning effect can be due to several different pathways and 
events, it is conceivable that in the same read-out, growth or no growth on 5'FOA, several effects 
are contained. Telomeric gene transcriptional silencing can change as a result of changes in 
telomeric length (Wotton and Shore, 1997), of changes in heterochromatin formation (Rundlett et 
al., 1996) or even as a result of changes in the formation of the silencing complex SIR2-3-4 
 (Aparicio et al., 1991; Moazed et al., 1997). The Sir2, Sir3, and Sir4 proteins are limiting within the 
cell, leading to an internal competition between the telomeres and the HM loci (Buck and Shore, 
1995) as well as between the telomeres and the rDNA (Smith et al., 1998) for these proteins. The 
observation that Δkhd1 Δrpd3 does not differ significantly in phenotype from both Δsir2 Δrpd3, 
mutant that does not form a functional SIR complex (Aparicio et al., 1991; Moazed et al., 1997), 
and Δsas2 Δrpd3, mutant that reduces SIR complex deposition at the telomeres (Suka et al., 2002), 
does not allow us to conclude whether it could be a SIR complex formation event or a SIR complex 
localization and targeting. Considering the fact that Khd1p has been proposed to be a translation 
repressor we also tested whether another translation repressor, like Vts1p (Aviv et al., 2002), also 
plays a role in TPE. Analysis of vts1 deletion mutants in the telomeric gene transcriptional silencing 
assay elicited some very interesting results (discussed later). In fact, as observed for khd1 
disruption, Δvts1 shows no effect on TPE alone. On the other hand, Δvts1 does not influence 
transcriptional silencing in Δrpd3 mutant cells. This is in contrast to what was observed for Δkhd1 
Δrpd3 mutant cells. Khd1p could play a direct role in the TPE process or it could be an indirect 
event, linked to the mRNA translation repressor function and associated to the specific mRNAs it 
binds to. Unfortunately, until now only ASH1 mRNA has been shown to be bound by Khd1p (Irie et 
al., 2002). 
An answer to these questions and a clearer picture on these Δkhd1 and Δpbp2 effects in TPE is still 
needed. 
 
8.2 Other roles in TPE for KHD1 in combination with other mutants? 
In order to get a clearer picture about the role of KHD1 in TPE, we combined a khd1 disruption 
with deletions from other genes already established to be involved in TPE. We observed that Δkhd1 
increases silencing of Δrif1 and of Δrif2 mutant. In contrast a pbp2 deletion in a Δrif1 causes the 
exact opposite, reversing the silencing effect observed for Δrif1. This indicates that i) PBP2 might 
counteract RIF complex function in telomeric length regulation, ii) can cause a change in 
heterochromatin establishment, leading to a lower transcriptional activation at the telomeric site, or 
iii) might contribute to SIR complex deposition at the telomere. 
 
8.3 Is KHD1 involved in telomeric length regulation? 
Although it has been described for both Δkhd1 and Δpbp2 to cause telomere elongation (Denisenko 
et al., 2002), results presented in this work have not shown the same. In fact, there was no 
 difference observed for khd1 or pbp2 disruptions as compared to the wildtype. Furthermore, both 
show no change in telomeric length in combination with ⊗rpd3, indicating that it is not telomeric 
length regulation to cause the phenotype changes observed on the TPE assay. 
Nevertheless, in support of the idea that khd1 plays a role in telomeric length regulation, we 
observed that in Δrif1 cells, which already have an extended telomeric region, an additional khd1 
deletion causes a further elongation. As Δrif1 is already transcriptionally silenced (Marsellach et al., 
2006), this additional khd1 disruption shows no detectable increase in the silencing phenotype 
observed for the TPE assay. Δpbp2, however, showed no such effect in combination with Δrif1. In 
fact, a double pbp2 rif1 disruption showed an elongated telomeric region but showed a loss of 
silencing as compared to a single Δrif1.These results point to a rescue of the silencing defect caused 
by RIF1 deletion due to the deletion of PBP2, which is independent from telomeric length. In 
addition these findings also confirmed that in combination with Δrif1 both Δkhd1 and Δpbp2 
contribute to telomeric elongation. 
Another interesting result is that a combination of Δrad27 Δrif1 Δkhd1 showed an elongated 
telomeric region, indicating that all three mutations regulate telomeric length in different ways. It is 
conceivable that this is so, taking into account that rif1 is responsible for shortening the telomere 
with each cell division (Wotton and Shore, 1997), rad27 is responsible for okazaki fragment 
maturation and rad27 disruption causes an elongated lagging strand (reviewed in Liu et al., 2004), 
khd1, which has been implicated in the telomeric rapid deletion pathway (Denisenko et al., 2002), 
thus cummulatively contributing to the elongation of the telomeric region. 
The longest telomeric region was observed for Δrif1 Δrif2 Δkhd1, which adds evidence to the fact 
that indeed Δkhd1 plays a role in telomeric elongation, since this triple mutant shows an even more 
elongated telomere than Δrif1 Δrif2. 
 
8.4 Can KHD1 be involved in Sir2p downregulation? 
The observation that a double khd1 rpd3 deletion mimicks a Δsir2 Δrpd3 or even a Δsas2 Δrpd3 led 
us to address the question whether Δkhd1 was responsible for Sir2p downregulation or for 
delocalization of the SIR complex from the telomere, thus causing the loss of silencing observed 
(discussed above). 
When Sir2p-myc9 levels were analysed in Δkhd1 and in Δpbp2, we observed that they remained 
unchanged in Δpbp2 but were significantly reduced in Δkhd1, independent of their respective SIR2 
mRNA levels, arguing for a post transcriptional regulation event in regard to Δkhd1. These results 
 clearly show that pbp2 and khd1 are acting in different pathways to regulate silencing and TPE. 
This downregulation of Sir2p-Myc9 could be an explanation for the weaker silencing observed for 
the rpd3 khd1 disrupted cells. 
To address the question whether Sir2p-myc9 is correctly localized, indirect immunofluorescence 
was performed. There was no observable difference in localization of Sir2p-Myc9 between 
wildtype and Δpbp2. The very low abundance of Sir2p-myc9 in Δkhd1 cells did not allow any 
conclusion regarding subcellular localization using the same technique (Fig. 28). 
Gene transcriptional silencing occurs at three loci, rDNA, telomeres and mating type loci. Sir2, 
Sir3, and Sir4 proteins are limiting within the cell, leading to an internal competition between the 
telomeres and the HM loci (Buck and Shore, 1995) as well as between the telomeres and the rDNA 
(Smith et al., 1998) for these proteins. The decrease of Sir2p in Δkhd1 cells could explain why non-
conventional mating occurs more frequently in khd1 disrupted cells than it does for the wildtype 
cells (data not shown), since the mating type loci might be less effectively silenced and the 
available Sir2p would be somehow tethered to the rDNA loci and to the telomeres. Sir2p deposition 
at rDNA loci prevents homologous recombination events that create rDNA circles that cause 
cellular ageing (Park et al., 1999; Kaeberlin et al., 1999; Gottlieb and Esposito, 1989; Guarante, 
2001). The fact that there is less Sir2p in a khd1 disrupted cell could mean that it ages faster than a 
wildtype. It would be interesting to investigate if this is true and if so, determine how faster does it 
age. Taking into account that khd1 has sequence homology to hnRNP K and hnRNP K has been 
shown to be involved in telomere regulation (Marsich et al., 2001; Bandiera et al., 2003) it would 
be interesting to test whether hnRNP K also affects levels of Sirtuins and thus aging regulation. It 
would also be interesting to determine whether there is a correlation between Khd1p function in 
yeast and hnRNP K functions in a more complex and regulated system, such as the human cell. 
 
8.5 Can the observed Δrpd3 Δkhd1 desilencing phenotype be rescued? 
The results presented and discussed above show that disruption of khd1 causes a decrease of Sir2p. 
Previous observations from other groups have shown that a sir2 disruption causes loss of gene 
transcriptional silencing (Shore et al., 1984)  and sir2 overexpression causes chromosome 
instability, leading even to chromosomal loss (Holmes et al., 1997). Although the loss of silencing 
is an expected outcome for a sir2 disruption, as the SIR complex cannot be properly formed, 
assembled and deposited at the silenced loci, it is not so intuitive that a SIR2 overexpression is 
detrimental for cell viability. A putative explanation could be that too much deacetylation of histone 
tails occurs (Braunstein et al., 1993) and so the overall level of transcription is severely reduced, 
 thus causing cell death in 5'FOA, an additional stressing factor. In fact, SIR2 expressed from a 
multicopy plasmid is indeed lethal for a wildtype cell. Interestingly this is not the case for Δkhd1 
disrupted cells (Fig. 30). 
When a SIR2 expressed from a low-copy plasmid, a partial rescue of gene transcriptional silencing 
could be observed for rpd3 khd1 double deletion, indicating that SIR2 is indeed one of the factors 
affected. The fact that the rescue observed is not complete might be due to the fact that SIR2 levels 
are very tightly balanced, as both an excess and a loss of SIR2 lead to desilencing. Another possible 
reason would be that another factor involved in telomeric gene transcriptional silencing is also 
affected by Δkhd1 and its loss is not completely rescued by additional copies of SIR2. 
 
8.6 Does Δkhd1 lead to a change in histone modifications? 
Sir2p is an essential enzyme in the formation of the euchromatin/heterochromatin boundary. This is 
an important step in regulating transcriptional silencing or desilencing. In this regard, the levels of 
acetylation of the histone tails are an important determinant for the establishment of this boundary. 
Acetylation of Lysine 16 of Histone H4 (HH4K16Ac) is the hallmark for heterochromatin boundary 
formation at the telomere and it is regulated by the competition between Sir2p, a histone 
deacetylase and Sas2p, an histone acetyl-transferase (Suka et al., 2002; Kimura et al., 2002). 
In order to explain the differences in silencing observed for Δkhd1 Δrpd3 and for Δpbp2 Δrpd3, the 
acetylation levels of Histone H4 Lysines 8 (K8), 12 (K12) and 16 (K16) were analysed. Although 
the levels for K8 and K12 were not significantly different in order to explain the changes in 
silencing observed, the changes in K16 acetylation were very striking. The fact that in Δkhd1 cells 
no changes in Histone H4 acetylation levels were observed, could mean that both Sir2p and Sas2p 
are downregulated or that another deacetylase, at least partially takes over Sir2p function. To better 
answer this question the amount of Sas2p should also be determined in order to rule out Sas2p 
downregulation. 
Whereas Δpbp2 Δrpd3 showed no significant difference, in Δkhd1Δrpd3 cells Histone H4K16 was 
3-fold more acetylated than on rpd3 disrupted cells, consistent with the previously observed 
downregulation of Sir2p function and with a more transcriptionally active region. 
The effects caused by pbp2 disruption and khd1 disruption, in spite of the domain similarity 
between these two genes, are not functional related. This is shown by the observation that pbp2 
disruption causes no significant change on Histone H4 acetylation and that khd1 deletion has, 
probably via Sir2p. It is conceivable that the phenotype observed for Δpbp2 in desilencing of rpd3 
disruption is related to histone H3 modifications, since rpd3 is a deacetylase of histone H3 tails and 
 so therefore its influence on telomeric silencing would be indirect. Furthermore, one can also 
hypothesize that pbp2 could contribute to trymethylation of histone H3 tails, an important regulator 
of transcription (Tamaru et al., 2003), and thus activate transcription at the telomeric region, 
resulting in the loss of silencing observed for Δpbp2 Δrpd3. 
 
In summary, 
• KHD1 plays a role in telomeric gene silencing. PBP2, a gene quite similar to KHD1, in 
that it also encodes for a 3-KH domain containing protein, also plays an almost similar 
role. These roles were proven to be independent of telomeric length and again, in this 
read-out, both Δpbp2 and Δkhd1 show similar results, leading to elongated telomeres (as 
proposed by Denisenko et al., 2002) only in combination with Δrif1.  
• However, when levels of Sir2p-Myc9 are analysed in both khd1 and pbp2 deletion 
mutants, Δkhd1 shows a clear difference whereas Δpbp2 shows no difference. These 
results clearly indicate that the mechanism uncovered involving an increase of Histone 
H4K16Ac and a decrease of Sir2p-Myc9 in regard to a khd1 disruption, is specific for 
khd1.  
• The fact that Δpbp2 causes a similar silencing rescue of Δrpd3, but does so 
independently of telomeric length control, Sir2p amount and of Histone H4K16Ac 
regulation suggests that pbp2 is involved in an entirely different pathway that does not 
involve Sir2p or changes in Histone H4K16Ac. 
 
8.7 Is Khd1p a part of an heterochromatin regulator complex? 
The observation that Δkhd1 causes a Sir2p downregulation led us to analyse whether Khd1p is a 
part of the SIR complex or a Sir2p interacting partner. 
The observation that Δkhd1 causes a further telomeric elongation for Δrif1 and for Δrif2 led us to 
investigate whether Khd1p was a part of the RIF protein complex.  
Results in figure 33 show that Khd1p can co-purify both Sir2p and Rif2p, but does so only in the 
presence of DNA. These results suggest that these interactions are likely to be indirect and require 
DNA. The previous observation that Khd1p binds to subtelomeric DNA (Denisenko et al., 2002) 
seems to support this DNA mediated indirect Khd1p-Sir2p and Khd1p-Rif2p interaction hypothesis. 
 
 8.8 Is KHD1 gene transcriptional silencing influenced by telomerase RNA subunit 
overexpression? 
Telomerase is an holoenzime, composed of three proteins, Est1-3p and an RNA subunit, the TLC1 
RNA. Proteins involved in telomeric silencing regulation, such as Est1-4p and Yku70p, have been 
shown to bind TLC1 (Peterson et al., 2001; Stellwagen et al., 2003; Lustig AJ, 2004) and be able to 
target it to the telomere, to tether it to its proper location.  
Results presented in figure 32 indicate that a multicopy plasmid containing TLC1 proves 
detrimental for growth of any khd1 disrupted cell tested. This means that an overexpressed TLC1 
causes a loss of telomeric gene transcriptional silencing in a khd1 disrupted cell. This observation is 
specific for Δkhd1, as a deletion of another mRNA binding protein, Δvts1, which is also a 
translation repressor, does not show a similar phenotype. In fact, these observations suggest that 
Khd1p also binds to TLC1 and contributes to the efficient tethering of TLC1 to the telomere. This 
hypothesis is supported by the model that an overexpressed TLC1 would titer Yku70p/Yku80p 
away from the telomere and would therefore lead to desilencing, as no SIR complex could be 
targeted and anchored at the telomeric region, via Sir4p-Yku70p binding.  
Furthermore, there is another complex of proteins apart from the telomerase and Yku70p that bind 
TLC1, which is the Sm complex – small nuclear ribonucleoprotein particle (Seto et al., 1999). This 
complex is proposed to be involved in the intracellular trafficking and maturation of the TLC1 RNA 
and it would be interesting to see if KHD1, being a shuttling protein, is somehow functionally 
related to this Sm complex. As TLC1 is a poly-adenylated RNA that is not translated and as Khd1p 
is a translation repressor, it is conceivable that the Khd1p-TLC1 interaction is an important part of 
telomerase biogenesis. 
Recently, increasing evidence has implicated mRNA surveillance mechanisms in telomerase 
function and biogenesis (Azzalin et al., 2006; Azzalin et al., 2007; Gallardo et al., 2008). As KHD1 
was shown to play a role in mRNA surveillance and NMD (Section 4.1) it is possible that KHD1 
plays a role also in regulating telomeric basal transcription events, by aiding the UPF pathway in 
dealing with excess transcripts originated in this manner (Azzalin et al., 2006). In addition, VTS1 is 
involved in CCR4-POP2-NOT function in deadenylation as a part of mRNA surveillance 
mechanisms and mRNA turnover. The observation that Δvts1 does not show a similar phenotype to 
khd1 disruption, seems to contradict this mRNA surveillance function hypothesis for KHD1, but it 
is possible that as TLC1 is not really a mature mRNA it eludes the CCR4-POP2-NOT machinery. 
In order to understand whether a link between Khd1p-TLC1 exists, a direct binding of Khd1p to 
TLC1 RNA should be investigated further. If there is a direct connection between Khd1p and TLC1, 
experiments should be designed to determine whether Khd1p and TLC1 RNA shuttle together (Fig. 
 46) and whether this binding is relevant for the translationally repressed trafficking. 
In addition, if the high-copy-TLC1 induced loss of silencing observed for khd1 disrupted cells (Fig. 
32) is related to Yku70p/80p delocalization from the telomere, a rescue of this silencing defect 
should be observed, when a high copy-Yku70/80 heterodimer is supplied to the cells. 
 
Fig. 46 - Putative Model for the connection between Khd1p and TLC1. As the binding between 
Khd1p and TLC1 RNA is still unconfirmed, it is unclear whether this model will hold. After 
confirmation of the Khd1p – TLC1 interaction it would be important to know where in the cell do 
they interact, whether they shuttle together from the nucleus to the cytoplasm, whether Khd1p is a 
translation repressor to TLC1 providing insights into what is the relevance of this interaction. 
 
8.9 Is KHD1 involved in DNA repair? 
Genes that are involved in telomeric gene transcriptional silencing are generally also involved in the 
DNA damage repair pathways. DNA repair is an extremely conserved process throughout evolution 
(Cromie et al., 2001). The major players that are involved in this process are conserved, with a few 
exceptions (Reviewed in Li and Heyer, 2008; Weterings and Chen, 2008; Shrivastav et al., 2008; 
Phillips and McKinnon, 2007). A telomere, is, in its essence a double stranded DNA break, that is 
not recognized as such and is not repaired and ligated to other lose  DNA ends. If this occured it 
would be detrimental for the cell, in terms of chromosome segregation and cell cycle progression 
(reviewed in Viscardi et al., 2005). A telomere could therefore be envisioned as a DNA damage that 
escapes repair. This escape is mediated by RAD52, that distinguishes double strand breaks (DSB's) 
from telomeres. Another gene that is involved in both pathways is the yeast Ku homolog, YKU70, 
which binds to TLC1 RNA and acts in DSB repair and non-homologous end joining (NHEJ) 
 (Boulton and Jackson, 1996). A protein complex that is involved in both telomere maintenance and 
DSB repair is the MRE11/RAD50/XRS2 complex (Wilson et al., 1999). It is responsible for 
homologous recombination events, both in the telomeric rapid deletion pathway, that relies on 
homologous recombination events to reduce long telomeric DNA regions to wildtype in a single 
cell division (Li and Lustig, 1996), and in the DSB repair pathway. Denisenko and Bomsztky 
proposed in 2002 that KHD1 is involved in the Telomeric Rapid Deletion Pathway. To assess the 
validity of this hypothesis, and determine whether KHD1 is, as the MRX complex (Ivanov et al., 
1992), also a RAD52-epistasis group member, an analysis of the genetic relationship between 
KHD1 and this complex was performed, as well with other members of the DNA DSB repair 
pathway. Not surprisingly, no genetic relationship was found between khd1 and yku70, khd1 and 
rad52 or khd1 and xrs2, under normal growing conditions. At an elevated growth temperature 
rad52 khd1 double disruption showed a slower growth phenotype. This observation cannot be 
attributed to any specific function of RAD52 or KHD1 but suggests that there is a relationship 
between DSB repair and KHD1. Supporting this hypothesis is the observation that mutations in 
genes involved in DNA related events, such as mitosis progression are temperature sensitive with 
RAD52, e.g. BUB2 and BUB3 (Myung et al., 2004). It is conceivable that one such relationship, if 
existing, would be more prominent under DNA damage stress, which will be discussed further in 
the following sections. 
 
8.10 Is KHD1 involved in Double Strand Break Repair? 
DNA damage repair can be normally assessed with studies on sensitivity to damage inducing drugs 
or radiation. Methyl-methanosulphonate, although initially thought to cause alkylation of the DNA 
and thus induce DSBs, causes stalling of the replication fork and mutants in the homologous 
recombination pathway cannot overcome this fork stalling and thus exhibit extreme sensitivity to 
this agent (Lundin et al., 2005). UV radiation, one example of radiation commonly used, induces 
thymidine dimer formation and can also cause stalling of the replication fork, and in addition 
nucleotide misincorporation and thus lead to deleterious mutations (Matsumu and Ananthaswamy, 
2004). Δkhd1 cells showed no increased sensitivity to UV radiation. Nor did they show any 
increased sensitivity in combination with Δrad52 when grown at 30 degrees. Δkhd1 did however 
show a decreased viability with Δxrs2 at high UV dosage (50μJ). The DNA repair defect caused by 
Δkhd1 is even more pronounced when Δrad52 Δkhd1 irradiated cells were grown at 37 degrees 
(Fig. 35). In this combination of conditions, Δrad52 Δkhd1 mutant cells exhibit an extremely 
reduced fitness, indicating indeed a defect in DNA repair, although the fact that this double mutant 
 combination leads to synthetic growth defect at elevated temperatures makes the results harder to 
interpret.  
The fact that both Δxrs2 Δkhd1 and Δrad52 Δkhd1 show no elevated sensitivity to increasing 
concentrations of hydroxyurea (Fig. 36), a DNA replication inhibitor, points to a direct role of 
KHD1 in DNA repair, independent of DNA replication. 
This defect in DNA repair is even more evident when the results for sensitivity to MMS are 
analysed. Again, although Δkhd1 alone shows no defect in regard to MMS sensitivity alone it does 
so with Δrad52 and also with Δxrs2, as seen for all MMS concentrations tested. These findings 
support the idea that KHD1 plays indeed a role in DNA DSB repair. The above results would 
indicate that RAD52 and KHD1 contribute to different pathways in DSB repair. As XRS2 is 
involved in both already characterized DSB repair pathways (Fig. 19), it is not surprising that khd1 
deletion also shows a DNA repair defect with xrs2 deletion. The results mentioned above suggest 
that KHD1 can play a role not in recombinational repair (rad52 dependent) but in non homologous 
end joining, a DSB repair pathway that does not require RAD52 but does YKU70/YKU80. The 
possibility that KHD1, a translation repressor involved in mRNA localization could also be 
involved in NHEJ and DNA related events is an extremely interesting possibility. One could fit a 
model to KHD1 that includes first, a cytoplasmic function, in translation repression and mRNA 
localization and second, a nuclear function, related to telomeres and NHEJ, that could also involve 
TLC1 RNA. This model could also be fitted with the observation that Khd1p can be trapped in the 
nucleus in an mRNA dependent manner, clearly showing that it is a shuttling protein and that it 
could have a nuclear function (Du et al., 2008). 
 
8.11 Is KHD1 involved in Non-Homologous End Joining? 
Non homologous end joining is a process where loose ends of DNA are ligated, and hence, repaired 
(Hefferin et al., 2005; Daley et al., 2005). This process, that does not need sequence homology 
between ends, requires a functional Yku70/80 heterodimer, to recognize the double stranded break 
and initiate the repair process (Boulton and Jackson, 1996; Boulton and Jackson, 1996; Boulton and 
Jackson, 1998) (Figs. 18 and 19). The presented results in figure 38 show a decrease in NHEJ 
efficiency assigned to KHD1 disruption in all mutant combinations analysed, except for YKU70 
KHD1 double disruption. This latter result, indicates epistasis between KHD1 and YKU70 in regard 
to NHEJ, supporting the proposed hypothesis that KHD1 plays a role in NHEJ. Although the result 
in itself is clear, it is not clear whether it really is due to Δkhd1 directly or to any of the mRNAs 
whose translation it regulates. This hypothesis cannot be disproven nor can the model for the two 
 independent and separate functions, a cytoplasmic function and a nuclear function for KHD1. 
Adding to this unclear situation is the fact that there are genes that are involved in NHEJ that show 
almost no change in strength of telomeric gene transcritptional silencing. Some of these genes show 
an increased non-conventional mating frequency and show different MMS sensitivities - e.g. POL4 
(Wilson and Lieber, 1999; Sterling et al., 2006) or show an effect for only a part of the 
observed Δkhd1 phenotypes, e.g. SIR2 (loss of SIR2 leads to telomeric gene transcriptional 
desilencing, NHEJ defect and MMS sensitivity - Cohen et al., 2004). One cannot rule out a 
pleiotropic effect related to mRNAs that are misregulated by KHD1 disruption that cause the 
observed phenotypes. Further experiments on this issue are required in order to assert which of the 
models is true. 
 
8.12 KHD1 disruption NHEJ deffect can be assigned to KH domain-2 
KH-domains, or hnRNP K homology domains, are capable of binding nucleic acids. In FMR1 a 
point  mutation in KH domain-3, Ile304Asn, was described to cause loss of FMR1 association to 
mRNA in polysomes (Laggerbauer et al., 2001). After alignment and structure modelling of each of 
the KH domains of Khd1p, we generated point mutants I59R, I68R, I183R in Khd1p that should 
disrupt the KH domain folds for KH domains 1 and 2 and a L284R on the third KH domain, 
corresponding to Ile304Asn of FMR-1, that should disrupt polysome association (Siomi et al., 
1994; Laggerbauer et al., 2001). The observation that point mutant L284R is still able to rescue the 
NHEJ defect of Δkhd1 (Fig. 39) indicates that this point mutant does not disrupt Khd1p function in 
the NHEJ context. On the other hand, the point mutant I183R no longer rescues this NHEJ defect 
and therefore one can assume that the KH domain 2 is the one that is responsible for Khd1p role in 
NHEJ. This result suggests that KH domain 2 either binds directly to DNA or binds an mRNA 
required for proper NHEJ. In order to elucidate this point, gel shift assays with subtelomeric DNA 
and ASH1-mRNA should be performed to determine whether this point mutant still binds nucleic 
acids and if not, which one does it no longer bind. This information could direct further research 
into the relevance of KHD1 in this process. 
In addition, it would be interesting to see if a point mutant in KH domain-1 also still rescues the 
NHEJ in order to confirm that KH-domain 2 alone is responsible for this NHEJ effect. 
  
8.13 Possible functional significance of KHD1/hnRNP K involvement in NHEJ: 
Inherited mutations that affect DNA repair genes are strongly associated with high cancer risks in 
 humans. Hereditary nonpolyposis colorectal cancer (HNPCC) is strongly associated with specific 
mutations in the DNA mismatch repair pathway. BRCA1 and BRCA2, two genes that when mutated 
confer a hugely increased risk of breast cancer on carriers, are both associated with a large number 
of DNA repair pathways, especially NHEJ and homologous recombination. If hnRNP K can be 
tracked down to show the same defect as Δkhd1 in NHEJ, then a direct connection between other 
types of cancer, not due to BRCA1 or BRCA2 mutations, can be looked for and studied.  
 
In summary 
• KHD1 is involved in DNA repair, showing increased sensitivity to UV and to MMS but not 
to hydroxyurea. 
• KHD1 contributes to NHEJ function. 
• A KH-domain2 point mutant, Khd1p-I183R mutant cannot rescue the NHEJ defect observed 
for KHD1 disruption. 
 
8.14 VTS1, another translation factor involved in telomeric silencing? 
The fact that KHD1 is a translation repressor involved in mRNA localization and also plays a role 
in telomere gene transcriptional silencing, DSB repair and NHEJ originated interesting new ideas 
on the role of translation repressors in the tight control of telomere maintenance and DNA related 
events. VTS1 is a translation repressor, homologous to Smaug (Aviv et al. 2003; Aviv et al., 2006 ) 
and was initially found to be involved in vesicle trafficking (Dilcher et al., 2001). VTS1 disruption 
causes a slighty stronger telomeric gene transcriptional silencing. Interestingly, VTS1 RIF1 double 
disrupted cells exhibit a temperature sensitivity and a complete gene transcriptional desilencing, 
indicating a telomere and DNA associated phenotype. This is a quite striking event as a RIF1 
disruption normally causes a transcriptional silence at the telomere site due to an overextended 
telomeric region (Marsellach et al., 2006; Levy et al., 2004; Mishra et al., 1999; Wotton et al., 
1997). In addition, KHD1 RIF1 double disruption showed a slightly better than ΔRIF1 gene 
transcriptional silencing, pointing that it is not general translation repressor related but a Δvts1 
specific event. Surprisingly, the fact that RIF2 VTS1 double disruption shows no temperature 
sensitive phenotype nor does it show such extreme gene transcriptional desilencing, suggests that it 
is a Δrif1 Δvts1 combination specific event. This is even more surprising, when taking into account 
that RIF1 and RIF2 have always been considered to act together, as a part of the same protein 
complex (Wotton and Shore, 1997) and this is the first indication of an event where they act 
separately. 
  
8.15 Does ΔVTS1 ΔRIF1 cause a cell cycle progression defect? 
Is it sensitive to hydroxyurea? 
Hydroxyurea is a drug that inhibits S-phase progression and is commonly used to assess defects in 
cell cycle progression. As a DNA replication inhibitor, causes ribonucleotide depletion and results 
in DNA double strand breaks near replication forks. In these growth conditions,  Δrif1 Δvts1 
definitely shows sensitivity to increasing concentrations of hydroxyurea whereas neither the single 
mutants nor Δrif2 Δvts1 do. These findings seem to indicate that Δrif1 Δvts1 have a cell cycle 
progression defect, although it cannot be ruled out that a differential cell wall permeability could 
explain the differences in hydroxyurea sensitivity. Furthermore, one other hypothesis that cannot 
also be ruled out is that both temperature stress, 5'FOA stress and hydroxyurea stress can easily tip 
the scale in a weak survival balance. In other words, it can be that Δrif1 Δvts1 is already so sick that 
an additional stress causes its death. This hypothesis was then disproven by FACS analysis of vts1 
rif1 double deletion, that show an increase in DNA content, possibly due to a citokinesis defect, as 
shown by the increased 2n, 3n, 4n peaks in the FACS analysis. This has also been shown to occur 
with guanydine depleted cells (Sagot et al., 2005) that also fail to complete proper cytokinesis. This 
cytokinesis defect hypothesis was then confirmed by a microscope analysis of these mutant cells 
(Fig. 43). Rif1 vts1 double mutant cells accumulate multiple buds, thus explaining the single 
increment in DNA content. Furthermore, they also show a number of tripartite spindles, lagging and 
bridging chromosomes, which is an indicator of a defect in chromosome segregation, most likely 
related to anaphase checkpoint defects  and spindle assembly, such as those related to MAD and 
BUB genes, to NDC80 complex and to CBF3 complex (Martinez-Exposito et al., 1999; Gillet et al., 
2004; Gardner et al., 2001; McCleland et al., 2003). 
Most importantly, Δrif2 Δvts1 showed no similar phenotype, supporting the initial observation that 
it is a Δrif1 Δvts1 combination specific effect. 
As VTS1 encodes a translation repressor, it cannot be ruled out that the observed phenotype is a 
result of a misregulation of specific mRNAs. In a recent publication, a set of 79 mRNAs were 
shown to be bound and regulated by Vts1p (Aviv et al., 2006). Of these, several were cell cycle 
related, such as CLN1, a cyclin, PHO85, a cyclin dependent kinase and 6 other cell cycle, spindle 
orientation and polarization related genes. The most relevant could be NNF1 (Shan et al., 1997), 
which has been shown to be involved in chromosomal segregation and kinetochore attachment, 
nuclear envelope integrity and other cell cycle regulated processes. It is therefore conceivable that 
this defect observed for Δrif1 Δvts1 is an underlying effect due solely to VTS1 disruption that the 
 additional RIF1 disruption brings into the spotlight. 
 
8.16 Can VTS1 encode also a shuttling protein, with a translation repressor function 
in the cytoplasm and another function in the nucleus? 
Some proteins can move in and out of the nucleus and are thus called shuttling proteins. She2p and 
Khd1p are two examples (Kruse et al., 2002; Du et al., 2008) that have already been discussed in 
previous sections. They can be trapped in the nucleus in an mRNA dependent manner, by use of a 
temperature sensitive allele of an mRNA nuclear export factor, MEX67 (Segref et al., 1999). Using 
the same tool and the same set up, Vts1p was shown not to accumulate in the nucleus in an mRNA 
dependent manner. The fact that it does not accumulate in the nucleus in an mRNA dependent 
manner does not mean altogether that it does not shuttle. In fact, other protein factors such as 
karyopherins (reviewed in Koehler and Hurt, 2007) are involved in the import and export of 
proteins and further experiments with these mutants would eventually show whether Vts1p is a 
shuttling protein. 
 
8.17 Is the phenotype observed related to telomeric length regulation? 
Rif1p is a part of the RIF complex that interacts with Rap1p (Wotton et al., 1997). Δrif1 causes an 
elongated telomere, due to loss of negative length regulation. The fact that Δrif1 Δvts1 shows a total 
loss of the subtelomeric region whereas a Δrif2 Δvts1 does not, further strengthens the model that it 
is Δrif1 Δvts1 specific observation. The recent observation that SMG1 deletion causes telomeric 
instability and can lead to telomere loss (Azzalin et al., 2006) strengthens the hypothesis that the 
same is true for the Δrif1 Δvts1 double mutant analysed. The observations presented above, 
hydroxyurea sensitivity, mitotic spindle misorientation and tribudded cells, point also to a 
ribonucleotide reductase defect and it would be interesting to determine whether the telomeric 
instability observed for Δrif1 Δvts1 can be linked to this enzymatic defect. 
 
In summary 
• Δrif1 Δvts1 cells show telomeric gene transcriptional desilencing and temperature 
sensitivity. 
• Δrif1 Δvts1 cells are sensitive to hydorxyurea and exhibit abnormal cell cycle 
progression, both evidenced by the FACS analysis results – increase of DNA content – 
and by the microscopic data – abnormal spindles and citokinesis defect.  
 • The Δrif1 Δvts1 cells analysed suffered telomeric catastrophy, as seen by the southern 
blot results. 
• All these observations were made only for Δrif1 Δvts1 and not for Δrif2 Δvts1, indicating 
a specific deffect associated to Δrif1 Δvts1 cells, independently of RIF2 function. 
• This is the first indication of a process where Rif1p and Rif2p do not act together.   
Although on the one hand the connection between Δrif1 Δvts1 and cell cycle progression is 
extremely interesting, on the other hand the possibility that it all might be due to a misregulation of 
mRNAs due to VTS1 disruption, makes it difficult to analyse. It would be interesting to see if any of 
the identified mRNAs bound by Vts1p (Aviv et al., 2006) rescues, either by over-expression or by 
deletion, the cytokinesis defect and/or the spindle orientation defect. Telomere checkpoint defects 
can also be associated to lagging and bridging chromosomes, as seen for spindle orientation 
mutants, which adds in complexity (Musaro et al., 2008; Lazzaro et al., 2008; Review in Viscardi et 
al., 2005). 
As Smaug is an extremely conserved translational repressor, the fact that a whole new field of study 
on Smaug function can now be available can be of a crucial importance and might bring several 
important hints in cell cycle control related to translation repression. 
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 10. Summary 
 
ASH1 mRNA translation has been shown to be required for efficient anchoring of ASH1 mRNA to 
the bud-tip during the process of mRNA localization. 
Khd1p, a 3-KH domain containing protein, has been shown to be involved in ASH1 mRNA 
localization and has been proposed to be a translation repressor (Irie et al., 2002). This thesis 
focuses on the role of Khd1p in ASH1 mRNP architecture, specially in its relationship to other 
members of the locasome. Results presented show that Khd1p is a part of an RNA-independent 
protein complex that includes She3p and She2p, indicating Khd1p is a part of the locasome via 
protein-protein interactions. Furthermore, the observation that Khd1p and She3p interact 
independently of She2p indicates that another protein complex exists and that this complex could be 
another cargo for the SHE mRNA localization machinery. On the other hand, results presented in 
this work show that Khd1p floats with ER membranes, as observed for She2p (Schmid et al., 2006) 
indicating that Khd1p is also implicated in ER-associated. The fact that Khd1p floats independently 
of She2p indicates that it might be involved in ER inheritance, via a direct binding to She3p. During 
the course of this work, it was shown that Khd1p is phosphorylated by Yck1p at the cellular 
periphery and upon phosphorylation, Khd1p releases the ASH1 mRNA translation block (Paquin et 
al., 2007) thus proving the model for Khd1p function in translation repression during ASH1 mRNA 
transport and localization. 
 
Khd1p, an hnRNP K homolog, has also been shown to play a role in telomeric silencing and be 
bound to subtelomeric chromatin (Denisenko et al., 2002). This thesis addresses how Khd1p, an 
mRNA binding protein, can also play a role in this process. Results presented show that Khd1p 
contributes to telomericgene transcriptional silencing. Associated to loss of KHD1 I found that 
Sir2p levels are downregulated, leading to loss of silencing in mutants known to be silenced (e.g. 
RPD3 – Rundlett et al., 1996). This loss of silencing could be partially rescued with wildtype copies 
of SIR2. 
Results presented in this work suggest that KHD1 is also involved in binding to the telomerase 
RNA subunit, TLC1 or even in its biogenesis. 
In addition, a loss of KHD1 also led to increased sensitivity to DNA damaging agents (UV and 
MMS) of rad52 and xrs2 null mutants. Results presented show that KHD1 contributes to NHEJ 
DNA repair efficiency and that this loss of NHEJ efficiency can be rescued with a wildtype copy of 
KHD1. In addition, a point mutant I183R, cannot rescue this NHEJ defect, thus implying that this 
 residue or the folding of this KH domain is essential for NHEJ function. 
Results presented in this thesis establish Khd1p as a putative new cargo for the SHE machinery and 
also as an ER associated protein. Furthermore, results presented here also establish Khd1p as a 
regulator of gene transcriptional telomeric silencing, associated to a downregulation of Sir2p. In 
addition, we show that Khd1p contributes to NHEJ DNA repair, indicating a much wider action 
than just in mRNA localization. 
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